Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,A1BG,Alpha-1B-glycoprotein,1541,59,24.18 [5.07-115.35],6.437167753542228e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AAMDC,Mth938 domain-containing protein,1483,60,0.85 [0.53-1.35],0.4834990373759196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,1737,71,1.01 [0.69-1.47],0.9613323937930688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABCA2,ATP-binding cassette sub-family A member 2,1485,57,1.81 [0.98-3.36],0.0600475139130486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABHD14B,Protein ABHD14B,1722,71,1.07 [0.74-1.55],0.7093213467774482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABL1,Tyrosine-protein kinase ABL1,1737,71,1.04 [0.78-1.40],0.7783848245524045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABO,Histo-blood group ABO system transferase,1537,60,0.95 [0.80-1.13],0.5832859671493511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABRAXAS2,BRISC complex subunit Abraxas 2,1485,57,0.95 [0.64-1.41],0.8080380221344479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",1685,69,1.21 [0.97-1.50],0.086287602355967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",1504,59,1.09 [0.75-1.59],0.6372534597723107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",1532,60,0.71 [0.53-0.96],0.0236618476759888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACAN,Aggrecan core protein,1732,72,0.81 [0.40-1.64],0.5635226282888415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE,Angiotensin-converting enzyme,1537,60,1.49 [0.60-3.72],0.3907030405440567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE2,Angiotensin-converting enzyme 2,1715,70,1.11 [0.82-1.51],0.4823628608184307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACHE,Acetylcholinesterase,1502,60,1.58 [0.87-2.88],0.1363522258438114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACOT13,Acyl-coenzyme A thioesterase 13,1522,57,0.85 [0.68-1.05],0.137224814299688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,1750,72,1.00 [0.66-1.49],0.9820206675328972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,1481,58,0.66 [0.36-1.21],0.1826295725164239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP5,Tartrate-resistant acid phosphatase type 5,1765,72,1.87 [1.05-3.34],0.0333729985828937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP6,Lysophosphatidic acid phosphatase type 6,1764,73,1.07 [0.76-1.49],0.7044936845781691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACRBP,Acrosin-binding protein,1526,59,0.84 [0.44-1.63],0.6111415767885431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACRV1,Acrosomal protein SP-10,1481,58,1.44 [1.14-1.82],0.0022793004192888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,1485,57,0.40 [0.16-1.03],0.0581684793471786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTA2,"Actin, aortic smooth muscle",1715,70,2.12 [1.52-2.96],8.846854129885558e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTN2,Alpha-actinin-2,1485,57,1.21 [0.83-1.76],0.3261108846557221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTN4,Alpha-actinin-4,1710,70,1.23 [0.61-2.49],0.5628371085446875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACVRL1,Serine/threonine-protein kinase receptor R3,1725,71,4.42 [2.43-8.04],1.1943097974133423e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACY1,Aminoacylase-1,1750,72,1.07 [0.81-1.41],0.6299308490370724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,1485,57,1.31 [0.89-1.94],0.1699217803362651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACYP1,Acylphosphatase-1,1496,59,0.86 [0.59-1.25],0.4295829296620465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA,Adenosine deaminase,1775,73,1.33 [0.76-2.35],0.3184398582812469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA2,Adenosine deaminase 2,1749,71,3.10 [2.06-4.65],5.56935512193392e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,1481,58,2.24 [1.28-3.92],0.0047142918604231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,1715,70,1.30 [0.68-2.51],0.4269665118547134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,1731,71,2.03 [1.15-3.57],0.0144649396270214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,1775,73,1.55 [0.83-2.88],0.1668973595476972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,1756,71,1.23 [0.61-2.51],0.5637839153437402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,1522,57,3.21 [1.86-5.54],2.904478569781504e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,1481,58,1.92 [0.98-3.74],0.056541621577143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,1773,72,1.51 [0.67-3.38],0.3190217846500016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,1737,71,1.53 [0.94-2.48],0.0884148440897681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,1715,70,1.22 [0.66-2.28],0.5261549928222788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,1481,58,2.11 [1.20-3.72],0.0097529898019927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,1749,73,0.77 [0.51-1.16],0.2085973862201992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL2,ADAMTS-like protein 2,1536,59,1.99 [1.20-3.30],0.0080141362434271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL4,ADAMTS-like protein 4,1483,60,2.20 [0.83-5.84],0.1140767321943118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL5,ADAMTS-like protein 5,1532,60,0.73 [0.39-1.36],0.3184228458388435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,1685,69,1.39 [0.88-2.19],0.1599751346419748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADD1,Alpha-adducin,1502,60,0.77 [0.54-1.10],0.1521574800682978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRB3,Adhesion G protein-coupled receptor B3,1725,71,2.83 [1.57-5.09],0.0005073164335698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRD1,Adhesion G-protein coupled receptor D1,1502,60,2.75 [1.69-4.47],4.933985309246608e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE1,Adhesion G protein-coupled receptor E1,1522,57,1.31 [0.86-2.00],0.2136391029987308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE2,Adhesion G protein-coupled receptor E2,1752,71,4.23 [2.28-7.85],4.8560052908583824e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE5,Adhesion G protein-coupled receptor E5,1769,72,2.55 [1.45-4.48],0.001122799545641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRF5,Adhesion G protein-coupled receptor F5,1532,60,3.55 [1.44-8.76],0.0058884047304504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG1,Adhesion G-protein coupled receptor G1,1737,71,1.52 [1.28-1.80],1.8763148813429048e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG2,Adhesion G-protein coupled receptor G2,1750,72,0.34 [0.18-0.65],0.0011544574820333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRV1,Adhesion G-protein coupled receptor V1,1478,58,0.71 [0.44-1.15],0.1640832123414535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH1B,All-trans-retinol dehydrogenase,1502,60,1.00 [0.77-1.30],0.997423823215777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,1715,70,0.83 [0.65-1.05],0.1182574150580855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADIPOQ,Adiponectin,1541,59,0.94 [0.67-1.33],0.734581471810207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADM,Pro-adrenomedullin,1767,73,4.53 [2.22-9.23],3.263970064739781e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADRA2A,Alpha-2A adrenergic receptor,1485,57,0.75 [0.48-1.19],0.2267904003340388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFAP1,Actin filament-associated protein 1,1502,60,0.95 [0.71-1.27],0.7367811910623415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFM,Afamin,1541,59,0.84 [0.30-2.39],0.7465649399223067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFP,Alpha-fetoprotein,1724,71,0.83 [0.59-1.17],0.2808981421021198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGBL2,Cytosolic carboxypeptidase 2,1478,58,1.19 [0.95-1.49],0.1218861456146775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGER,Advanced glycosylation end product-specific receptor,1743,71,1.68 [1.04-2.71],0.0325597963389621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR2,Anterior gradient protein 2 homolog,1674,69,1.62 [1.31-2.00],9.791843093710104e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR3,Anterior gradient protein 3,1683,69,1.36 [0.96-1.92],0.0850629906637247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRN,Agrin,1752,71,2.38 [1.63-3.50],8.723452782129411e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRP,Agouti-related protein,1775,73,1.82 [1.22-2.73],0.003432900712843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGT,Angiotensinogen,1537,60,0.65 [0.20-2.11],0.4749654952935678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGXT,Serine--pyruvate aminotransferase,1750,72,1.09 [0.86-1.38],0.4900617484863934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHCY,Adenosylhomocysteinase,1750,72,1.01 [0.75-1.36],0.9418352188593108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,1483,60,1.07 [0.51-2.22],0.8665389121426466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHNAK2,Protein AHNAK2,1483,60,1.06 [0.45-2.49],0.8946426325056231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,1526,59,0.67 [0.41-1.09],0.10507232638018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSG,Alpha-2-HS-glycoprotein,1537,60,1.96 [0.79-4.87],0.1463435302420254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSP,Alpha-hemoglobin-stabilizing protein,1752,72,0.97 [0.76-1.24],0.7957451658163126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIDA,"Axin interactor, dorsalization-associated protein",1489,57,0.90 [0.65-1.24],0.507119057424735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIF1,Allograft inflammatory factor 1,1685,69,1.16 [0.78-1.72],0.4747201866309448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIF1L,Allograft inflammatory factor 1-like,1483,60,0.97 [0.60-1.56],0.8916376568461929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",1733,71,0.99 [0.82-1.21],0.9455032029257092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AK1,Adenylate kinase isoenzyme 1,1750,72,0.84 [0.60-1.17],0.294148372404704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AK2,"Adenylate kinase 2, mitochondrial",1517,58,0.86 [0.68-1.09],0.2044579647855817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKAP12,A-kinase anchor protein 12,1502,60,1.05 [0.31-3.51],0.9414786289321774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1B1,Aldo-keto reductase family 1 member B1,1685,69,1.14 [0.87-1.51],0.3478556521171512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1B10,Aldo-keto reductase family 1 member B10,1489,57,1.16 [0.88-1.52],0.286277821818628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1C4,Aldo-keto reductase family 1 member C4,1715,70,0.93 [0.59-1.47],0.7701528723202332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,1481,58,1.16 [0.85-1.58],0.3403479149468672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT1S1,Proline-rich AKT1 substrate 1,1687,70,0.96 [0.70-1.31],0.7812795135562125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT2,RAC-beta serine/threonine-protein kinase,1532,59,0.89 [0.74-1.07],0.2105047103614969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT3,RAC-gamma serine/threonine-protein kinase,1672,69,1.10 [0.77-1.58],0.5922518848491629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALCAM,CD166 antigen,1773,72,3.19 [1.31-7.78],0.0106984938124949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH1A1,Retinal dehydrogenase 1,1756,72,0.95 [0.69-1.30],0.7374383900719375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",1526,59,1.27 [0.89-1.80],0.1853865506851424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",1745,72,1.00 [0.79-1.27],0.9845204452799928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",1532,59,0.75 [0.44-1.27],0.2856362932598626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALMS1,Alstrom syndrome protein 1,1504,59,1.50 [0.92-2.44],0.1083313330587212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALPI,Intestinal-type alkaline phosphatase,1481,58,1.05 [0.87-1.27],0.6164631877281905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALPP,"Alkaline phosphatase, placental type",1737,71,1.08 [0.90-1.30],0.3979850615739334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBN,Ameloblastin,1710,70,0.32 [0.12-0.85],0.0215639363719289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBP,Protein AMBP,1764,73,9.49 [4.11-21.94],1.405378315981943e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,1536,59,1.25 [0.44-3.54],0.6682286104051243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMFR,E3 ubiquitin-protein ligase AMFR,1687,70,0.98 [0.67-1.41],0.8958128586994231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMIGO1,Amphoterin-induced protein 1,1489,57,0.70 [0.39-1.27],0.2396311066564816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMIGO2,Amphoterin-induced protein 2,1737,71,2.75 [1.13-6.68],0.0257966432941869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMN,Protein amnionless,1710,70,1.16 [0.76-1.78],0.4822339409869806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMOT,Angiomotin,1502,60,1.21 [0.67-2.19],0.5297203592630535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMOTL2,Angiomotin-like protein 2,1523,59,0.91 [0.56-1.49],0.7186086984847943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMPD3,AMP deaminase 3,1517,58,1.23 [0.88-1.74],0.2299413651318414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,1431,55,0.67 [0.40-1.13],0.1341760435078306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY2A,Pancreatic alpha-amylase,1674,69,0.88 [0.59-1.33],0.5512124311462517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY2B,Alpha-amylase 2B,1621,64,0.88 [0.57-1.34],0.5380487146155413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANG,Angiogenin,1754,71,2.25 [1.33-3.83],0.0026774007138691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT1,Angiopoietin-1,1739,71,1.19 [0.93-1.53],0.16181296354701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT2,Angiopoietin-2,1767,73,3.11 [1.95-4.95],1.708750405715394e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL1,Angiopoietin-related protein 1,1722,69,1.65 [0.84-3.28],0.1485436662821559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL2,Angiopoietin-related protein 2,1744,70,1.17 [0.71-1.91],0.5363534732341794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL3,Angiopoietin-related protein 3,1756,71,0.99 [0.57-1.72],0.9763250714959656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL4,Angiopoietin-related protein 4,1750,71,2.67 [1.71-4.15],1.438943350483712e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL7,Angiopoietin-related protein 7,1767,73,2.11 [1.38-3.22],0.0005588681662649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANK2,Ankyrin-2,1485,57,1.07 [0.76-1.52],0.6902727997297287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,1481,58,0.83 [0.61-1.12],0.2257483100358134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKRA2,Ankyrin repeat family A protein 2,1473,59,0.86 [0.56-1.33],0.5029602395058982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKRD54,Ankyrin repeat domain-containing protein 54,1685,69,0.97 [0.67-1.40],0.8577415219891645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,1483,60,1.02 [0.53-1.96],0.948058892593944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANPEP,Aminopeptidase N,1757,72,1.52 [0.77-3.00],0.2266304201656742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA1,Annexin A1,1493,59,1.18 [0.76-1.82],0.4649353240989473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA10,Annexin A10,1687,70,1.30 [1.04-1.64],0.0231166564263563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA11,Annexin A11,1747,72,0.83 [0.63-1.10],0.1983117802307893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA2,Annexin A2,1463,58,0.95 [0.65-1.37],0.7635375889249392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA3,Annexin A3,1756,71,1.02 [0.76-1.36],0.8955352988344167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA4,Annexin A4,1739,71,0.93 [0.71-1.24],0.6309558608640867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA5,Annexin A5,1680,70,3.04 [1.72-5.36],0.0001273890028511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],1710,70,0.98 [0.66-1.47],0.9303893712319204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC3,Membrane primary amine oxidase,1760,72,4.90 [2.69-8.92],2.032872040123149e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP1G2,AP-1 complex subunit gamma-like 2,1526,59,0.84 [0.62-1.14],0.2760820360897708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP2B1,AP-2 complex subunit beta,1489,57,0.82 [0.48-1.39],0.4594270322900513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP3B1,AP-3 complex subunit beta-1,1522,57,0.91 [0.66-1.27],0.5919230940459714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP3S2,AP-3 complex subunit sigma-2,1517,58,0.76 [0.45-1.29],0.3102698467747398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,1737,71,1.47 [1.00-2.16],0.0508508791635761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APCS,Serum amyloid P-component,1525,58,0.98 [0.47-2.04],0.9518064459336494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,1763,73,1.20 [0.86-1.68],0.2903823274466781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APLP1,Amyloid-like protein 1,1750,72,0.67 [0.45-1.00],0.0478818753738518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA1,Apolipoprotein A-I,1541,59,1.51 [0.61-3.75],0.3758087062839013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA2,Apolipoprotein A-II,1537,60,1.34 [0.85-2.13],0.2113616208308801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA4,Apolipoprotein A-IV,1541,59,2.23 [1.27-3.90],0.0050663515595434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOB,Apolipoprotein B-100,1537,60,0.65 [0.23-1.86],0.42164347157077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOBR,Apolipoprotein B receptor,1483,60,0.73 [0.42-1.27],0.2673819532322408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOC1,Apolipoprotein C-I,1535,58,0.55 [0.28-1.08],0.0807772005301596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOD,Apolipoprotein D,1486,54,0.45 [0.19-1.06],0.0690391400442166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOE,Apolipoprotein E,1541,59,1.01 [0.65-1.57],0.9591426661500502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOF,Apolipoprotein F,1537,60,0.96 [0.49-1.89],0.8999838177000574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOH,Beta-2-glycoprotein 1,1756,72,1.37 [0.79-2.39],0.2647908977600308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOL1,Apolipoprotein L1,1537,60,0.70 [0.43-1.14],0.1501365909125844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOM,Apolipoprotein M,1760,72,0.84 [0.41-1.71],0.6284453278310431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APP,Amyloid-beta precursor protein,1755,71,1.33 [0.99-1.80],0.0581297643723161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APPL2,DCC-interacting protein 13-beta,1502,60,0.93 [0.75-1.15],0.5139733318793716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APRT,Adenine phosphoribosyltransferase,1730,71,0.92 [0.59-1.43],0.7107355273192022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARAF,Serine/threonine-protein kinase A-Raf,1504,59,0.88 [0.60-1.27],0.4850025523733914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AREG,Amphiregulin,1737,71,2.51 [1.79-3.53],1.0346277895699557e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARF6,ADP-ribosylation factor 6,1522,57,0.89 [0.71-1.11],0.3075291035586746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARFIP1,Arfaptin-1,1532,59,0.99 [0.69-1.40],0.9332997384546312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARG1,Arginase-1,1746,72,0.84 [0.56-1.24],0.3713280967776988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARG2,"Arginase-2, mitochondrial",1526,59,1.12 [0.66-1.90],0.6792371533813394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP1,Rho GTPase-activating protein 1,1685,69,0.68 [0.42-1.08],0.1022465038145734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP25,Rho GTPase-activating protein 25,1685,69,1.01 [0.71-1.43],0.9621521209838364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP30,Rho GTPase-activating protein 30,1504,59,0.99 [0.53-1.83],0.9638974812999804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP45,Rho GTPase-activating protein 45,1502,60,0.88 [0.66-1.18],0.3946821391914253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP5,Rho GTPase-activating protein 5,1473,59,1.04 [0.74-1.45],0.8205984851188066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,1517,58,0.95 [0.71-1.26],0.7124242427332539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,1532,59,0.90 [0.70-1.16],0.4327169056747834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,1749,72,0.96 [0.78-1.16],0.6500137506513878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,1478,58,1.24 [0.92-1.67],0.1610983951663344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARID3A,AT-rich interactive domain-containing protein 3A,1478,58,0.72 [0.35-1.46],0.3601271379422878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARID4B,AT-rich interactive domain-containing protein 4B,1687,70,1.02 [0.62-1.68],0.9239169856527348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARL13B,ADP-ribosylation factor-like protein 13B,1485,57,0.89 [0.61-1.29],0.5301899628853453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,1485,57,0.76 [0.41-1.42],0.3942343253913607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,1478,58,1.08 [0.72-1.62],0.718297785328933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,1710,70,1.36 [1.00-1.84],0.0470303578154872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,1485,57,0.89 [0.49-1.61],0.6892945604270415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARSA,Arylsulfatase A,1756,72,0.91 [0.58-1.43],0.6955072727839036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARSB,Arylsulfatase B,1737,71,1.00 [0.69-1.44],0.9942585444256212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART3,Ecto-ADP-ribosyltransferase 3,1760,72,1.78 [1.07-2.97],0.0271578490331216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART5,Ecto-ADP-ribosyltransferase 5,1478,58,1.20 [0.86-1.67],0.2809856079279238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARTN,Artemin,1710,70,1.37 [0.92-2.04],0.1230171533100452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASAH1,Acid ceramidase,1528,59,0.90 [0.52-1.56],0.7107385140788474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASAH2,Neutral ceramidase,1731,71,1.05 [0.72-1.54],0.7884153349070749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR1,Asialoglycoprotein receptor 1,1731,71,2.86 [1.80-4.52],7.503914060510691e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR2,Asialoglycoprotein receptor 2,1537,60,3.03 [1.39-6.61],0.0052395406069846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPN,Asporin,1532,60,2.48 [1.29-4.75],0.0063085181177921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPSCR1,Tether containing UBX domain for GLUT4,1532,59,0.90 [0.62-1.30],0.5644044242510317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,1483,60,0.89 [0.70-1.13],0.3422195229670892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASS1,Argininosuccinate synthase,1485,57,1.04 [0.78-1.39],0.7854331698578103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,1687,70,1.19 [0.94-1.51],0.1407998549042939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,1473,59,0.50 [0.21-1.22],0.1281216253902345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATG16L1,Autophagy-related protein 16-1,1522,57,0.98 [0.74-1.32],0.918942949631674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATG4A,Cysteine protease ATG4A,1685,69,0.95 [0.67-1.37],0.8010716289356435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATOX1,Copper transport protein ATOX1,1749,73,1.17 [0.87-1.57],0.2942836310602461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,1485,57,0.50 [0.24-1.05],0.0661861788373097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,1485,57,1.29 [0.69-2.40],0.4189934297978713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,1485,57,1.33 [0.76-2.34],0.3125549761069783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B4,Protein ATP1B4,1473,59,0.79 [0.41-1.55],0.4981301071945211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,1485,57,0.81 [0.50-1.31],0.38606913281105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",1485,57,1.01 [0.63-1.63],0.9506658216921692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5IF1,"ATPase inhibitor, mitochondrial",1752,71,1.01 [0.84-1.22],0.8847996030257693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5PO,"ATP synthase subunit O, mitochondrial",1687,70,1.29 [0.81-2.05],0.2872545510317638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6AP2,Renin receptor,1685,69,1.42 [0.92-2.18],0.1133059205940948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1D,V-type proton ATPase subunit D,1737,71,1.85 [1.08-3.16],0.0241575490151289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1F,V-type proton ATPase subunit F,1681,70,1.13 [0.84-1.52],0.4087548120683423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1G1,V-type proton ATPase subunit G 1,1483,60,0.87 [0.62-1.22],0.4243394788109204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1G2,V-type proton ATPase subunit G 2,1485,57,1.09 [0.83-1.44],0.5441511341914179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRAID,All-trans retinoic acid-induced differentiation factor,1522,57,2.53 [1.46-4.37],0.0009124236784943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRN,"Attractin, Isoform 2",1541,59,7.07 [1.57-31.87],0.0108716846585044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN10,Ataxin-10,1687,70,0.95 [0.73-1.24],0.7071470329101923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN2,Ataxin-2,1478,58,1.11 [0.92-1.35],0.2877662656486379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN2L,Ataxin-2-like protein,1532,59,0.72 [0.42-1.24],0.2423152487427808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN3,Ataxin-3,1517,58,0.94 [0.63-1.41],0.7706821357210086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AXIN1,Axin-1,1749,72,0.92 [0.75-1.14],0.4476896857810596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AXL,Tyrosine-protein kinase receptor UFO,1760,72,1.45 [0.71-2.99],0.3082728350932369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AZI2,5-azacytidine-induced protein 2,1532,59,0.85 [0.55-1.32],0.4679223439769788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AZU1,Azurocidin,1707,71,1.06 [0.83-1.36],0.6203998578949175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B2M,Beta-2-microglobulin,1541,59,2.75 [1.61-4.71],0.0002072686014986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,1485,57,0.28 [0.08-0.94],0.0387197906762532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",1483,60,5.59 [2.85-10.97],5.336077816638777e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",1752,71,2.98 [1.57-5.67],0.0008564540793795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",1756,72,2.13 [0.91-4.98],0.0810241473516487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BABAM1,BRISC and BRCA1-A complex member 1,1481,58,0.50 [0.19-1.37],0.1793423796130095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BACH1,Transcription regulator protein BACH1,1749,72,1.02 [0.77-1.34],0.9008881080207304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG3,BAG family molecular chaperone regulator 3,1725,71,1.10 [0.65-1.84],0.7273086539399578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG4,BAG family molecular chaperone regulator 4,1481,58,0.83 [0.49-1.38],0.4637934362729899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG6,Large proline-rich protein BAG6,1715,70,1.00 [0.57-1.74],0.9966196507853876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,1685,69,1.47 [1.15-1.90],0.0024649838402191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,1685,69,2.57 [1.69-3.91],1.1023918479885792e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BANK1,B-cell scaffold protein with ankyrin repeats,1749,72,0.98 [0.81-1.19],0.8581383138596083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAP18,Chromatin complexes subunit BAP18,1517,58,1.03 [0.74-1.44],0.8612581973562075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BATF,Basic leucine zipper transcriptional factor ATF-like,1489,57,0.89 [0.62-1.29],0.546708602699471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAX,Apoptosis regulator BAX,1685,70,1.02 [0.81-1.28],0.8839053787574196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAM,Basal cell adhesion molecule,1756,72,3.44 [1.59-7.45],0.0016965615925274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAN,Brevican core protein,1731,71,0.65 [0.37-1.14],0.1367811594765424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",1532,60,0.65 [0.29-1.43],0.2840818309821188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",1478,58,0.94 [0.58-1.52],0.7877374270773073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCHE,Cholinesterase,1511,58,1.14 [0.46-2.80],0.7744283047065055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2,Apoptosis regulator Bcl-2,1522,57,1.18 [0.75-1.86],0.4633240260908332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L1,Bcl-2-like protein 1,1517,58,0.89 [0.70-1.15],0.3752325393394738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",1749,72,3.36 [1.84-6.14],8.238795581775296e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L15,Bcl-2-like protein 15,1481,58,1.30 [0.92-1.83],0.1380026572214678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,1473,59,0.70 [0.44-1.12],0.1418527567586814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,1526,59,0.72 [0.38-1.37],0.3232569114287696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCR,Breakpoint cluster region protein,1749,72,1.01 [0.81-1.26],0.9372796848177096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BDNF,Brain-derived neurotrophic factor,1536,59,1.37 [1.00-1.86],0.0471632921655311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BECN1,Beclin-1,1483,60,0.88 [0.58-1.33],0.5352296679708626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BEX3,Protein BEX3,1473,59,0.70 [0.36-1.35],0.2818354088426744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BGLAP,Osteocalcin,1536,59,0.89 [0.69-1.15],0.3798416009561439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BGN,Biglycan,1682,69,0.99 [0.83-1.19],0.9351830168324436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BHLHE40,Class E basic helix-loop-helix protein 40,1478,58,0.90 [0.60-1.37],0.6332005023755194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,1485,57,0.66 [0.23-1.88],0.4309503296891209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BID,BH3-interacting domain death agonist,1749,72,0.95 [0.70-1.28],0.7254163786662668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BIN2,Bridging integrator 2,1756,72,0.94 [0.75-1.19],0.6103021583732631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BIRC2,Baculoviral IAP repeat-containing protein 2,1685,69,0.95 [0.68-1.32],0.7423137464732025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLMH,Bleomycin hydrolase,1773,72,1.01 [0.54-1.88],0.9830140300309078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLNK,B-cell linker protein,1481,58,0.66 [0.32-1.35],0.2506998714609917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,1478,58,0.66 [0.45-0.97],0.0357147922650377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,1517,58,0.90 [0.50-1.61],0.7225641845048156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLVRB,Flavin reductase,1756,72,0.94 [0.69-1.28],0.6823234044480676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP10,Bone morphogenetic protein 10,1502,60,2.35 [0.98-5.63],0.0547377282030729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP4,Bone morphogenetic protein 4,1725,71,1.09 [0.71-1.65],0.6981835142773725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP6,Bone morphogenetic protein 6,1714,70,1.76 [1.06-2.94],0.0294426647462014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMPER,BMP-binding endothelial regulator protein,1502,60,3.94 [1.56-9.95],0.0037783305898791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,1532,60,0.53 [0.24-1.13],0.1013073372854592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,1481,58,1.15 [0.70-1.91],0.5759126819723038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOC,Brother of CDO,1715,70,3.10 [1.25-7.73],0.0149789594435621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOLA1,BolA-like protein 1,1478,58,0.90 [0.56-1.45],0.6688185030309214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOLA2_BOLA2B,BolA-like protein 2,1483,60,0.77 [0.48-1.22],0.263559370952813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFA2,BPI fold-containing family A member 2,1444,59,0.82 [0.65-1.03],0.0859441214690684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFB1,BPI fold-containing family B member 1,1749,71,0.94 [0.69-1.28],0.6829107609776834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFB2,BPI fold-containing family B member 2,1531,60,0.90 [0.65-1.26],0.5505818740954049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRAP,BRCA1-associated protein,1505,57,1.01 [0.81-1.27],0.9117398458433494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD1,Bromodomain-containing protein 1,1504,59,0.82 [0.35-1.92],0.650302338619962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD2,Bromodomain-containing protein 2,1478,58,0.32 [0.12-0.85],0.0220026276671527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD3,Bromodomain-containing protein 3,1485,57,0.66 [0.33-1.30],0.2279429862357304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRDT,Bromodomain testis-specific protein,1485,57,0.84 [0.42-1.69],0.6205535617974112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRK1,Protein BRICK1,1687,70,0.73 [0.46-1.16],0.1854040704342488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRME1,Break repair meiotic recombinase recruitment factor 1,1478,58,1.10 [0.59-2.06],0.7576767320694835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRSK2,Serine/threonine-protein kinase BRSK2,1532,59,1.09 [0.59-2.03],0.7737708748068775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSG,Basigin,1772,73,4.45 [2.14-9.25],6.41492879895772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSND,Barttin,1473,59,1.57 [0.92-2.67],0.0969745090242643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,1759,71,3.94 [1.84-8.41],0.0004023456045802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST2,Bone marrow stromal antigen 2,1759,71,1.34 [1.00-1.79],0.0497087416721829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTC,Probetacellulin,1685,69,1.13 [0.85-1.51],0.389962677825393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTD,Biotinidase,1541,59,5.14 [1.50-17.60],0.0091505994460739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTLA,B- and T-lymphocyte attenuator,1473,59,1.04 [0.79-1.36],0.7869830531281319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN1A1,Butyrophilin subfamily 1 member A1,1523,59,1.08 [0.63-1.85],0.7748556757889342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN2A1,Butyrophilin subfamily 2 member A1,1752,71,4.64 [2.80-7.71],2.9540678515091352e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN3A2,Butyrophilin subfamily 3 member A2,1749,72,3.07 [1.83-5.14],2.1640108735947505e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTNL10,Butyrophilin-like protein 10,1473,59,0.39 [0.15-0.96],0.0412457359408516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C19orf12,Protein C19orf12,1687,70,1.07 [0.85-1.35],0.5777719979080902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1GALT1C1,C1GALT1-specific chaperone 1,1485,57,2.13 [1.15-3.95],0.016379960838281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QA,Complement C1q subcomponent subunit A,1764,73,1.47 [0.61-3.55],0.3964018562427105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",1532,59,0.87 [0.54-1.38],0.5435126028583411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QL2,Complement C1q-like protein 2,1481,58,0.62 [0.34-1.16],0.1352843664909663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,1760,72,2.36 [1.54-3.62],7.827579981549991e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,1502,60,0.86 [0.45-1.65],0.6512017201493115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,1532,59,1.18 [0.54-2.58],0.6808997820636881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,1499,60,1.36 [0.80-2.31],0.2618860661227677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1R,Complement C1r subcomponent,1541,59,0.77 [0.18-3.34],0.7252080250930991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1RL,Complement C1r subcomponent-like protein,1537,59,1.84 [0.53-6.37],0.3390364286231019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1S,Complement C1s subcomponent,1541,59,1.28 [0.41-3.98],0.6677084568682795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2,Complement C2,1760,72,5.54 [1.99-15.44],0.0010654715167822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2CD2L,Phospholipid transfer protein C2CD2L,1681,70,1.25 [0.76-2.07],0.3839203255258293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2orf69,UPF0565 protein C2orf69,1489,57,0.59 [0.33-1.03],0.0650620517442402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C3,Complement C3,1458,57,0.88 [0.48-1.60],0.6753211986814709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C4BPB,C4b-binding protein beta chain,1749,73,0.89 [0.55-1.45],0.6506643219638149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C5,Complement C5,1541,59,2.63 [0.60-11.53],0.1989003519342462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7,Complement component C7,1501,57,3.75 [2.06-6.83],1.56560846784395e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7orf50,Uncharacterized protein C7orf50,1517,58,1.13 [0.46-2.75],0.7883400181461165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C8B,Complement component C8 beta chain,1541,59,2.45 [1.21-4.97],0.0129289314687583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C9,Complement component C9,1537,60,0.93 [0.64-1.35],0.69418078119471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C9orf40,Uncharacterized protein C9orf40,1522,57,0.84 [0.61-1.15],0.2745399940384517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA1,Carbonic anhydrase 1,1724,71,0.84 [0.60-1.19],0.3309701510346117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA11,Carbonic anhydrase-related protein 11,1685,69,1.51 [1.00-2.27],0.051211928017197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA12,Carbonic anhydrase 12,1737,71,3.32 [2.39-4.60],5.749473089582474e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA13,Carbonic anhydrase 13,1730,70,1.01 [0.83-1.23],0.9107395491111324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA14,Carbonic anhydrase 14,1767,73,1.37 [0.83-2.26],0.2205384991812829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA2,Carbonic anhydrase 2,1750,72,0.93 [0.70-1.25],0.6512392267342231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA3,Carbonic anhydrase 3,1770,72,1.15 [0.83-1.59],0.4071131694856306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA4,Carbonic anhydrase 4,1773,72,1.72 [0.77-3.84],0.1827088783326436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",1715,70,1.07 [0.88-1.30],0.4865752727929925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA6,Carbonic anhydrase 6,1749,71,0.72 [0.53-0.99],0.0412705604886109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA7,Carbonic anhydrase 7,1504,59,0.71 [0.29-1.72],0.4424679130081458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA8,Carbonic anhydrase-related protein,1481,58,0.45 [0.13-1.58],0.2111062023843397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA9,Carbonic anhydrase 9,1767,73,2.03 [1.49-2.78],8.335207664839759e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CABP2,Calcium-binding protein 2,1489,57,0.94 [0.63-1.38],0.7377043607427614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,1478,58,1.09 [0.46-2.56],0.8466657047583483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,1485,57,0.77 [0.44-1.36],0.375466995058092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,1478,58,0.88 [0.55-1.39],0.5755058264454842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,1532,59,0.83 [0.63-1.10],0.2049976043404237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACYBP,Calcyclin-binding protein,1498,59,0.88 [0.69-1.11],0.2710069869153354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CADPS,Calcium-dependent secretion activator 1,1489,57,0.86 [0.44-1.66],0.6464475723173343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB1,Calbindin,1737,71,1.75 [1.09-2.81],0.0209775186305026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB2,Calretinin,1687,70,3.46 [1.78-6.72],0.0002402710196341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCA,Calcitonin,1725,71,1.50 [1.17-1.94],0.0017155465771369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCB,Calcitonin gene-related peptide 2,1517,58,1.72 [1.18-2.50],0.0045168187341067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,1760,73,1.01 [0.83-1.23],0.8938353758523649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,1483,60,0.82 [0.59-1.14],0.247173794117747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALY,Neuron-specific vesicular protein calcyon,1485,57,0.62 [0.27-1.41],0.2507401631037317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,1685,69,1.20 [0.75-1.92],0.4435549508546562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,1489,57,1.08 [0.70-1.68],0.7213362302478032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,1532,59,0.89 [0.71-1.12],0.3096581307286721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CANT1,Soluble calcium-activated nucleotidase 1,1742,72,5.79 [2.19-15.33],0.0004069199223588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPG,Macrophage-capping protein,1740,73,1.19 [0.87-1.63],0.2874494730248496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPN3,Calpain-3,1526,59,0.79 [0.39-1.58],0.499526405255784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPS,Calcyphosin,1517,58,0.90 [0.66-1.21],0.4730483010074007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CARHSP1,Calcium-regulated heat-stable protein 1,1687,70,0.95 [0.63-1.44],0.819496168155229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASC3,Protein CASC3,1489,57,0.81 [0.45-1.44],0.4711571559311602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP1,Caspase-1,1687,70,1.10 [0.84-1.44],0.4926297080696652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP10,Caspase-10,1687,70,0.94 [0.70-1.26],0.6799665971943059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP2,Caspase-2,1749,72,0.93 [0.69-1.25],0.6264729313074475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP3,Caspase-3,1773,72,0.94 [0.75-1.18],0.6078275711368986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP4,Caspase-4,1504,59,0.99 [0.86-1.15],0.942520872478423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP7,Caspase-7,1517,58,0.97 [0.72-1.30],0.8466258047292468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP8,Caspase-8,1761,73,0.93 [0.67-1.28],0.6548086726276958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP9,Caspase-9,1481,58,0.91 [0.60-1.37],0.638009756063219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASQ2,Calsequestrin-2,1485,57,1.29 [0.82-2.01],0.26854735188629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAT,Catalase,1514,57,1.05 [0.67-1.65],0.8398979234926115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLIF,Cobalamin binding intrinsic factor,1750,72,1.68 [1.32-2.15],3.26862734331656e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN1,Cerebellin-1,1478,58,1.20 [0.96-1.51],0.1125177545197027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN4,Cerebellin-4,1767,73,0.59 [0.32-1.08],0.0886894827497744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBS,Cystathionine beta-synthase,1483,60,0.99 [0.66-1.49],0.9592990001131788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBX2,Chromobox protein homolog 2,1485,57,0.91 [0.45-1.85],0.8018172619623372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,1731,71,1.09 [0.83-1.43],0.5256314860299349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCAR2,Cell cycle and apoptosis regulator protein 2,1517,58,0.97 [0.60-1.58],0.9101361620214432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC134,Coiled-coil domain-containing protein 134,1526,59,0.69 [0.41-1.17],0.1686897528685208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC28A,Coiled-coil domain-containing protein 28A,1489,57,1.27 [0.52-3.08],0.5983598958703953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC50,Coiled-coil domain-containing protein 50,1532,59,1.29 [1.05-1.58],0.0170345195441244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC80,Coiled-coil domain-containing protein 80,1750,72,1.64 [0.89-3.00],0.1106880613469226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,1483,60,1.02 [0.71-1.44],0.9329399195036634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL11,Eotaxin,1775,73,2.52 [1.60-3.97],6.216324505824951e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL13,C-C motif chemokine 13,1770,72,1.56 [1.16-2.09],0.0030246359935879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL14,C-C motif chemokine 14,1754,71,2.48 [1.67-3.68],7.130549889263389e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL15,C-C motif chemokine 15,1773,72,2.04 [1.40-2.97],0.0001920428688744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL16,C-C motif chemokine 16,1773,72,1.73 [1.17-2.57],0.0061199737190631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL17,C-C motif chemokine 17,1745,71,1.08 [0.87-1.35],0.4851945573589368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL18,C-C motif chemokine 18,1738,71,1.19 [0.92-1.53],0.1797834312902208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL19,C-C motif chemokine 19,1759,71,0.93 [0.76-1.14],0.4683405845199125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL2,C-C motif chemokine 2,1725,71,1.77 [1.21-2.59],0.0032989137879991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL20,C-C motif chemokine 20,1775,73,1.16 [0.95-1.42],0.1565585404632488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL21,C-C motif chemokine 21,1752,71,1.56 [1.11-2.21],0.0110630855091835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL22,C-C motif chemokine 22,1731,69,1.45 [0.98-2.16],0.0652495481394389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL23,C-C motif chemokine 23,1752,71,1.22 [0.76-1.96],0.4024317806209183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL24,C-C motif chemokine 24,1750,71,0.99 [0.78-1.27],0.9555487416571812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL25,C-C motif chemokine 25,1775,73,1.52 [1.03-2.25],0.0339180589528391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL26,C-C motif chemokine 26,1749,72,0.88 [0.69-1.12],0.2961651261058383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL27,C-C motif chemokine 27,1750,72,0.94 [0.69-1.28],0.6799218218687255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL28,C-C motif chemokine 28,1742,71,1.34 [0.97-1.86],0.073621686291268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL3,C-C motif chemokine 3,1749,72,1.36 [1.16-1.59],0.0001428356649854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL4,C-C motif chemokine 4,1750,71,1.42 [1.11-1.82],0.0049214732821029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL5,C-C motif chemokine 5,1760,72,1.19 [0.99-1.44],0.0659005307789661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL7,C-C motif chemokine 7,1749,72,1.33 [0.95-1.86],0.0941290152482946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL8,C-C motif chemokine 8,1764,73,1.57 [1.10-2.23],0.0131355006465691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN1,CCN family member 1,1734,71,1.62 [1.19-2.21],0.002162134441096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN2,CCN family member 2,1745,71,1.58 [1.12-2.25],0.0102401434774494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN3,CCN family member 3,1766,72,1.96 [1.18-3.24],0.0092429883418734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN4,CCN family member 4,1767,73,2.94 [1.94-4.45],3.925579724119432e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN5,CCN family member 5,1756,72,1.98 [1.19-3.28],0.0080536679698753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCND2,G1/S-specific cyclin-D2,1504,59,0.98 [0.50-1.91],0.946133950653838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCNE1,G1/S-specific cyclin-E1,1481,58,0.92 [0.67-1.27],0.6186894978204129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCS,Copper chaperone for superoxide dismutase,1731,71,0.73 [0.46-1.15],0.1690932647898531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCT5,T-complex protein 1 subunit epsilon,1685,69,1.02 [0.63-1.65],0.9258556393849592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD101,Immunoglobulin superfamily member 2,1522,57,1.18 [0.63-2.21],0.6089969829073335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD109,CD109 antigen,1756,72,2.08 [1.15-3.76],0.0159722111658765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD14,Monocyte differentiation antigen CD14,1722,68,3.11 [1.96-4.92],1.370502531593735e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD160,CD160 antigen,1775,73,1.89 [1.32-2.70],0.0004585990986415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,1760,72,1.36 [0.87-2.11],0.1729221464790292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164,Sialomucin core protein 24,1756,72,1.56 [1.16-2.10],0.0030284753171619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164L2,CD164 sialomucin-like 2 protein,1489,57,1.40 [0.79-2.50],0.2537345052260823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD177,CD177 antigen,1753,72,1.05 [0.89-1.24],0.5751363761811442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD1C,T-cell surface glycoprotein CD1c,1749,73,1.09 [0.51-2.36],0.8224870733233957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD2,T-cell surface antigen CD2,1485,57,1.29 [0.71-2.35],0.3989319181137827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200,OX-2 membrane glycoprotein,1749,72,4.19 [2.01-8.70],0.0001265784317167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,1741,71,1.32 [0.72-2.44],0.3674177574317849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD207,C-type lectin domain family 4 member K,1709,70,2.08 [1.28-3.40],0.0033085863820245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD209,CD209 antigen,1750,69,0.86 [0.48-1.53],0.6073384345705863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD22,B-cell receptor CD22,1775,73,1.68 [1.08-2.62],0.0217463110147145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD226,CD226 antigen,1481,58,1.13 [0.62-2.04],0.6938025433225412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD244,Natural killer cell receptor 2B4,1775,73,1.39 [0.69-2.80],0.3590926259642755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD248,Endosialin,1536,59,0.82 [0.45-1.49],0.516196445897156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD27,CD27 antigen,1749,73,3.19 [2.31-4.41],2.2021112766089868e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD274,Programmed cell death 1 ligand 1,1731,71,2.16 [1.24-3.76],0.0063818850885374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD276,CD276 antigen,1745,71,3.46 [2.11-5.69],9.532978577858756e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD28,T-cell-specific surface glycoprotein CD28,1685,69,2.47 [1.54-3.95],0.0001676874298607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD2AP,CD2-associated protein,1750,72,0.91 [0.66-1.27],0.5882024987419625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300A,CMRF35-like molecule 8,1502,60,2.11 [1.03-4.31],0.0406142309695424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300C,CMRF35-like molecule 6,1759,71,2.49 [1.45-4.30],0.0009877772175942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300E,CMRF35-like molecule 2,1761,73,1.97 [1.29-2.98],0.0015016827164704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LF,CMRF35-like molecule 1,1767,73,1.41 [0.98-2.03],0.0644158849542687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LG,CMRF35-like molecule 9,1756,72,2.41 [1.45-4.01],0.0007379714187581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD302,CD302 antigen,1737,71,2.39 [1.47-3.87],0.0004271955710681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD33,Myeloid cell surface antigen CD33,1749,73,1.48 [1.10-2.00],0.0106613420576197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD34,Hematopoietic progenitor cell antigen CD34,1753,71,1.29 [0.56-2.95],0.5525454092426703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD36,Platelet glycoprotein 4,1481,58,1.39 [0.85-2.27],0.1866319829897331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1737,71,1.00 [0.53-1.92],0.9901657548045224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3D,T-cell surface glycoprotein CD3 delta chain,1478,58,0.83 [0.34-2.03],0.6808011009368391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,1504,59,0.68 [0.28-1.64],0.3883299281395462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,1481,58,1.07 [0.84-1.37],0.5579124443578036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD4,T-cell surface glycoprotein CD4,1746,71,3.49 [2.07-5.89],2.9124727732231274e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40,Tumor necrosis factor receptor superfamily member 5,1748,71,1.29 [0.89-1.87],0.1724142235595104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40LG,CD40 ligand,1775,73,1.17 [0.91-1.52],0.2200800586346988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD46,Membrane cofactor protein,1746,70,2.87 [1.48-5.59],0.0018733520168294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD48,CD48 antigen,1750,71,3.91 [2.07-7.36],2.506149646870096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5,T-cell surface glycoprotein CD5,1764,73,2.80 [1.74-4.51],2.2837713745902304e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD55,Complement decay-accelerating factor,1695,69,2.86 [1.39-5.89],0.0043501257802451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD58,Lymphocyte function-associated antigen 3,1742,71,2.21 [0.66-7.35],0.1958697361021619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD59,CD59 glycoprotein,1699,70,3.46 [1.95-6.15],2.234133305042118e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5L,CD5 antigen-like,1532,58,1.34 [0.82-2.19],0.2382816382766124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD6,T-cell differentiation antigen CD6,1772,73,1.13 [0.75-1.71],0.5506679245387662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD63,CD63 antigen,1725,71,1.55 [1.01-2.37],0.0461138103289058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD69,Early activation antigen CD69,1744,72,0.93 [0.74-1.18],0.5672436661238422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD7,T-cell antigen CD7,1476,58,1.38 [0.77-2.47],0.2727206856615997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD70,CD70 antigen,1749,72,1.33 [0.83-2.13],0.2309946280369626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD72,B-cell differentiation antigen CD72,1502,60,1.56 [0.96-2.56],0.0742456048000205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD74,HLA class II histocompatibility antigen gamma chain,1759,71,3.66 [2.27-5.90],1.0659356422408664e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,1775,73,2.34 [1.66-3.29],1.1713794885635978e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD80,T-lymphocyte activation antigen CD80,1532,60,3.62 [2.01-6.52],1.7946528548201755e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD82,CD82 antigen,1504,59,1.01 [0.55-1.84],0.9774547312896054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD83,CD83 antigen,1749,72,2.39 [1.45-3.95],0.0006788714648111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD84,SLAM family member 5,1749,72,0.87 [0.46-1.65],0.6690083504649044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD86,T-lymphocyte activation antigen CD86,1522,57,0.95 [0.40-2.27],0.9133215438000376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,1759,71,1.16 [0.77-1.76],0.4762298928260456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD93,Complement component C1q receptor,1686,66,2.33 [1.29-4.20],0.0050291763634575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99,CD99 antigen,1756,72,2.71 [1.00-7.37],0.0508593943570187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99L2,CD99 antigen-like protein 2,1756,72,2.17 [0.98-4.82],0.0574562767536229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDA,Cytidine deaminase,1530,60,0.85 [0.51-1.40],0.5165487502725684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDAN1,Codanin-1,1517,58,0.42 [0.12-1.43],0.1658527699585831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC123,Cell division cycle protein 123 homolog,1473,59,1.12 [0.76-1.66],0.5605725265566186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC25A,M-phase inducer phosphatase 1,1473,59,0.60 [0.30-1.21],0.1532610836978609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC26,Anaphase-promoting complex subunit CDC26,1521,57,0.85 [0.59-1.22],0.37020552093446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC27,Cell division cycle protein 27 homolog,1685,69,1.07 [0.76-1.52],0.6820156904551453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC37,Hsp90 co-chaperone Cdc37,1749,73,0.92 [0.73-1.18],0.5282008999322136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,1522,57,0.89 [0.70-1.13],0.3211828785833701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDCP1,CUB domain-containing protein 1,1731,71,1.60 [1.16-2.20],0.00381100229261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH1,Cadherin-1,1698,71,2.07 [1.53-2.79],2.067000599871853e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH15,Cadherin-15,1753,71,1.13 [0.88-1.46],0.3247432247578896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH17,Cadherin-17,1750,72,1.37 [1.04-1.81],0.0260995583494949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH2,Cadherin-2,1750,72,2.19 [1.30-3.70],0.0032397328883137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH22,Cadherin-22,1504,59,1.68 [0.76-3.73],0.1995984063422674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH23,Cadherin-23,1517,58,0.89 [0.32-2.43],0.8157114531924056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH3,Cadherin-3,1759,71,2.08 [1.25-3.47],0.004800248663359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH4,Cadherin-4,1478,58,0.60 [0.30-1.19],0.1456579288560479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH5,Cadherin-5,1773,72,1.18 [0.62-2.28],0.6111050610163804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH6,Cadherin-6,1750,72,1.52 [0.94-2.47],0.08916579628683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR1,Cadherin-related family member 1,1687,70,0.76 [0.45-1.29],0.3082291057874184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR2,Cadherin-related family member 2,1737,71,1.14 [0.85-1.53],0.3898570911894286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR5,Cadherin-related family member 5,1750,72,0.66 [0.39-1.12],0.1224516396085826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDK1,Cyclin-dependent kinase 1,1473,59,0.87 [0.43-1.78],0.7096410971385578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,1532,59,0.72 [0.45-1.15],0.1684467523768255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKL5,Cyclin-dependent kinase-like 5,1478,58,0.77 [0.42-1.43],0.4087459132004716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,1737,71,1.11 [0.92-1.34],0.2637507281931343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,1737,71,0.96 [0.77-1.19],0.6833911105168182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDNF,Cerebral dopamine neurotrophic factor,1737,71,1.61 [0.91-2.87],0.1033334373308576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,1747,71,1.10 [0.52-2.33],0.8071633425185839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDSN,Corneodesmosin,1767,73,1.47 [0.94-2.31],0.0949455605693666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,1748,73,3.38 [1.52-7.55],0.0029292376905584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,1522,57,0.80 [0.59-1.09],0.1545465535682545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,1504,59,1.10 [0.83-1.45],0.5033795968449027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,1522,57,0.90 [0.47-1.70],0.7403828943529618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,1504,59,1.22 [0.70-2.11],0.4807611267281614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,1749,72,1.10 [0.88-1.38],0.3917495555865821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,1685,69,1.05 [0.68-1.62],0.8313215931335659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,1665,67,1.51 [1.08-2.11],0.0152185664684291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,1536,59,1.10 [0.61-2.01],0.7439128000876207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,1715,70,1.16 [0.78-1.73],0.4674703306313471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEBPA,CCAAT/enhancer-binding protein alpha,1481,58,1.00 [0.53-1.91],0.9935011490643604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEBPB,CCAAT/enhancer-binding protein beta,1715,70,0.92 [0.53-1.58],0.7509331368039849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELA2A,Chymotrypsin-like elastase family member 2A,1536,59,0.85 [0.59-1.22],0.3744835735972982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELA3A,Chymotrypsin-like elastase family member 3A,1771,72,0.93 [0.67-1.28],0.6392157609521916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,1502,60,1.57 [0.68-3.64],0.2954364065138321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEMIP2,Cell surface hyaluronidase,1481,58,1.43 [0.84-2.43],0.1872228360584398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,1478,58,0.99 [0.64-1.53],0.9773590026403768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CENPF,Centromere protein F,1504,59,0.80 [0.49-1.28],0.350099113209439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CENPJ,Centromere protein J,1504,59,1.02 [0.73-1.43],0.904855321961207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP112,Centrosomal protein of 112 kDa,1485,57,1.04 [0.67-1.61],0.8578924879493068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP152,Centrosomal protein of 152 kDa,1473,59,0.96 [0.53-1.71],0.877169979262551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP164,Centrosomal protein of 164 kDa,1710,70,0.96 [0.68-1.36],0.8351098049897661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP170,Centrosomal protein of 170 kDa,1483,60,0.89 [0.64-1.24],0.4769521097527581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP20,Centrosomal protein 20,1685,69,0.98 [0.73-1.30],0.8625629129311505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP290,Centrosomal protein of 290 kDa,1504,59,0.86 [0.51-1.45],0.5740931145878649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP350,Centrosome-associated protein 350,1473,59,1.58 [0.82-3.06],0.1718843039782725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP43,Centrosomal protein 43,1702,68,0.99 [0.73-1.35],0.972209798832174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP85,Centrosomal protein of 85 kDa,1685,69,1.05 [0.76-1.45],0.7736389587836561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CERT,Ceramide transfer protein,1687,70,1.10 [0.78-1.55],0.5877731255429404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES1,Liver carboxylesterase 1,1749,72,1.04 [0.86-1.25],0.7043952317574647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES2,Cocaine esterase,1737,71,1.49 [1.08-2.07],0.0161131217301982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES3,Carboxylesterase 3,1737,71,0.94 [0.71-1.24],0.6664185128457902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CETN2,Centrin-2,1687,70,1.08 [0.80-1.46],0.6046267119356095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CETN3,Centrin-3,1522,57,0.86 [0.62-1.18],0.3499694717364455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFB,Complement factor B,1516,58,2.50 [1.17-5.32],0.017934358779569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFC1,Cryptic protein,1685,69,1.42 [0.94-2.13],0.0942254040700158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFD,Complement factor D,1541,59,2.08 [0.76-5.70],0.1532183552068329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFH,Complement factor H,1454,56,4.30 [1.44-12.86],0.0089848348217349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR2,Complement factor H-related protein 2,1532,59,1.18 [0.75-1.86],0.4689054439817662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR4,Complement factor H-related protein 4,1537,59,1.06 [0.76-1.49],0.7242723337926233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR5,Complement factor H-related protein 5,1511,58,1.10 [0.63-1.95],0.7315414575301902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFI,Complement factor I,1541,59,1.95 [0.58-6.51],0.277750906757144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFP,Properdin,1541,59,0.82 [0.27-2.49],0.7275313474431788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGA,Glycoprotein hormones alpha chain,1756,72,1.62 [1.27-2.08],0.0001328365125757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,1537,60,1.17 [0.74-1.85],0.5073930322311841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGN,Cingulin,1489,57,0.79 [0.40-1.56],0.4955641951978059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGREF1,Cell growth regulator with EF hand domain protein 1,1750,72,2.00 [1.32-3.02],0.0009992816989344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,1685,69,1.04 [0.71-1.51],0.853310264876792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAD,Chondroadherin,1502,60,0.44 [0.28-0.69],0.0003216553957064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",1517,58,2.32 [1.43-3.78],0.0006860939624749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD6,MICOS complex subunit MIC25,1526,59,1.52 [0.91-2.55],0.1130207945345752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHEK2,Serine/threonine-protein kinase Chk2,1715,70,1.01 [0.51-1.99],0.9878721925800124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGA,Chromogranin-A,1536,59,1.45 [1.20-1.75],0.00010891029716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGB,Secretogranin-1,1749,71,1.84 [1.19-2.85],0.0059101126758205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHI3L1,Chitinase-3-like protein 1,1707,68,1.55 [1.25-1.92],6.439668123912992e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHIT1,Chitotriosidase-1,1762,71,1.12 [0.95-1.31],0.1756093196430962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHL1,Neural cell adhesion molecule L1-like protein,1756,70,1.43 [0.72-2.86],0.3059772435416928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHM,Rab proteins geranylgeranyltransferase component A 1,1489,57,0.72 [0.46-1.11],0.1397729149185535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHMP1A,Charged multivesicular body protein 1a,1731,71,1.04 [0.80-1.36],0.7631804072964552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHMP6,Charged multivesicular body protein 6,1532,60,0.87 [0.57-1.32],0.5008248609275714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHP1,Calcineurin B homologous protein 1,1478,58,1.05 [0.77-1.43],0.7511286020057116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL1,Chordin-like protein 1,1750,71,4.82 [2.70-8.59],1.0206520526576985e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL2,Chordin-like protein 2,1750,72,0.91 [0.62-1.35],0.6543647887859947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRM1,Muscarinic acetylcholine receptor M1,1489,57,0.66 [0.29-1.47],0.3044225069568683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIAPIN1,Anamorsin,1749,73,1.01 [0.73-1.40],0.9652869273226632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CILP,Cartilage intermediate layer protein 1,1536,59,1.60 [1.01-2.53],0.0443388319284569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CINP,Cyclin-dependent kinase 2-interacting protein,1504,59,0.63 [0.31-1.26],0.1892068118094197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIRBP,Cold-inducible RNA-binding protein,1522,57,0.90 [0.69-1.16],0.4181330216360641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIT,Citron Rho-interacting kinase,1489,57,0.83 [0.47-1.46],0.51700545233501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKAP4,Cytoskeleton-associated protein 4,1770,73,4.45 [2.62-7.57],3.5109640792322665e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKB,Creatine kinase B-type,1536,59,1.77 [1.25-2.50],0.001264395053048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",1743,71,1.41 [1.02-1.95],0.0357633373788801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLASP1,CLIP-associating protein 1,1473,59,0.88 [0.62-1.26],0.4871573492237452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLC,Galectin-10,1746,72,1.15 [0.85-1.54],0.3624007187521543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC10A,C-type lectin domain family 10 member A,1731,71,2.70 [1.52-4.79],0.0006878078110224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC11A,C-type lectin domain family 11 member A,1750,72,0.83 [0.54-1.28],0.4026203637120394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC12A,C-type lectin domain family 12 member A,1481,58,0.90 [0.25-3.25],0.870971057391531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC14A,C-type lectin domain family 14 member A,1756,72,3.03 [1.72-5.34],0.0001314557745967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1A,C-type lectin domain family 1 member A,1715,70,1.98 [1.16-3.38],0.0128926600499334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1B,C-type lectin domain family 1 member B,1759,71,1.03 [0.84-1.28],0.7587856800707202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC2L,C-type lectin domain family 2 member L,1489,57,1.01 [0.63-1.62],0.9802577691234698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC3B,Tetranectin,1508,58,0.42 [0.14-1.23],0.112745765689598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4A,C-type lectin domain family 4 member A,1749,72,0.78 [0.45-1.35],0.3808243441825115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4C,C-type lectin domain family 4 member C,1749,72,1.15 [0.75-1.76],0.5175011577117543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4D,C-type lectin domain family 4 member D,1749,72,1.35 [0.99-1.84],0.0547488404378838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4G,C-type lectin domain family 4 member G,1749,72,0.97 [0.52-1.78],0.9099804531580846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4M,C-type lectin domain family 4 member M,1535,59,0.74 [0.43-1.25],0.2553435102025372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC5A,C-type lectin domain family 5 member A,1748,72,1.68 [0.91-3.08],0.0968306378106163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC6A,C-type lectin domain family 6 member A,1685,69,1.36 [0.93-1.99],0.1167347927059502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC7A,C-type lectin domain family 7 member A,1775,73,1.54 [1.04-2.28],0.0299597597854929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLGN,Calmegin,1489,57,1.45 [0.83-2.54],0.1959304350001818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLIC5,Chloride intracellular channel protein 5,1489,57,0.94 [0.43-2.08],0.8797152841003258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLINT1,Clathrin interactor 1,1473,59,0.95 [0.54-1.65],0.8464040942375668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLIP2,CAP-Gly domain-containing linker protein 2,1749,72,0.93 [0.78-1.11],0.4253021360157071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLMP,CXADR-like membrane protein,1767,73,4.43 [2.09-9.38],0.0001009030634727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLNS1A,Methylosome subunit pICln,1489,57,0.50 [0.21-1.22],0.1286164669751217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",1725,71,1.03 [0.84-1.28],0.7629155552504886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLPS,Colipase,1752,72,0.87 [0.67-1.13],0.2858823669605534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSPN,Claspin,1681,70,0.75 [0.37-1.50],0.4092559474050792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN1,Calsyntenin-1,1687,70,0.48 [0.29-0.80],0.0046620901729483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN2,Calsyntenin-2,1775,73,2.01 [1.43-2.81],5.472997510287143e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN3,Calsyntenin-3,1517,58,1.70 [0.77-3.75],0.1849209092368934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLTA,Clathrin light chain A,1715,70,1.08 [0.66-1.76],0.7526141649078024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLU,Clusterin,1541,59,1.24 [0.52-2.97],0.6285822197375692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLUL1,Clusterin-like protein 1,1745,72,0.92 [0.59-1.44],0.7188333947699136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CMC1,COX assembly mitochondrial protein homolog,1532,60,0.84 [0.65-1.10],0.2079694843778584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CMIP,C-Maf-inducing protein,1526,59,0.86 [0.65-1.14],0.2959580370211773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNDP1,Beta-Ala-His dipeptidase,1760,72,1.18 [0.75-1.87],0.4661045889737288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,1478,58,1.12 [0.85-1.46],0.420313747929301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",1482,60,0.91 [0.67-1.25],0.5589201598518996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNPY2,Protein canopy homolog 2,1715,70,1.42 [1.10-1.85],0.0079150467158619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNPY4,Protein canopy homolog 4,1737,71,1.02 [0.77-1.34],0.9109137654966524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNST,Consortin,1750,72,0.95 [0.79-1.15],0.6109876498160329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTF,Ciliary neurotrophic factor,1478,58,0.72 [0.36-1.45],0.3605496870175861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN1,Contactin-1,1773,72,1.84 [0.87-3.92],0.1131920520472302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN2,Contactin-2,1767,73,1.58 [1.02-2.44],0.0382836632938034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN3,Contactin-3,1756,72,1.97 [1.01-3.83],0.0466964626218592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN4,Contactin-4,1756,72,2.14 [0.92-4.96],0.0776359714136113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN5,Contactin-5,1745,70,0.58 [0.33-1.02],0.0572667459946722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTNAP2,Contactin-associated protein-like 2,1749,72,1.62 [1.03-2.54],0.0365297628795866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTNAP4,Contactin-associated protein-like 4,1489,57,0.96 [0.75-1.23],0.7702298023482578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COCH,Cochlin,1532,60,1.68 [1.10-2.58],0.016302199880034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL15A1,Collagen alpha-1(XV) chain,1536,59,0.65 [0.27-1.55],0.332249659132488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL18A1,Collagen alpha-1(XVIII) chain,1761,71,7.45 [3.52-15.78],1.589443224396465e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL1A1,Collagen alpha-1(I) chain,1773,72,0.70 [0.31-1.61],0.4047319280864211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL24A1,Collagen alpha-1(XXIV) chain,1522,57,1.39 [0.87-2.21],0.1648902325001874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL28A1,Collagen alpha-1(XXVIII) chain,1489,57,1.22 [0.92-1.62],0.1729673432030348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL2A1,Collagen alpha-1(II) chain,1483,60,1.13 [0.85-1.51],0.3933830416162298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL3A1,Collagen alpha-1(III) chain,1536,59,1.82 [0.78-4.27],0.1667312787520599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A1,Collagen alpha-1(IV) chain,1750,72,2.01 [1.36-2.97],0.0004482535538109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A4,Collagen alpha-4(IV) chain,1498,59,1.01 [0.62-1.65],0.9581666908220554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL5A1,Collagen alpha-1(V) chain,1502,60,1.46 [1.05-2.02],0.0233934832847891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL6A3,Collagen alpha-3(VI) chain,1773,72,3.06 [1.98-4.75],5.286795019901419e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL9A1,Collagen alpha-1(IX) chain,1749,72,1.23 [0.83-1.84],0.2973411175105908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL9A2,Collagen alpha-2(IX) chain,1504,59,0.96 [0.55-1.70],0.897827286580142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COLEC12,Collectin-12,1745,71,4.53 [2.50-8.22],6.739693607892159e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMMD1,COMM domain-containing protein 1,1483,60,0.90 [0.61-1.35],0.6202911096307274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMMD9,COMM domain-containing protein 9,1526,59,0.79 [0.41-1.54],0.4944326352766809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMP,Cartilage oligomeric matrix protein,1743,71,0.77 [0.42-1.40],0.3851538509916943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMT,Catechol O-methyltransferase,1694,67,0.99 [0.77-1.29],0.9681395562599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COPB2,Coatomer subunit beta',1485,57,1.07 [0.62-1.84],0.8208038638813289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COPE,Coatomer subunit epsilon,1687,70,1.30 [0.91-1.87],0.1468943846852473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",1483,60,1.33 [0.82-2.18],0.2515432341537907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CORO1A,Coronin-1A,1719,71,1.03 [0.82-1.31],0.7741215059185034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CORO6,Coronin-6,1478,58,0.84 [0.42-1.66],0.6178230929830344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",1737,71,1.13 [0.83-1.52],0.4401831161958037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COX6B1,Cytochrome c oxidase subunit 6B1,1532,60,0.46 [0.21-1.02],0.0545780060343661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA1,Carboxypeptidase A1,1773,72,0.94 [0.70-1.27],0.6894195907125596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA2,Carboxypeptidase A2,1751,71,1.28 [0.99-1.65],0.0588569533998694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA4,Carboxypeptidase A4,1472,58,0.78 [0.46-1.32],0.3473027168551645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPB1,Carboxypeptidase B,1773,72,1.02 [0.75-1.38],0.9032994155780628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPB2,Carboxypeptidase B2,1535,58,2.07 [0.69-6.19],0.1917930594189672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPE,Carboxypeptidase E,1756,73,1.02 [0.62-1.69],0.9390358841386438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPLX2,Complexin-2,1473,59,1.30 [0.64-2.64],0.4691623435272389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPM,Carboxypeptidase M,1749,71,2.53 [1.44-4.45],0.0013101762466633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",1481,58,0.79 [0.32-1.99],0.6196735827187213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,1759,71,0.85 [0.62-1.16],0.3050866553228796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPQ,Carboxypeptidase Q,1535,59,1.45 [0.73-2.87],0.2878174010427927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPTP,Ceramide-1-phosphate transfer protein,1485,57,0.78 [0.36-1.66],0.513109743381972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPVL,Probable serine carboxypeptidase CPVL,1763,72,1.29 [0.77-2.16],0.3244568535453236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM1,Probable carboxypeptidase X1,1749,73,1.36 [1.03-1.80],0.0286912000165543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM2,Inactive carboxypeptidase-like protein X2,1532,60,3.64 [1.64-8.08],0.0015353782646549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR1,Complement receptor type 1,1531,59,1.31 [0.66-2.59],0.4360874611218003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR2,Complement receptor type 2,1760,72,1.40 [0.91-2.15],0.1260310862543683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,1685,69,1.12 [0.89-1.40],0.340576843649567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRADD,Death domain-containing protein CRADD,1725,71,1.03 [0.79-1.36],0.8087614542392528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREB3,Cyclic AMP-responsive element-binding protein 3,1473,59,0.76 [0.44-1.29],0.3030454680976416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREBZF,CREB/ATF bZIP transcription factor,1473,59,0.78 [0.26-2.29],0.6455630723427028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREG1,Protein CREG1,1723,73,0.63 [0.41-0.97],0.0348241042381787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD1,Protein disulfide isomerase CRELD1,1502,60,3.26 [1.77-5.98],0.0001404338187616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD2,Protein disulfide isomerase CRELD2,1750,71,1.33 [0.94-1.87],0.1029241340248276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRH,Corticoliberin,1681,69,0.91 [0.71-1.17],0.4834358523373814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRHBP,Corticotropin-releasing factor-binding protein,1745,71,2.64 [1.30-5.39],0.0074125041940246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRHR1,Corticotropin-releasing factor receptor 1,1715,70,0.70 [0.47-1.06],0.0963898842306372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIM1,Cysteine-rich motor neuron 1 protein,1752,71,6.31 [2.71-14.66],1.89190035708348e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIP2,Cysteine-rich protein 2,1731,71,1.68 [1.07-2.65],0.0252707353196407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRISP2,Cysteine-rich secretory protein 2,1767,73,0.96 [0.67-1.36],0.8148853884556917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRISP3,Cysteine-rich secretory protein 3,1517,59,0.47 [0.20-1.10],0.0827525015025384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRKL,Crk-like protein,1747,71,1.00 [0.82-1.21],0.9964670692712824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRLF1,Cytokine receptor-like factor 1,1752,71,2.94 [1.36-6.33],0.0060026110257266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRNN,Cornulin,1692,70,1.25 [0.93-1.67],0.1418287183109253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAC1,Cartilage acidic protein 1,1773,72,0.81 [0.43-1.52],0.5144192717458168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAM,Cytotoxic and regulatory T-cell molecule,1731,71,1.28 [0.85-1.93],0.2329374439438213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAP,Cartilage-associated protein,1489,57,0.75 [0.41-1.36],0.3427183757602126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRX,Cone-rod homeobox protein,1715,70,1.15 [0.95-1.39],0.1520481431896363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYBB1,Beta-crystallin B1,1532,60,0.85 [0.59-1.23],0.3931730141363536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYBB2,Beta-crystallin B2,1517,58,1.02 [0.76-1.37],0.9020852502392374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYGD,Gamma-crystallin D,1517,58,1.09 [0.85-1.40],0.4943043619063245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYM,Ketimine reductase mu-crystallin,1478,58,0.99 [0.71-1.39],0.9590163589487236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYZL1,Quinone oxidoreductase-like protein 1,1483,60,0.86 [0.65-1.13],0.2721442968594225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSDE1,Cold shock domain-containing protein E1,1485,57,0.93 [0.74-1.16],0.5231057448283265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1,Macrophage colony-stimulating factor 1,1752,71,3.33 [1.76-6.27],0.0002023688447712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,1537,60,1.79 [1.05-3.05],0.0337087244730716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2,Granulocyte-macrophage colony-stimulating factor,1485,57,1.18 [0.60-2.33],0.6279747360820367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,1731,71,1.27 [0.92-1.76],0.1486306649592052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2RB,Cytokine receptor common subunit beta,1481,58,0.73 [0.42-1.27],0.2598353464828442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF3,Granulocyte colony-stimulating factor,1710,70,0.95 [0.60-1.50],0.8199681536964829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF3R,Granulocyte colony-stimulating factor receptor,1481,58,1.19 [0.60-2.38],0.6204172067143378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSH1,Chorionic somatomammotropin hormone 1,1537,60,0.60 [0.26-1.39],0.2323775062163252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSNK1D,Casein kinase I isoform delta,1481,58,0.79 [0.51-1.23],0.2931636970986622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSNK2A1,Casein kinase II subunit alpha,1532,59,0.65 [0.36-1.18],0.1559836268386533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG4,Chondroitin sulfate proteoglycan 4,1536,59,2.11 [1.04-4.30],0.0387657767488337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG5,Chondroitin sulfate proteoglycan 5,1478,58,1.07 [0.66-1.76],0.7769420677535688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSRP3,Cysteine and glycine-rich protein 3,1485,57,0.95 [0.72-1.25],0.7220884032466253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST1,Cystatin-SN,1337,50,0.78 [0.59-1.04],0.0880454259291757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST3,Cystatin-C,1752,72,2.98 [1.71-5.22],0.000128425661368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST5,Cystatin-D,1716,71,1.38 [0.96-2.00],0.0857089809677991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST6,Cystatin-M,1702,71,1.43 [0.95-2.15],0.0837169419582432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST7,Cystatin-F,1750,71,1.03 [0.83-1.28],0.771944424506703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSTB,Cystatin-B,1730,71,1.44 [0.92-2.25],0.1138672222327652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,1498,59,0.80 [0.48-1.33],0.3887137910533318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTBS,Di-N-acetylchitobiase,1507,58,1.12 [0.49-2.58],0.7839678141207782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTF1,Cardiotrophin-1,1715,70,0.86 [0.67-1.11],0.2552457667957699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTHRC1,Collagen triple helix repeat-containing protein 1,1536,59,2.55 [1.17-5.54],0.0179572830068129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTLA4,Cytotoxic T-lymphocyte protein 4,1536,59,1.09 [0.43-2.76],0.8478536666620444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTNNA1,Catenin alpha-1,1478,58,0.67 [0.27-1.69],0.39950034287826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRB1,Chymotrypsinogen B,1756,72,0.84 [0.61-1.16],0.2970177393070866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRC,Chymotrypsin-C,1743,71,0.58 [0.45-0.76],5.8145297981840896e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRL,Chymotrypsin-like protease CTRL-1,1517,58,0.50 [0.36-0.69],2.517281448188939e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSB,Cathepsin B,1754,72,1.64 [1.13-2.39],0.0087937315755213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSC,Dipeptidyl peptidase 1,1743,71,1.33 [0.85-2.08],0.2124102585328247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSD,Cathepsin D,1648,68,1.34 [0.84-2.13],0.2128566641727639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSE,Cathepsin E,1502,60,1.46 [0.96-2.23],0.076411298953339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSF,Cathepsin F,1749,73,1.08 [0.66-1.76],0.7573558733207268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSH,Pro-cathepsin H,1713,70,1.25 [0.93-1.68],0.140020635140725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSL,Cathepsin L1,1750,72,1.43 [0.61-3.35],0.4040754768598965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSO,Cathepsin O,1775,73,2.27 [1.21-4.25],0.0106168982556611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSS,Cathepsin S,1375,57,1.88 [0.69-5.12],0.21972723841809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSV,Cathepsin L2,1761,72,0.80 [0.50-1.29],0.3684989433856075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSZ,Cathepsin Z,1756,72,2.05 [1.10-3.79],0.0231390205498478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,1489,57,1.14 [0.71-1.83],0.5966634302696974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CWC15,Spliceosome-associated protein CWC15 homolog,1512,56,0.98 [0.66-1.44],0.9025272995028468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CX3CL1,Fractalkine,1731,71,3.27 [1.96-5.44],5.273269527605813e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXADR,Coxsackievirus and adenovirus receptor,1749,72,1.65 [1.17-2.35],0.0048171253052633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL1,Growth-regulated alpha protein,1748,71,1.06 [0.86-1.31],0.5911662252098038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL10,C-X-C motif chemokine 10,1752,71,1.27 [0.96-1.69],0.0984712996505867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL11,C-X-C motif chemokine 11,1759,71,1.24 [0.99-1.56],0.0638854897423574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL12,Stromal cell-derived factor 1,1710,70,1.49 [0.92-2.42],0.1047082737069439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL13,C-X-C motif chemokine 13,1759,71,1.16 [0.81-1.65],0.4226330768152149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL14,C-X-C motif chemokine 14,1710,70,1.21 [0.91-1.60],0.1912642726562544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL16,C-X-C motif chemokine 16,1772,72,5.96 [2.97-11.95],5.060839679761336e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL17,C-X-C motif chemokine 17,1775,73,1.07 [0.69-1.67],0.7566566365359367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL3,C-X-C motif chemokine 3,1748,71,1.05 [0.84-1.30],0.6876007513603044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL5,C-X-C motif chemokine 5,1747,71,1.18 [0.99-1.41],0.061549478482081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL6,C-X-C motif chemokine 6,1775,73,1.46 [1.13-1.89],0.0037632800558755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL8,Interleukin-8,1737,72,1.44 [1.19-1.73],0.0001277015082496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL9,C-X-C motif chemokine 9,1752,71,1.44 [1.09-1.90],0.0110569190484106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYB5A,Cytochrome b5,1473,59,0.97 [0.67-1.39],0.8508032224461791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYB5R2,NADH-cytochrome b5 reductase 2,1496,55,1.02 [0.67-1.57],0.9184235798881594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",1485,57,0.86 [0.60-1.24],0.4147545997896822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYTH3,Cytohesin-3,1473,59,0.92 [0.64-1.31],0.6379034086559703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYTL1,Cytokine-like protein 1,1536,59,1.16 [0.46-2.92],0.7446492063607826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAAM1,Disheveled-associated activator of morphogenesis 1,1502,60,0.86 [0.64-1.16],0.3180789982610513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAB2,Disabled homolog 2,1767,73,0.97 [0.81-1.16],0.7535601260892943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAG1,Dystroglycan,1752,71,1.59 [1.03-2.45],0.0349737158300553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAND5,DAN domain family member 5,1481,58,0.87 [0.62-1.22],0.4188748722183656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAPK2,Death-associated protein kinase 2,1481,58,0.87 [0.55-1.39],0.5652870601520954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,1749,72,0.93 [0.79-1.08],0.3498553888132413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",1725,71,0.93 [0.70-1.24],0.6359400246075908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBH,Dopamine beta-hydroxylase,1535,60,0.81 [0.67-0.98],0.033667997084566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBI,Acyl-CoA-binding protein,1746,71,1.11 [0.85-1.45],0.4455407810848185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBN1,Drebrin,1481,58,0.80 [0.49-1.32],0.385855666521583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBNL,Drebrin-like protein,1752,71,0.98 [0.78-1.22],0.8444848846112056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",1749,73,3.37 [2.03-5.59],2.6883145540270507e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCC,Netrin receptor DCC,1489,57,0.43 [0.11-1.69],0.2262759087185284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCDC2C,Doublecortin domain-containing protein 2C,1473,59,1.09 [0.75-1.57],0.667077840346695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCLRE1C,Protein artemis,1473,59,1.10 [0.49-2.47],0.8168917336349389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCN,Decorin,1715,70,4.46 [1.82-10.95],0.001095476186247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTD,Deoxycytidylate deaminase,1502,60,0.89 [0.69-1.14],0.3599303829687396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN1,Dynactin subunit 1,1767,73,0.97 [0.71-1.33],0.8682121804348072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN2,Dynactin subunit 2,1737,71,1.15 [0.93-1.41],0.1971743349319262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN6,Dynactin subunit 6,1687,70,0.77 [0.55-1.07],0.1177173908433512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTPP1,dCTP pyrophosphatase 1,1750,72,0.75 [0.38-1.47],0.4061825910497667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCUN1D1,DCN1-like protein 1,1478,58,0.89 [0.61-1.31],0.5615322071910853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCUN1D2,DCN1-like protein 2,1473,59,0.82 [0.57-1.19],0.2970909203013674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCXR,L-xylulose reductase,1749,73,0.95 [0.68-1.33],0.7691090576471467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDA1,DET1- and DDB1-associated protein 1,1485,57,0.70 [0.33-1.52],0.3707806283247307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",1737,71,1.47 [0.98-2.20],0.0597393407793748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDC,Aromatic-L-amino-acid decarboxylase,1750,72,1.07 [0.74-1.56],0.7145132470030782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDHD2,Phospholipase DDHD2,1532,59,0.86 [0.59-1.26],0.442810117670033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDI2,Protein DDI1 homolog 2,1502,60,0.92 [0.67-1.26],0.5839193330684938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDR1,Epithelial discoidin domain-containing receptor 1,1759,71,4.20 [2.19-8.05],1.5294442305510658e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDT,D-dopachrome decarboxylase,1536,59,1.11 [0.63-1.94],0.7148432990012529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX1,ATP-dependent RNA helicase DDX1,1522,57,1.00 [0.61-1.62],0.9865201394918622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX25,ATP-dependent RNA helicase DDX25,1489,57,1.36 [0.79-2.36],0.2696348752892463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX39A,ATP-dependent RNA helicase DDX39A,1481,58,1.18 [0.37-3.73],0.7799537439516226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX4,Probable ATP-dependent RNA helicase DDX4,1481,58,0.57 [0.30-1.08],0.082277145882621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX53,Probable ATP-dependent RNA helicase DDX53,1489,57,0.56 [0.27-1.17],0.1253529761290566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX58,Antiviral innate immune response receptor RIG-I,1685,69,1.13 [0.84-1.54],0.418442061338523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",1749,72,0.93 [0.75-1.16],0.5253117024418443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFA1_DEFA1B,Neutrophil defensin 1,1717,70,1.49 [1.07-2.07],0.0178722305902785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB103A_DEFB103B,Beta-defensin 103,1473,57,1.26 [0.80-1.98],0.3192878124054727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB104A_DEFB104B,Beta-defensin 104,1478,58,1.03 [0.62-1.73],0.8961668120830488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB116,Beta-defensin 116,1478,58,1.02 [0.75-1.40],0.8889105910722626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB118,Beta-defensin 118,1478,58,0.94 [0.61-1.45],0.7939476258813514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB4A_DEFB4B,Beta-defensin 4A,1721,70,1.04 [0.91-1.20],0.5653524693814924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DENND2B,DENN domain-containing protein 2B,1485,57,1.32 [0.85-2.04],0.2225252938114001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DENR,Density-regulated protein,1481,58,0.75 [0.47-1.20],0.2275631832212808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DFFA,DNA fragmentation factor subunit alpha,1775,73,1.04 [0.77-1.40],0.8083371924326199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGCR6,Protein DGCR6,1478,58,0.84 [0.45-1.58],0.5916420547795778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGKA,Diacylglycerol kinase alpha,1481,58,0.91 [0.58-1.42],0.6720766637670659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGKZ,Diacylglycerol kinase zeta,1710,70,0.86 [0.46-1.60],0.6314105751498555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHODH,Dihydroorotate dehydrogenase,1485,57,1.24 [0.72-2.17],0.4386515541477065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHPS,Deoxyhypusine synthase,1526,59,1.32 [0.82-2.12],0.2470193287912184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,1517,58,0.96 [0.56-1.65],0.8953288245410348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIABLO,"Diablo homolog, mitochondrial",1748,72,0.94 [0.79-1.13],0.5358360733586196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIPK1C,Divergent protein kinase domain 1C,1489,57,0.58 [0.28-1.20],0.1425175820571315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIPK2B,Divergent protein kinase domain 2B,1502,60,0.73 [0.31-1.73],0.4765315219993529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK1,Dickkopf-related protein 1,1759,71,1.53 [1.08-2.16],0.0164740088041871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK3,Dickkopf-related protein 3,1773,72,3.26 [1.67-6.35],0.0005334264419292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK4,Dickkopf-related protein 4,1729,71,1.87 [1.34-2.60],0.0002486326460217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKKL1,Dickkopf-like protein 1,1737,71,0.86 [0.68-1.09],0.2087984022769508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLG4,Disks large homolog 4,1517,58,0.83 [0.59-1.17],0.2947112764010968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLGAP5,Disks large-associated protein 5,1532,59,0.92 [0.49-1.72],0.7837639127075415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLK1,Protein delta homolog 1,1773,72,0.90 [0.64-1.27],0.5636188739188783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL1,Delta-like protein 1,1749,73,5.33 [3.19-8.92],1.717256941852074e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL4,Delta-like protein 4,1483,60,1.05 [0.83-1.33],0.6576857044405737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMD,Dystrophin,1483,60,1.18 [0.77-1.82],0.4489966509226266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMP1,Dentin matrix acidic phosphoprotein 1,1483,60,0.56 [0.42-0.75],8.51424256082176e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA1,DnaJ homolog subfamily A member 1,1473,59,0.57 [0.27-1.19],0.1324531913801036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA2,DnaJ homolog subfamily A member 2,1773,73,0.96 [0.75-1.23],0.735023981465555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA4,DnaJ homolog subfamily A member 4,1517,58,1.01 [0.72-1.43],0.9329911325027948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB1,DnaJ homolog subfamily B member 1,1737,71,1.11 [0.88-1.42],0.3790694606046738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB14,DnaJ homolog subfamily B member 14,1522,57,1.07 [0.74-1.53],0.7268303982323945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB2,DnaJ homolog subfamily B member 2,1502,60,0.83 [0.52-1.31],0.423876211277022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB6,DnaJ homolog subfamily B member 6,1486,58,0.87 [0.65-1.16],0.3316319798094602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB8,DnaJ homolog subfamily B member 8,1715,70,0.97 [0.66-1.44],0.8951886672656102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC21,DnaJ homolog subfamily C member 21,1517,58,0.68 [0.35-1.32],0.2570010828558469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,1483,60,0.96 [0.73-1.28],0.8030750993046626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC9,DnaJ homolog subfamily C member 9,1522,57,0.89 [0.64-1.24],0.4816465835672502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,1736,70,0.48 [0.22-1.05],0.066644158066983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNLZ,DNL-type zinc finger protein,1478,58,0.91 [0.64-1.29],0.5912732531657832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNM1,Dynamin-1,1522,57,0.89 [0.72-1.10],0.2638814590798954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNM3,Dynamin-3,1532,59,1.23 [0.83-1.82],0.3025218861298946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNMBP,Dynamin-binding protein,1731,71,1.24 [0.92-1.67],0.1640945935547764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNPEP,Aspartyl aminopeptidase,1517,58,1.13 [0.74-1.71],0.5788823119686457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,1749,71,0.88 [0.59-1.32],0.5348163702523065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOC2B,Double C2-like domain-containing protein beta,1489,57,0.60 [0.25-1.42],0.2444018137878549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOCK9,Dedicator of cytokinesis protein 9,1478,58,0.92 [0.71-1.18],0.5095091600160369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOK1,Docking protein 1,1517,58,0.90 [0.75-1.07],0.2328622299715481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOK2,Docking protein 2,1750,72,0.97 [0.83-1.14],0.7382038373814748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPEP1,Dipeptidase 1,1725,71,0.74 [0.49-1.13],0.1625025869175173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPEP2,Dipeptidase 2,1737,71,0.73 [0.35-1.55],0.4138772529440261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP10,Inactive dipeptidyl peptidase 10,1749,72,1.39 [0.92-2.09],0.1145023028396243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP4,Dipeptidyl peptidase 4,1731,69,0.74 [0.37-1.46],0.3786565333131769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,1737,71,2.82 [1.68-4.71],7.888908915816582e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP7,Dipeptidyl peptidase 2,1736,71,1.10 [0.78-1.53],0.5933359078568978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPT,Dermatopontin,1773,72,2.29 [0.98-5.37],0.0561462705585113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPY30,Protein dpy-30 homolog,1763,73,1.31 [0.98-1.75],0.0676778353929915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRAXIN,Draxin,1731,71,2.70 [1.68-4.34],4.419774089890731e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRG2,Developmentally-regulated GTP-binding protein 2,1737,71,1.09 [0.76-1.57],0.6279362637166019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSC2,Desmocollin-2,1735,70,2.27 [1.68-3.06],7.874045428404835e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSCAM,Down syndrome cell adhesion molecule,1532,59,2.17 [1.19-3.96],0.0111296633488705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG2,Desmoglein-2,1756,72,3.46 [1.72-6.94],0.000475815153692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG3,Desmoglein-3,1762,73,0.94 [0.53-1.68],0.8334533934380859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG4,Desmoglein-4,1726,70,0.56 [0.36-0.87],0.0094929373114353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTD1,D-aminoacyl-tRNA deacylase 1,1502,60,0.86 [0.65-1.12],0.2609299908626884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTNB,Dystrobrevin beta,1525,59,1.72 [1.10-2.69],0.0166996307154407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,1489,57,0.85 [0.53-1.37],0.5014265268124514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,1737,71,2.19 [1.04-4.62],0.0390340660003673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTYMK,Thymidylate kinase,1532,60,0.87 [0.62-1.23],0.4416918055597336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUOX2,Dual oxidase 2,1715,70,0.74 [0.49-1.10],0.1402603360715457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,1526,59,0.59 [0.32-1.09],0.0932633468051337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP29,Dual specificity phosphatase 29,1489,57,0.99 [0.66-1.48],0.960062272449322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP3,Dual specificity protein phosphatase 3,1687,70,0.88 [0.66-1.17],0.3817082525303112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",1522,57,0.94 [0.73-1.19],0.5884084966481099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DXO,Decapping and exoribonuclease protein,1517,58,0.76 [0.44-1.32],0.3375023132009551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,1526,59,0.81 [0.42-1.56],0.5307653494662151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNLT1,Dynein light chain Tctex-type 1,1489,57,0.81 [0.58-1.13],0.2157389365979024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNLT3,Dynein light chain Tctex-type 3,1526,59,0.42 [0.23-0.74],0.0031104292223482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,1731,71,1.04 [0.84-1.29],0.6914981393999593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBI3_IL27,Interleukin-27,1764,73,3.40 [1.93-5.98],2.1558665833793577e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECE1,Endothelin-converting enzyme 1,1687,70,0.88 [0.49-1.59],0.6832907543136044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",1532,60,1.16 [0.90-1.51],0.2536182715006992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",1483,60,0.92 [0.72-1.18],0.5158372920272182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECI2,Enoyl-CoA delta isomerase 2,1485,57,0.97 [0.64-1.46],0.8776097969360308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECM1,Extracellular matrix protein 1,1499,56,0.95 [0.50-1.78],0.8615819285372552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECSCR,Endothelial cell-specific chemotaxis regulator,1478,58,0.88 [0.52-1.50],0.641654099679316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,1767,73,3.38 [2.40-4.76],3.2314256244204853e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,1749,72,1.17 [0.94-1.45],0.1619787399037028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDDM3B,Epididymal secretory protein E3-beta,1526,59,0.90 [0.57-1.42],0.6426999512685738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,1485,57,1.63 [1.04-2.56],0.0338127215334804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDF1,Endothelial differentiation-related factor 1,1532,59,1.14 [0.81-1.60],0.4399805746211044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,1715,70,1.74 [0.98-3.10],0.0602856837300525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDN1,Endothelin-1,1483,60,2.79 [1.40-5.55],0.0034987725414988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDNRB,Endothelin receptor type B,1481,58,0.45 [0.20-1.02],0.0559854224224399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EEF1D,Elongation factor 1-delta,1532,60,1.00 [0.77-1.29],0.9923628804687724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,1522,57,3.21 [1.79-5.77],9.371978890692606e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB2,Dynein regulatory complex protein 8,1504,59,0.68 [0.33-1.42],0.3063045925886521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,1759,72,4.70 [2.70-8.20],4.7490821511748273e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFHD1,EF-hand domain-containing protein D1,1532,59,1.89 [1.10-3.24],0.0207545505676187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,1754,72,4.19 [2.46-7.11],1.1708715535394268e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA4,Ephrin-A4,1725,71,5.16 [3.36-7.93],7.566295289280354e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNB2,Ephrin-B2,1489,57,1.12 [0.77-1.65],0.5507845628614754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGF,Pro-epidermal growth factor,1738,71,1.11 [0.91-1.35],0.2986751518072399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFL7,Epidermal growth factor-like protein 7,1685,69,2.59 [1.57-4.26],0.0001851603065001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFLAM,Pikachurin,1522,57,2.01 [1.08-3.74],0.0284929115238654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFR,Epidermal growth factor receptor,1773,72,1.49 [0.44-4.99],0.5198713498941924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGLN1,Egl nine homolog 1,1749,72,1.24 [0.94-1.64],0.1287123143304631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EHBP1,EH domain-binding protein 1,1532,60,0.84 [0.61-1.16],0.2966197776246527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EHD3,EH domain-containing protein 3,1483,60,0.96 [0.78-1.18],0.6812078317104686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",1517,58,0.81 [0.49-1.34],0.4142618658965864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",1518,57,0.92 [0.74-1.15],0.4664903884919039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,1485,57,0.72 [0.47-1.10],0.1253061056018896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,1483,60,0.63 [0.33-1.19],0.1550689024425443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4B,Eukaryotic translation initiation factor 4B,1731,71,0.92 [0.63-1.32],0.6355718133476493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4E,Eukaryotic translation initiation factor 4E,1481,58,0.82 [0.62-1.09],0.1772905869357273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,1750,72,0.98 [0.71-1.34],0.8918031094125303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,1775,73,1.03 [0.83-1.27],0.8020076363385066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,1532,59,0.77 [0.53-1.11],0.1590014779733274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF5,Eukaryotic translation initiation factor 5,1485,57,0.69 [0.35-1.34],0.2715925286107357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF5A,Eukaryotic translation initiation factor 5A-1,1710,70,1.03 [0.52-2.03],0.933359475577736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,1532,59,0.87 [0.65-1.17],0.3584943165896954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELAVL4,ELAV-like protein 4,1478,58,1.21 [0.93-1.57],0.1504418605354766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELN,Elastin,1532,60,2.42 [1.29-4.52],0.0056153201603173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELOA,Elongin-A,1737,71,1.11 [0.80-1.54],0.5317972027229745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELOB,Elongin-B,1485,57,0.75 [0.36-1.54],0.4294553591118546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENAH,Protein enabled homolog,1710,70,1.22 [0.78-1.93],0.3844807216712318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENDOU,Poly(U)-specific endoribonuclease,1396,53,1.32 [0.84-2.08],0.2230300391305383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENG,Endoglin,1773,72,2.38 [0.78-7.28],0.1276866627665098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO1,Alpha-enolase,1746,71,0.91 [0.70-1.20],0.5130144296793699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO2,Gamma-enolase,1759,71,0.92 [0.68-1.26],0.6149343594858174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO3,Beta-enolase,1483,60,0.75 [0.50-1.10],0.1432502377925505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENOPH1,Enolase-phosphatase E1,1526,59,0.44 [0.26-0.76],0.0031460332046011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,1485,57,0.45 [0.16-1.26],0.1283974332227727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPEP,Glutamyl aminopeptidase,1485,57,1.08 [0.60-1.93],0.8007549660921447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,1773,72,1.62 [0.84-3.14],0.152513234850413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,1752,71,0.69 [0.50-0.94],0.0206216390243903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,1483,60,1.16 [0.60-2.27],0.6596845082031288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,1692,71,1.29 [1.02-1.62],0.029898210788078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENSA,Alpha-endosulfine,1526,59,0.86 [0.54-1.38],0.5427903198804134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,1685,69,1.22 [0.83-1.79],0.3144170072766141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,1715,70,1.08 [0.41-2.84],0.883278751872151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,1715,70,3.36 [1.25-8.99],0.0159010689048993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTR1,Endosome-associated-trafficking regulator 1,1483,60,0.95 [0.68-1.33],0.7577665885351248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EP300,Histone acetyltransferase p300,1481,58,0.83 [0.38-1.83],0.6483922336415469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPB41L5,Band 4.1-like protein 5,1489,57,0.91 [0.59-1.39],0.6623995273284214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPCAM,Epithelial cell adhesion molecule,1744,71,0.95 [0.75-1.21],0.687179853862247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPGN,Epigen,1526,59,0.94 [0.49-1.82],0.860250335781464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA1,Ephrin type-A receptor 1,1749,71,2.12 [1.13-3.98],0.0189182430983126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA10,Ephrin type-A receptor 10,1687,70,1.24 [0.94-1.64],0.1330492443943884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA2,Ephrin type-A receptor 2,1681,69,3.51 [2.27-5.44],1.9172683623472147e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA4,Ephrin type-A receptor 4,1502,60,1.37 [0.60-3.12],0.4516645315804853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB4,Ephrin type-B receptor 4,1773,72,5.20 [2.97-9.11],8.42013561565394e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB6,Ephrin type-B receptor 6,1725,71,3.27 [1.92-5.57],1.3769097670156612e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHX2,Bifunctional epoxide hydrolase 2,1715,70,1.16 [0.85-1.59],0.3595700267627513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPN1,Epsin-1,1504,59,0.53 [0.23-1.19],0.1233473902116769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPO,Erythropoietin,1749,72,1.21 [0.96-1.53],0.1040146885949317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPPK1,Epiplakin,1483,60,0.79 [0.56-1.11],0.1777750657516849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,1766,73,1.54 [0.88-2.69],0.1318224581851013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,1749,73,2.05 [0.95-4.40],0.066126065222079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,1742,71,7.96 [3.22-19.68],6.986437814640182e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,1749,73,4.22 [2.06-8.65],8.350602222793574e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBIN,Erbin,1737,71,0.98 [0.80-1.20],0.8607049326607775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERC2,ERC protein 2,1489,57,0.70 [0.43-1.14],0.1483517460032296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERCC1,DNA excision repair protein ERCC-1,1473,59,0.44 [0.19-1.04],0.06147786687374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EREG,Proepiregulin,1725,71,1.16 [0.92-1.46],0.2059557538490167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERI1,3'-5' exoribonuclease 1,1504,59,1.01 [0.50-2.03],0.9841787031068758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERMAP,Erythroid membrane-associated protein,1481,58,1.71 [1.01-2.88],0.0454571790248406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,1526,59,1.10 [0.54-2.23],0.8019525611011694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERP29,Endoplasmic reticulum resident protein 29,1502,60,0.88 [0.71-1.07],0.1992114618854482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERP44,Endoplasmic reticulum resident protein 44,1734,71,0.91 [0.42-1.98],0.8180004324594828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,1485,57,1.50 [0.92-2.45],0.1078563979000582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESAM,Endothelial cell-selective adhesion molecule,1773,72,3.04 [1.81-5.13],2.919590940487546e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESM1,Endothelial cell-specific molecule 1,1745,71,1.96 [1.15-3.35],0.0132670436457231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESPL1,Separin,1473,59,1.26 [0.88-1.79],0.2082244469238971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESR1,Estrogen receptor,1481,58,0.55 [0.28-1.06],0.075109733238857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESYT2,Extended synaptotagmin-2,1517,58,0.89 [0.66-1.21],0.4648790137103944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVI2B,Protein EVI2B,1473,59,0.68 [0.30-1.57],0.3678542882343173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVI5,Ecotropic viral integration site 5 protein homolog,1481,58,0.88 [0.67-1.15],0.3415550238257452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVPL,Envoplakin,1504,59,1.26 [0.58-2.75],0.5643040804416372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXOSC10,Exosome component 10,1485,57,0.45 [0.22-0.92],0.0286492848987401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXTL1,Exostosin-like 1,1485,57,1.26 [0.80-1.98],0.3103535274561659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EZR,Ezrin,1759,71,1.57 [0.71-3.45],0.262163057974875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F10,Coagulation factor X,1537,60,0.88 [0.38-2.02],0.7551086014315946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F11,Coagulation factor XI,1519,57,2.90 [1.29-6.52],0.0101319239419883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F11R,Junctional adhesion molecule A,1756,72,1.17 [0.82-1.69],0.3856916897690819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F12,Coagulation factor XII,1541,59,1.27 [0.69-2.34],0.449199308545811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F13B,Coagulation factor XIII B chain,1532,58,1.58 [0.61-4.07],0.3456753058032042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2,Prothrombin,1541,59,0.40 [0.08-1.97],0.2580490989810339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2R,Proteinase-activated receptor 1,1750,71,1.52 [1.07-2.16],0.0200038970982833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F3,Tissue factor,1754,73,2.51 [1.34-4.71],0.0040839593769645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F7,Coagulation factor VII,1759,72,1.09 [0.58-2.04],0.7955825041288862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F9,Coagulation factor IX,1760,72,2.10 [0.66-6.71],0.2109809787658866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP1,"Fatty acid-binding protein, liver",1745,71,1.46 [1.22-1.76],4.6941422597120665e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP2,"Fatty acid-binding protein, intestinal",1750,72,1.36 [1.08-1.71],0.0091849645067327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP3,"Fatty acid-binding protein, heart",1532,60,2.38 [1.70-3.32],3.634198703402819e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP4,"Fatty acid-binding protein, adipocyte",1773,72,2.10 [1.58-2.80],4.243081419339085e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP5,Fatty acid-binding protein 5,1756,71,1.21 [0.88-1.66],0.2336795452593365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP6,Gastrotropin,1712,70,1.38 [1.01-1.87],0.0400447657194081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP9,Fatty acid-binding protein 9,1749,72,0.91 [0.63-1.33],0.6401201040392279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FADD,FAS-associated death domain protein,1750,72,0.94 [0.72-1.23],0.6631015522747711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM13A,Protein FAM13A,1522,57,0.97 [0.67-1.40],0.8560653442524839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM171A2,Protein FAM171A2,1532,59,1.05 [0.91-1.21],0.5333234773668689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM171B,Protein FAM171B,1526,59,1.13 [0.50-2.53],0.7682385539358089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM172A,Cotranscriptional regulator FAM172A,1483,60,0.74 [0.50-1.11],0.1442438265319738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM20A,Pseudokinase FAM20A,1532,60,1.21 [0.53-2.78],0.6472382168404549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3B,Protein FAM3B,1737,71,2.07 [1.22-3.53],0.0073611115836885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3C,Protein FAM3C,1750,72,4.32 [2.57-7.27],3.26424644641904e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3D,Protein FAM3D,1522,57,1.50 [1.13-1.99],0.0050724952909901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAP,Prolyl endopeptidase FAP,1773,72,0.74 [0.39-1.42],0.364437371955071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,1489,57,1.06 [0.75-1.49],0.7452725547755131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAS,Tumor necrosis factor receptor superfamily member 6,1771,72,1.49 [1.00-2.21],0.0492382890263945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FASLG,Tumor necrosis factor ligand superfamily member 6,1775,73,1.37 [0.79-2.34],0.2592372480064823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBLN2,Fibulin-2,1536,59,1.91 [0.99-3.67],0.0532722530278821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBN2,Fibrillin-2,1489,57,1.37 [0.93-2.03],0.1151980807304478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBP1,"Fructose-1,6-bisphosphatase 1",1750,72,1.19 [0.94-1.52],0.1496256947822856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,1532,60,1.23 [0.89-1.69],0.2133649582137731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCAR,Immunoglobulin alpha Fc receptor,1749,72,1.68 [1.11-2.53],0.013934312085217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,1532,59,1.09 [0.43-2.79],0.8494570030847384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,1756,72,1.56 [1.16-2.10],0.003341956613247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,1752,71,1.17 [0.80-1.71],0.4131762789907075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,1685,69,1.02 [0.72-1.46],0.8915066469078596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,1758,72,1.07 [0.71-1.63],0.7424760788998519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN1,Ficolin-1,1535,60,1.54 [0.95-2.48],0.0799450651768279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN2,Ficolin-2,1749,71,0.81 [0.50-1.31],0.3811800834701119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL1,Fc receptor-like protein 1,1750,72,1.32 [0.86-2.03],0.2084211178568113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL2,Fc receptor-like protein 2,1763,73,1.77 [1.24-2.53],0.001703611690862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL3,Fc receptor-like protein 3,1710,70,1.23 [0.85-1.77],0.269140362977215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL5,Fc receptor-like protein 5,1756,72,1.30 [0.93-1.82],0.118842176897092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL6,Fc receptor-like protein 6,1749,72,1.46 [1.07-2.00],0.0179010201522423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRLB,Fc receptor-like B,1685,69,1.32 [0.98-1.78],0.0674188223963098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FDX1,"Adrenodoxin, mitochondrial",1485,57,1.22 [0.89-1.67],0.2082630097010404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FDX2,"Ferredoxin-2, mitochondrial",1485,57,1.49 [1.05-2.11],0.0259053011979734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FEN1,Flap endonuclease 1,1685,69,1.14 [0.90-1.46],0.2822490095052679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FES,Tyrosine-protein kinase Fes/Fps,1685,69,0.80 [0.50-1.29],0.3647794139273416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FETUB,Fetuin-B,1760,72,0.88 [0.46-1.69],0.6989170718498086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGA,Fibrinogen alpha chain,1504,58,1.63 [0.77-3.46],0.2057957457978132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",1532,59,0.93 [0.69-1.25],0.6132413837576132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF12,Fibroblast growth factor 12,1481,58,0.87 [0.45-1.68],0.669135679428996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF16,Fibroblast growth factor 16,1481,58,0.62 [0.34-1.14],0.1245900882292166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF19,Fibroblast growth factor 19,1752,71,1.21 [0.94-1.56],0.134866028604239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF2,Fibroblast growth factor 2,1749,72,1.10 [0.83-1.46],0.5186149968093621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF20,Fibroblast growth factor 20,1481,58,0.62 [0.28-1.41],0.2574951687132727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF21,Fibroblast growth factor 21,1764,73,1.38 [1.19-1.61],2.285697631908709e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF23,Fibroblast growth factor 23,1761,73,1.54 [1.24-1.91],8.281487330488366e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF3,Fibroblast growth factor 3,1481,58,1.47 [0.62-3.48],0.3841782225168189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF5,Fibroblast growth factor 5,1710,70,2.04 [1.38-3.01],0.0003766754014532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF6,Fibroblast growth factor 6,1481,58,1.01 [0.51-2.02],0.970640967714782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF7,Fibroblast growth factor 7,1473,59,0.55 [0.33-0.90],0.0187812837903706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF9,Fibroblast growth factor 9,1469,59,0.94 [0.51-1.73],0.8361514136680575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP1,Fibroblast growth factor-binding protein 1,1749,73,0.61 [0.39-0.97],0.0354481217360307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP2,Fibroblast growth factor-binding protein 2,1536,59,0.86 [0.54-1.37],0.5231257703578629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP3,Fibroblast growth factor-binding protein 3,1517,58,1.22 [0.64-2.33],0.542068477902413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR2,Fibroblast growth factor receptor 2,1749,73,3.75 [2.27-6.20],2.587407588085704e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR4,Fibroblast growth factor receptor 4,1502,60,1.17 [0.72-1.88],0.5293845664919974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGL1,Fibrinogen-like protein 1,1537,60,1.80 [1.26-2.55],0.0010662083469732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGR,Tyrosine-protein kinase Fgr,1687,70,1.03 [0.76-1.39],0.8357472155915361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FH,"Fumarate hydratase, mitochondrial",1478,58,1.07 [0.82-1.39],0.634337107065627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,1485,57,0.51 [0.27-0.95],0.0328339494804493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FHIT,Bis(5'-adenosyl)-triphosphatase,1687,70,0.79 [0.59-1.05],0.1038175435361052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FIS1,Mitochondrial fission 1 protein,1747,71,1.01 [0.77-1.31],0.959120644475764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,1532,59,0.91 [0.71-1.17],0.4493726775337445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,1758,73,1.07 [0.90-1.26],0.4586806621400584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,1731,71,1.23 [0.75-2.02],0.4157101552674985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,1731,71,0.99 [0.79-1.23],0.9060092526832492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,1681,70,1.09 [0.72-1.65],0.6876764721090232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBPL,FK506-binding protein-like,1522,57,1.03 [0.67-1.57],0.8955387960496393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLI1,Friend leukemia integration 1 transcription factor,1685,69,1.02 [0.84-1.23],0.8756842849984872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,1731,71,1.92 [0.99-3.72],0.0538002619198798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT1,Vascular endothelial growth factor receptor 1,1736,71,1.36 [0.53-3.47],0.518650704623908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,1685,69,0.76 [0.37-1.59],0.4675232367779254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,1775,73,1.81 [1.01-3.26],0.046215093817068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT4,Vascular endothelial growth factor receptor 3,1749,73,1.39 [0.78-2.50],0.2665779155055547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FMNL1,Formin-like protein 1,1687,70,1.12 [0.88-1.43],0.3505299700993093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FMR1,Synaptic functional regulator FMR1,1685,69,1.17 [0.63-2.18],0.6127874059906915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FN1,Fibronectin,1541,59,0.58 [0.24-1.40],0.2227009321779532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FNDC1,Fibronectin type III domain-containing protein 1,1517,58,1.16 [0.70-1.92],0.5704563037396468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,1526,59,0.90 [0.42-1.94],0.7813906945865806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLH1,Glutamate carboxypeptidase 2,1481,58,0.97 [0.75-1.25],0.7954347076256731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR1,Folate receptor alpha,1744,73,3.26 [1.92-5.52],1.194404557372772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR2,Folate receptor beta,1759,71,1.71 [0.86-3.40],0.1246904670975489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR3,Folate receptor gamma,1746,73,0.99 [0.88-1.10],0.7920162661619875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOS,Proto-oncogene c-Fos,1469,59,1.65 [0.83-3.27],0.1544994007594946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOSB,Protein fosB,1687,70,1.05 [0.63-1.75],0.8384447261927487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXJ3,Forkhead box protein J3,1481,58,0.75 [0.42-1.35],0.3408049031836535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXO1,Forkhead box protein O1,1749,72,0.99 [0.79-1.26],0.963310080742286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXO3,Forkhead box protein O3,1685,69,1.04 [0.83-1.30],0.7337774256784378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRMD4B,FERM domain-containing protein 4B,1485,57,0.80 [0.55-1.16],0.2452244514499636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRMD7,FERM domain-containing protein 7,1489,57,1.29 [0.66-2.53],0.4523767144573072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRZB,Secreted frizzled-related protein 3,1722,71,1.23 [0.54-2.79],0.6187248725111539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSHB,Follitropin subunit beta,1483,60,1.30 [0.81-2.09],0.2720751751047356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FST,Follistatin,1750,71,1.51 [0.99-2.31],0.0545602772602761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL1,Follistatin-related protein 1,1483,60,2.48 [0.90-6.85],0.0792898271421568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL3,Follistatin-related protein 3,1743,71,3.67 [2.38-5.64],3.233530116999712e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FTCD,Formimidoyltransferase-cyclodeaminase,1516,58,1.06 [0.84-1.33],0.6219813045146393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUCA1,Tissue alpha-L-fucosidase,1765,72,1.09 [0.84-1.41],0.5221459263149963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUOM,Fucose mutarotase,1502,60,1.18 [0.86-1.62],0.3013120490209594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FURIN,Furin,1749,73,0.78 [0.47-1.30],0.3328237983360115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUS,RNA-binding protein FUS,1679,69,1.48 [0.89-2.45],0.1292747805079368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",1500,59,1.01 [0.67-1.52],0.9674703238852552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,1759,71,1.76 [1.13-2.76],0.012874863891362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT8,"Alpha-(1,6)-fucosyltransferase",1731,71,1.14 [0.80-1.62],0.4713555170379414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FXN,"Frataxin, mitochondrial",1767,73,0.96 [0.73-1.27],0.7771474305274585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FXYD5,FXYD domain-containing ion transport regulator 5,1710,70,0.97 [0.71-1.33],0.8477151433213852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FYB1,FYN-binding protein 1,1752,72,0.96 [0.77-1.20],0.7385696908630863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FZD10,Frizzled-10,1489,57,0.83 [0.48-1.44],0.5107492804315437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FZD8,Frizzled-8,1478,58,1.26 [0.73-2.18],0.4087116777487101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,1526,59,1.12 [0.69-1.84],0.6476687326962787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,1504,59,0.90 [0.61-1.33],0.6059439261003137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,1478,58,1.02 [0.71-1.45],0.9313640000710446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAD1,Glutamate decarboxylase 1,1473,59,0.71 [0.27-1.87],0.4918796705732726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAD2,Glutamate decarboxylase 2,1481,58,0.96 [0.51-1.79],0.8979257504071526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,1504,59,0.98 [0.59-1.62],0.9346292298069074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,1483,60,0.72 [0.45-1.16],0.1781783665134985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAGE2A,G antigen 2A,1473,59,0.79 [0.50-1.25],0.317066190772892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAL,Galanin peptides,1752,71,1.07 [0.78-1.46],0.6800013992820533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,1737,71,2.34 [1.15-4.75],0.0185862057080737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,1767,73,0.76 [0.36-1.58],0.4550428094760569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,1710,70,1.69 [1.07-2.65],0.0232028844590726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,1532,60,1.11 [0.46-2.69],0.8111697217680411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT7,N-acetylgalactosaminyltransferase 7,1737,71,2.58 [0.89-7.45],0.0806696741198669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAMT,Guanidinoacetate N-methyltransferase,1485,57,0.81 [0.39-1.69],0.5718616474415736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,1471,57,2.60 [0.95-7.07],0.0617741292584211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GART,Trifunctional purine biosynthetic protein adenosine-3,1532,59,0.64 [0.21-1.98],0.4391175696720879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAS2,Growth arrest-specific protein 2,1504,59,0.86 [0.52-1.43],0.5711667840755754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAS6,Growth arrest-specific protein 6,1766,72,2.40 [1.11-5.16],0.0254796453200586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GASK1A,Golgi-associated kinase 1A,1485,57,0.62 [0.35-1.09],0.0970713399427504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAST,Gastrin,1517,58,1.19 [1.03-1.39],0.020281228904727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,1473,59,0.29 [0.12-0.70],0.0055305602384804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",1483,60,0.82 [0.60-1.12],0.2078787172501038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBA,Lysosomal acid glucosylceramidase,1489,57,1.05 [0.65-1.69],0.8561569226194551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP1,Guanylate-binding protein 1,1514,58,1.21 [0.85-1.73],0.2866815842530701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP2,Guanylate-binding protein 2,1710,70,1.11 [0.79-1.56],0.5550519935186464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP4,Guanylate-binding protein 4,1687,70,1.09 [0.71-1.67],0.6854850851345553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP6,Guanylate-binding protein 6,1485,57,1.30 [0.84-2.01],0.2334570418756901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GC,Vitamin D-binding protein,1541,59,2.39 [0.94-6.04],0.0664509997231211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCC1,GRIP and coiled-coil domain-containing protein 1,1517,58,0.90 [0.72-1.12],0.3518885677543366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCG,Pro-glucagon,1685,69,1.28 [1.08-1.51],0.004370993753591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,1464,57,1.09 [0.70-1.70],0.6990047006254698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCLM,Glutamate--cysteine ligase regulatory subunit,1485,57,0.83 [0.47-1.48],0.5359463401439214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",1737,71,2.17 [1.21-3.89],0.0097723517059742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF15,Growth/differentiation factor 15,1773,72,2.80 [2.16-3.63],1.0059406865887548e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF2,Growth/differentiation factor 2,1750,72,1.24 [0.71-2.16],0.4544719767740331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDNF,Glial cell line-derived neurotrophic factor,1687,70,1.92 [1.21-3.06],0.0058274145925189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GET3,ATPase GET3,1532,60,1.23 [0.84-1.81],0.2908807549781668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFAP,Glial fibrillary acidic protein,1683,69,1.29 [0.84-1.98],0.2502095388112817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFER,FAD-linked sulfhydryl oxidase ALR,1685,69,1.16 [0.85-1.60],0.3491199296529531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,1685,69,1.00 [0.84-1.19],0.989605561581426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA1,GDNF family receptor alpha-1,1764,73,4.27 [2.35-7.76],1.8564018748005208e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA2,GDNF family receptor alpha-2,1737,71,1.24 [0.44-3.54],0.6864983352579925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA3,GDNF family receptor alpha-3,1729,71,3.34 [1.71-6.55],0.0004249822585453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRAL,GDNF family receptor alpha-like,1477,57,0.90 [0.60-1.35],0.605296490913692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGA1,ADP-ribosylation factor-binding protein GGA1,1687,70,0.74 [0.50-1.11],0.1504910497191136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGACT,Gamma-glutamylaminecyclotransferase,1532,60,0.92 [0.64-1.31],0.6370377294981463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGCT,Gamma-glutamylcyclotransferase,1531,60,0.83 [0.49-1.40],0.4818961637435532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGH,Gamma-glutamyl hydrolase,1733,70,0.73 [0.38-1.40],0.3427776594441268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT1,Glutathione hydrolase 1 proenzyme,1754,72,1.43 [1.04-1.97],0.0283194893647579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT5,Glutathione hydrolase 5 proenzyme,1731,71,4.63 [2.41-8.90],4.396652701310132e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GH1,Somatotropin,1750,72,1.05 [0.94-1.17],0.4289785633206631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GH2,Growth hormone variant,1685,69,0.96 [0.83-1.10],0.5167948168248545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHR,Growth hormone receptor,1502,60,0.51 [0.22-1.16],0.1064988503356176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHRHR,Growth hormone-releasing hormone receptor,1687,70,1.05 [0.70-1.57],0.828524827055481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHRL,Appetite-regulating hormone,1750,72,1.02 [0.79-1.31],0.8800953530270879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GID8,Glucose-induced degradation protein 8 homolog,1532,59,0.98 [0.44-2.19],0.9695167419136496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIGYF2,GRB10-interacting GYF protein 2,1532,59,1.01 [0.74-1.38],0.9389182754746505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIMAP7,GTPase IMAP family member 7,1502,60,1.13 [0.55-2.29],0.743198462251071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIMAP8,GTPase IMAP family member 8,1473,59,1.00 [0.61-1.66],0.9922499387474188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIP,Gastric inhibitory polypeptide,1483,60,1.09 [0.65-1.81],0.7525067210387044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC2,PDZ domain-containing protein GIPC2,1517,58,2.65 [1.38-5.08],0.0033372829947145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC3,PDZ domain-containing protein GIPC3,1522,57,0.85 [0.67-1.09],0.2049875501239361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPR,Gastric inhibitory polypeptide receptor,1481,58,1.36 [0.91-2.05],0.1344708587866527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIT1,ARF GTPase-activating protein GIT1,1481,58,0.86 [0.66-1.11],0.2404472977081093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GJA8,Gap junction alpha-8 protein,1473,59,0.79 [0.49-1.28],0.3400671103565214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GKN1,Gastrokine-1,1647,69,1.12 [0.52-2.42],0.7709497418120843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLA,Alpha-galactosidase A,1498,59,1.51 [0.80-2.84],0.2006747687946722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLB1,Beta-galactosidase,1731,71,1.00 [0.62-1.62],0.9863569394995716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLI2,Zinc finger protein GLI2,1481,58,0.59 [0.23-1.54],0.2789612240287833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLO1,Lactoylglutathione lyase,1715,70,0.88 [0.60-1.27],0.4914006371190844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLOD4,Glyoxalase domain-containing protein 4,1745,71,0.97 [0.53-1.75],0.908351011729914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLP1R,Glucagon-like peptide 1 receptor,1478,58,1.11 [0.56-2.19],0.7584637816754771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLRX,Glutaredoxin-1,1737,72,0.90 [0.63-1.29],0.5733023848319736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",1502,60,0.87 [0.66-1.15],0.3205022467011391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,1687,70,1.60 [1.16-2.20],0.0039480169957518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLYR1,Putative oxidoreductase GLYR1,1526,59,0.82 [0.50-1.34],0.4213591097559994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GM2A,Ganglioside GM2 activator,1505,58,2.23 [1.41-3.55],0.0006379043056911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMFG,Glia maturation factor gamma,1532,60,0.86 [0.62-1.21],0.3978978774957549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMPR,GMP reductase 1,1775,73,0.92 [0.61-1.39],0.7070822718777788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMPR2,GMP reductase 2,1502,60,0.84 [0.57-1.22],0.3520466391928526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNAS,Neuroendocrine secretory protein 55,1532,59,0.85 [0.64-1.15],0.2921736308610055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,1685,69,0.91 [0.64-1.28],0.5905781128069505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,1489,57,0.94 [0.56-1.56],0.8059472570829038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNLY,Granulysin,1756,72,1.14 [0.79-1.66],0.4807627362490435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,1483,60,1.13 [0.60-2.12],0.7077328300409742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,1502,60,0.61 [0.33-1.15],0.1282013490724219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLGA3,Golgin subfamily A member 3,1532,59,0.87 [0.62-1.21],0.4009592620234987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLM2,Protein GOLM2,1759,71,2.39 [1.05-5.46],0.0386950661177914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,1749,72,1.05 [0.86-1.28],0.6561441556268448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GORASP2,Golgi reassembly-stacking protein 2,1522,57,0.71 [0.41-1.21],0.2036942448812087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOT1,"Aspartate aminotransferase, cytoplasmic",1536,59,0.87 [0.53-1.43],0.5741650825542872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP1BA,Platelet glycoprotein Ib alpha chain,1747,71,0.97 [0.52-1.79],0.9139283253360324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP1BB,Platelet glycoprotein Ib beta chain,1485,57,0.86 [0.59-1.26],0.4357664644336947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,1689,70,1.14 [0.93-1.40],0.2089462336327215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP5,Platelet glycoprotein V,1502,60,1.08 [0.53-2.18],0.8310851822146752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP6,Platelet glycoprotein VI,1752,72,1.01 [0.80-1.28],0.9054695507845684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPA33,Cell surface A33 antigen,1737,71,0.80 [0.68-0.95],0.0092275020994757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPC1,Glypican-1,1767,73,1.29 [0.66-2.54],0.4608609777788522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPC5,Glypican-5,1731,71,0.95 [0.66-1.37],0.7807410011157906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPD1,Glycerol-3-phosphate dehydrogenase,1526,59,1.06 [0.73-1.54],0.76657934733048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPHA2,Glycoprotein hormone alpha-2,1522,57,0.75 [0.38-1.50],0.4159857615196478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPI,Glucose-6-phosphate isomerase,1537,60,0.91 [0.55-1.50],0.7188753989928778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,1522,57,1.12 [0.78-1.60],0.5430104363335846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPKOW,G-patch domain and KOW motifs-containing protein,1687,70,1.41 [0.86-2.32],0.1772700238586398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPNMB,Transmembrane glycoprotein NMB,1704,70,2.00 [0.98-4.11],0.0577346794016377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR101,Probable G-protein coupled receptor 101,1478,58,1.14 [0.82-1.58],0.444170506135314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR158,Probable G-protein coupled receptor 158,1532,59,1.38 [0.79-2.39],0.2526898980598439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR15L,Protein GPR15L,1522,57,1.03 [0.70-1.53],0.8692970120752883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR37,Prosaposin receptor GPR37,1715,70,2.54 [1.88-3.42],8.395752465824463e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPRC5C,G-protein coupled receptor family C group 5 member C,1526,59,1.54 [1.13-2.10],0.0067586113350165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRAP2,GRB2-related adapter protein 2,1750,72,0.97 [0.83-1.14],0.726925425236687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,1532,60,0.99 [0.67-1.45],0.9417307649462872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",1532,59,0.53 [0.25-1.16],0.1125886260500045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",1478,58,0.79 [0.46-1.38],0.411907845500208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRK5,G protein-coupled receptor kinase 5,1715,70,0.92 [0.62-1.38],0.6947044603790813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRN,Progranulin,1748,72,3.46 [1.52-7.91],0.0031620281557943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRP,Gastrin-releasing peptide,1483,60,1.01 [0.64-1.60],0.9665472456074464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",1737,71,1.26 [0.95-1.67],0.1024750166773777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRSF1,G-rich sequence factor 1,1464,59,0.87 [0.64-1.18],0.3693620915688351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSAP,Gamma-secretase-activating protein,1685,69,0.97 [0.74-1.27],0.8215298668076325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSN,Gelsolin,1529,60,0.41 [0.16-1.05],0.0625499087216813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSR,"Glutathione reductase, mitochondrial",1528,59,0.73 [0.29-1.80],0.4900965331041437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTA1,Glutathione S-transferase A1,1746,72,0.91 [0.73-1.12],0.3579794538128886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTA3,Glutathione S-transferase A3,1685,69,0.87 [0.68-1.10],0.2471422054790987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTM4,Glutathione S-transferase Mu 4,1485,57,1.04 [0.76-1.43],0.8063884813598965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTP1,Glutathione S-transferase P,1677,70,0.87 [0.62-1.22],0.4263041486560063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTT2B,Glutathione S-transferase theta-2B,1517,58,0.99 [0.89-1.10],0.8631067985783478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,1504,59,0.97 [0.69-1.39],0.886818146756958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GTPBP2,GTP-binding protein 2,1489,57,0.86 [0.63-1.18],0.3529056606641511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCA2A,Guanylin,1744,72,2.15 [1.32-3.49],0.0019466561108417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCY2C,Heat-stable enterotoxin receptor,1504,59,1.07 [0.79-1.44],0.665183150212363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUK1,Guanylate kinase,1485,57,0.88 [0.39-1.98],0.7613307088806537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUSB,Beta-glucuronidase,1765,72,1.00 [0.74-1.35],0.9923123540577548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GYS1,"Glycogen [starch] synthase, muscle",1715,70,0.89 [0.71-1.12],0.3368355691697616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMA,Granzyme A,1775,73,1.65 [0.93-2.92],0.0841071198355155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMB,Granzyme B,1749,72,0.69 [0.48-1.01],0.0539100447828477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMH,Granzyme H,1715,70,0.97 [0.73-1.27],0.8106228647011694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,H2AP,Huntingtin-interacting protein M,1473,59,0.90 [0.53-1.53],0.7014628663234417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",1485,57,1.28 [0.95-1.74],0.1072088356674382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",1761,73,0.90 [0.67-1.21],0.4839079371108027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAO1,Hydroxyacid oxidase 1,1767,73,1.00 [0.86-1.17],0.9900213949214552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",1756,72,0.98 [0.75-1.27],0.8541554991832824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR1,Hepatitis A virus cellular receptor 1,1764,73,2.05 [1.71-2.47],2.1914933204303703e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR2,Hepatitis A virus cellular receptor 2,1756,72,3.03 [1.90-4.83],3.306888839185184e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBEGF,Proheparin-binding EGF-like growth factor,1761,73,1.26 [0.96-1.65],0.0897099798956173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBQ1,Hemoglobin subunit theta-1,1767,73,0.65 [0.46-0.93],0.0175168818679278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBZ,Hemoglobin subunit zeta,1532,60,0.83 [0.65-1.06],0.1326873423577915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HCG22,Protein PBMUCL2,1485,57,1.04 [0.66-1.62],0.8797992342088047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HCLS1,Hematopoietic lineage cell-specific protein,1775,73,0.88 [0.60-1.29],0.5230668305160895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDAC8,Histone deacetylase 8,1481,58,0.77 [0.44-1.33],0.3430406537758312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDAC9,Histone deacetylase 9,1478,58,0.69 [0.41-1.18],0.1745471247996569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDDC2,5'-deoxynucleotidase HDDC2,1522,57,1.08 [0.60-1.92],0.8005762291515998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDGF,Hepatoma-derived growth factor,1764,73,1.03 [0.82-1.29],0.7833412387738612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,1517,58,1.04 [0.71-1.52],0.8383476447434954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEBP1,Heme-binding protein 1,1715,70,0.83 [0.52-1.32],0.4352451882064249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEG1,Protein HEG homolog 1,1502,60,2.19 [0.95-5.03],0.0657621880926156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPACAM2,HEPACAM family member 2,1517,58,0.68 [0.39-1.20],0.1803005901937149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPH,Hephaestin,1532,60,4.98 [2.00-12.40],0.0005603775868305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEXIM1,Protein HEXIM1,1749,72,0.97 [0.75-1.25],0.7913690094219639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGF,Hepatocyte growth factor,1775,73,1.28 [0.75-2.16],0.3662095915708107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGFAC,Hepatocyte growth factor activator,1524,58,1.63 [0.64-4.14],0.3042087017622804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,1685,69,0.99 [0.75-1.30],0.9377386008644556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,1517,58,1.08 [0.78-1.48],0.6509111831418251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIF1A,Hypoxia-inducible factor 1-alpha,1481,58,1.04 [0.73-1.49],0.8263849159982111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIP1,Huntingtin-interacting protein 1,1485,57,0.84 [0.39-1.82],0.661405478423717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIP1R,Huntingtin-interacting protein 1-related protein,1517,58,1.26 [0.96-1.65],0.092879057034559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HJV,Hemojuvelin,1532,59,1.22 [0.71-2.10],0.4689376976960877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HK2,Hexokinase-2,1715,70,0.70 [0.31-1.54],0.3706252121196571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",1532,59,2.81 [1.24-6.36],0.0134490637453936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",1744,71,1.68 [0.98-2.86],0.058226034702549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",1749,72,2.26 [1.31-3.89],0.0033379508674475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMBS,Porphobilinogen deaminase,1767,73,0.80 [0.49-1.29],0.3584355560832966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMCN2,Hemicentin-2,1499,59,0.92 [0.61-1.40],0.7045575118516059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",1483,60,0.73 [0.44-1.22],0.2288082002699781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",1485,57,0.95 [0.53-1.71],0.8670777490311615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMMR,Hyaluronan mediated motility receptor,1472,59,0.89 [0.53-1.50],0.6536133576348415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX1,Heme oxygenase 1,1735,71,1.00 [0.66-1.51],0.9937759182574314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX2,Heme oxygenase 2,1687,70,1.36 [0.96-1.94],0.0879827317677559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNF1A,Hepatocyte nuclear factor 1-alpha,1489,57,0.90 [0.61-1.33],0.5983726079876814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNMT,Histamine N-methyltransferase,1718,71,1.51 [1.07-2.12],0.0176228640518585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,1710,70,0.94 [0.71-1.23],0.6421085262144393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,1532,59,1.15 [0.74-1.78],0.5353884933107206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPCAL1,Hippocalcin-like protein 1,1775,73,0.89 [0.69-1.16],0.3999677224328548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPGDS,Hematopoietic prostaglandin D synthase,1685,69,0.51 [0.29-0.90],0.0204786845149056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPSE,Heparanase,1523,58,1.16 [0.89-1.52],0.2664022479705425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRAS,GTPase Hras,1502,59,0.91 [0.68-1.22],0.5216077764676521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,1483,60,1.57 [0.88-2.78],0.1254710491422423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRG,Histidine-rich glycoprotein,1532,58,2.73 [1.20-6.18],0.0162666963629442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS1BP3,HCLS1-binding protein 3,1483,60,0.86 [0.66-1.13],0.2908398178877229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,1737,71,1.15 [0.68-1.94],0.5918195971870246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,1767,73,1.17 [0.66-2.08],0.5955921736067418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,1481,58,1.79 [0.98-3.27],0.0578874820182331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSBP1,Heat shock factor-binding protein 1,1483,60,1.04 [0.80-1.34],0.7892123069669028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,1749,72,1.06 [0.66-1.71],0.8030534875171429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,1517,58,1.15 [0.79-1.67],0.4672796263948503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,1485,57,0.94 [0.55-1.62],0.8335411310990807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,1483,60,1.12 [0.69-1.83],0.6374129982204086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSP90B1,Endoplasmin,1683,70,1.06 [0.79-1.43],0.7021399543425718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA1A,Heat shock 70 kDa protein 1A,1749,71,1.00 [0.76-1.33],0.9748666728245168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA2,Heat shock-related 70 kDa protein 2,1526,59,1.22 [0.69-2.16],0.4862276347596803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB1,Heat shock protein beta-1,1721,72,0.98 [0.73-1.33],0.9187479284113208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB6,Heat shock protein beta-6,1767,73,2.41 [1.56-3.72],7.385725381329282e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,1747,71,2.99 [1.81-4.93],1.7355293918381226e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTR1A,5-hydroxytryptamine receptor 1A,1478,58,0.62 [0.37-1.03],0.0630554904073297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTR1B,5-hydroxytryptamine receptor 1B,1478,58,1.08 [0.62-1.87],0.788553731251475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTRA2,"Serine protease HTRA2, mitochondrial",1749,73,1.10 [0.80-1.52],0.5515258691600085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYAL1,Hyaluronidase-1,1739,72,3.72 [1.63-8.49],0.0017527943461963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYOU1,Hypoxia up-regulated protein 1,1773,72,3.12 [1.40-6.95],0.0055060672132629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICA1,Islet cell autoantigen 1,1710,70,0.91 [0.70-1.19],0.506575111616107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM1,Intercellular adhesion molecule 1,1752,71,2.08 [1.13-3.82],0.0188403712435416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM2,Intercellular adhesion molecule 2,1773,72,2.55 [1.33-4.90],0.0047859816233424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM3,Intercellular adhesion molecule 3,1773,72,1.86 [0.91-3.80],0.087493356781053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM4,Intercellular adhesion molecule 4,1749,72,0.87 [0.59-1.29],0.4946850582935121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM5,Intercellular adhesion molecule 5,1750,72,1.24 [0.78-1.98],0.3702760101922387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICOSLG,ICOS ligand,1737,71,2.01 [0.69-5.84],0.2013524846411701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ID4,DNA-binding protein inhibitor ID-4,1504,59,1.02 [0.59-1.75],0.9506195561492604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,1687,70,1.29 [0.85-1.96],0.2249510146026434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDO1,"Indoleamine 2,3-dioxygenase 1",1483,60,1.18 [0.82-1.71],0.3731504688325252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDS,Iduronate 2-sulfatase,1775,73,0.39 [0.04-3.55],0.4030241209643239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDUA,Alpha-L-iduronidase,1767,73,1.44 [0.92-2.27],0.1142508030130767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,1475,54,1.34 [0.71-2.52],0.3663130107805185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,1504,59,1.04 [0.63-1.70],0.8880204646059952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,1504,59,0.86 [0.46-1.63],0.6463025268397912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNAR1,Interferon alpha/beta receptor 1,1522,57,1.41 [0.51-3.87],0.5073512610302963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNG,Interferon gamma,1710,70,1.06 [0.87-1.28],0.5761945750174065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR1,Interferon gamma receptor 1,1752,71,4.55 [2.00-10.36],0.0003007007663412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR2,Interferon gamma receptor 2,1731,71,1.34 [0.93-1.94],0.1184265778795066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL1,Interferon lambda-1,1687,70,1.23 [0.84-1.80],0.286444311817615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL2,Interferon lambda-2,1478,58,1.18 [0.80-1.74],0.3970530139115217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNLR1,Interferon lambda receptor 1,1749,72,1.30 [0.78-2.16],0.3115077214900383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNW1,Interferon omega-1,1485,57,1.06 [0.53-2.13],0.8667943309139008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFT20,Intraflagellar transport protein 20 homolog,1489,57,0.85 [0.48-1.50],0.5729578036401648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGBP1,Immunoglobulin-binding protein 1,1532,59,0.87 [0.58-1.30],0.4879009878676559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,1478,58,0.61 [0.29-1.25],0.177275533624402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,1536,59,0.64 [0.26-1.58],0.3324391893625699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF1R,Insulin-like growth factor 1 receptor,1737,71,6.76 [2.93-15.63],7.778334593585327e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,1485,57,0.34 [0.15-0.75],0.0075226691072469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF2R,Cation-independent mannose-6-phosphate receptor,1756,72,2.78 [1.23-6.25],0.0135782083161695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP1,Insulin-like growth factor-binding protein 1,1770,72,1.26 [1.07-1.47],0.004839587622535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP2,Insulin-like growth factor-binding protein 2,1771,72,1.66 [1.26-2.19],0.0003348248082977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP3,Insulin-like growth factor-binding protein 3,1760,72,0.68 [0.42-1.12],0.1283368004918646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP4,Insulin-like growth factor-binding protein 4,1728,70,2.49 [1.79-3.45],5.6333841575270895e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP6,Insulin-like growth factor-binding protein 6,1752,71,2.15 [1.29-3.58],0.0034577006970471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP7,Insulin-like growth factor-binding protein 7,1773,72,2.68 [1.71-4.21],1.878555302899408e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,1750,72,2.67 [1.73-4.11],8.388798875771e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFL4,Insulin growth factor-like family member 4,1481,58,0.86 [0.56-1.32],0.4901860610251797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGHMBP2,DNA-binding protein SMUBP-2,1485,57,1.01 [0.66-1.54],0.9708122749171364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGLC2,Immunoglobulin lambda constant 2,1536,59,1.91 [0.89-4.10],0.0980340771265058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGLON5,IgLON family member 5,1473,59,1.01 [0.76-1.34],0.9584578667966324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF21,Immunoglobulin superfamily member 21,1483,60,1.38 [0.93-2.05],0.1055653307175529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF3,Immunoglobulin superfamily member 3,1737,71,1.85 [1.22-2.81],0.0037756907062574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF8,Immunoglobulin superfamily member 8,1750,72,3.01 [1.65-5.47],0.0003063063988598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF9,Protein turtle homolog A,1532,60,1.44 [1.13-1.84],0.0028326953184871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IKBKG,NF-kappa-B essential modulator,1749,72,0.99 [0.79-1.25],0.961975060893508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IKZF2,Zinc finger protein Helios,1685,69,1.01 [0.80-1.28],0.9180215541991597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10,Interleukin-10,1710,70,1.18 [0.91-1.52],0.2135808338850471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RA,Interleukin-10 receptor subunit alpha,1710,70,1.02 [0.73-1.42],0.9041430993020332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RB,Interleukin-10 receptor subunit beta,1752,71,4.97 [2.75-9.00],1.161058831096114e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL11,Interleukin-11,1710,70,1.15 [0.86-1.54],0.3468395927262452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12A_IL12B,Interleukin-12,1737,71,1.31 [1.02-1.67],0.0319885431801199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12B,Interleukin-12 subunit beta,1775,73,1.39 [0.97-1.99],0.0707942329211373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12RB1,Interleukin-12 receptor subunit beta-1,1710,70,1.76 [1.01-3.05],0.0460158415830524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12RB2,Interleukin-12 receptor subunit beta-2,1481,58,1.03 [0.58-1.81],0.9294411013949586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13,Interleukin-13,1710,70,0.80 [0.48-1.34],0.4047768228584033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,1721,72,1.61 [0.70-3.72],0.265687294120659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,1478,58,0.56 [0.23-1.37],0.2010951085746981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15,Interleukin-15,1749,72,2.26 [1.51-3.38],7.67644343347401e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15RA,Interleukin-15 receptor subunit alpha,1710,70,1.79 [1.03-3.11],0.0390766394687675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL16,Pro-interleukin-16,1775,73,1.18 [0.78-1.78],0.4316618496251238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17A,Interleukin-17A,1708,70,0.87 [0.50-1.50],0.6213617376105952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17C,Interleukin-17C,1710,70,1.50 [1.21-1.85],0.0001778884596838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17D,Interleukin-17D,1710,70,1.83 [1.07-3.14],0.0280755738778497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17F,Interleukin-17F,1710,70,0.87 [0.63-1.21],0.4099615707267585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17RA,Interleukin-17 receptor A,1756,72,0.92 [0.57-1.48],0.718397356569152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17RB,Interleukin-17 receptor B,1725,72,1.07 [0.74-1.55],0.7288067880613361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18,Interleukin-18,1742,71,1.64 [1.06-2.52],0.0251662307469016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18BP,Interleukin-18-binding protein,1760,72,3.29 [1.98-5.48],4.517912350228706e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18R1,Interleukin-18 receptor 1,1775,73,2.63 [1.61-4.29],0.0001105410928157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18RAP,Interleukin-18 receptor accessory protein,1712,70,0.86 [0.75-0.99],0.0324897974297151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL19,Interleukin-19,1703,70,1.26 [0.98-1.64],0.0766663290987737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1A,Interleukin-1 alpha,1710,70,0.94 [0.65-1.37],0.7565196053411631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1B,Interleukin-1 beta,1704,70,0.84 [0.58-1.21],0.3548490687557366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R1,Interleukin-1 receptor type 1,1754,72,5.81 [3.02-11.19],1.4495637273268937e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R2,Interleukin-1 receptor type 2,1744,71,2.55 [0.93-6.98],0.0686302715941275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RAP,Interleukin-1 receptor accessory protein,1756,72,0.97 [0.61-1.53],0.887405140562575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL1,Interleukin-1 receptor-like 1,1771,72,1.57 [1.02-2.42],0.040688058193941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL2,Interleukin-1 receptor-like 2,1710,70,1.61 [0.92-2.82],0.0951154442325381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RN,Interleukin-1 receptor antagonist protein,1740,70,1.30 [0.97-1.75],0.0747694957825759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2,Interleukin-2,1710,70,2.57 [1.32-5.04],0.0057378957876195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20,Interleukin-20,1710,70,1.04 [0.73-1.48],0.8370442656838996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20RA,Interleukin-20 receptor subunit alpha,1710,70,1.53 [1.08-2.18],0.0181145510032064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20RB,Interleukin-20 receptor subunit beta,1481,58,1.03 [0.58-1.83],0.9060950661702448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL21R,Interleukin-21 receptor,1481,58,0.40 [0.20-0.77],0.0065269739130029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL22,Interleukin-22,1526,59,1.05 [0.74-1.51],0.774820008689503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,1710,70,1.18 [0.77-1.83],0.4444791723056832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL24,Interleukin-24,1710,70,1.33 [0.88-2.00],0.1798872005099726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL25,Interleukin-25,1467,59,0.81 [0.39-1.67],0.5646411514114572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RA,Interleukin-2 receptor subunit alpha,1748,71,2.59 [1.66-4.02],2.4666756169264805e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RB,Interleukin-2 receptor subunit beta,1710,70,1.42 [0.84-2.39],0.1867737846150501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RG,Cytokine receptor common subunit gamma,1526,59,1.46 [1.01-2.12],0.0440533492350543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL3,Interleukin-3,1473,59,0.92 [0.61-1.38],0.6765831017628767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL31,Interleukin-31,1481,58,0.96 [0.61-1.53],0.8764982607756627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL31RA,Interleukin-31 receptor subunit alpha,1476,58,1.52 [0.81-2.84],0.1888401645829218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL32,Interleukin-32,1749,72,1.23 [0.85-1.77],0.2698109958897086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL33,Interleukin-33,1710,70,1.39 [0.85-2.27],0.1942351740261629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL34,Interleukin-34,1685,70,1.43 [0.80-2.55],0.233427831169823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL36A,Interleukin-36 alpha,1481,58,0.52 [0.28-0.94],0.0316901331383324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL36G,Interleukin-36 gamma,1479,58,0.82 [0.53-1.26],0.3618323916289248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL3RA,Interleukin-3 receptor subunit alpha,1710,70,1.45 [0.74-2.83],0.2798196265056979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4,Interleukin-4,1710,70,0.97 [0.75-1.25],0.7987556733560155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4R,Interleukin-4 receptor subunit alpha,1749,72,2.58 [1.67-3.99],1.8359639143609764e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL5,Interleukin-5,1710,70,0.90 [0.76-1.07],0.2189742593209876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL5RA,Interleukin-5 receptor subunit alpha,1749,72,1.24 [0.88-1.75],0.2280070546080917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6,Interleukin-6,1737,71,1.01 [0.77-1.34],0.9192860771893976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6R,Interleukin-6 receptor subunit alpha,1748,71,2.26 [1.23-4.15],0.0088533665465813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6ST,Interleukin-6 receptor subunit beta,1750,72,4.51 [1.50-13.57],0.0072982358712491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL7,Interleukin-7,1749,72,0.78 [0.56-1.07],0.1205316489326105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL7R,Interleukin-7 receptor subunit alpha,1756,72,1.11 [0.75-1.65],0.5892729226933973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL9,Interleukin-9,1504,59,0.88 [0.51-1.51],0.6439902002697857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,1686,70,0.90 [0.63-1.31],0.5930260701636991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMMT,MICOS complex subunit MIC60,1526,59,1.72 [1.16-2.57],0.0074487240691567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPA1,Inositol monophosphatase 1,1731,71,0.98 [0.70-1.38],0.9269940762427612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPACT,Protein IMPACT,1517,58,0.76 [0.48-1.20],0.2363622666228423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,1478,58,0.35 [0.13-0.99],0.0488446506112382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ING1,Inhibitor of growth protein 1,1681,70,0.92 [0.59-1.44],0.7192808785722317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBB,Inhibin beta B chain,1502,60,2.31 [1.59-3.37],1.2601813408495416e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBC,Inhibin beta C chain,1756,72,1.73 [0.99-3.04],0.0548422374137205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP1,Inositol polyphosphate 1-phosphatase,1737,71,1.13 [0.77-1.64],0.5291799439939555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",1483,60,1.02 [0.67-1.55],0.9342134602134105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",1532,59,1.40 [0.80-2.42],0.2359580924091272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",1737,71,0.99 [0.80-1.22],0.931148412448408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL3,Insulin-like 3,1517,58,0.79 [0.59-1.05],0.1090944622294039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL4,Early placenta insulin-like peptide,1526,59,1.55 [1.10-2.18],0.0114883291097174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL5,Insulin-like peptide INSL5,1522,57,1.25 [0.99-1.59],0.0602135539135785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSR,Insulin receptor,1481,58,4.83 [1.56-14.91],0.0062208026375686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,1725,71,1.05 [0.83-1.33],0.6680506034981347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,1737,71,1.21 [0.85-1.73],0.2897742250079903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",1715,70,1.08 [0.86-1.34],0.5089519502186352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAK1,Interleukin-1 receptor-associated kinase 1,1710,70,1.01 [0.75-1.35],0.965188191807361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAK4,Interleukin-1 receptor-associated kinase 4,1749,72,0.96 [0.79-1.17],0.7023135172018937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,1656,69,0.71 [0.41-1.25],0.2423786457928888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISM1,Isthmin-1,1749,72,1.04 [0.63-1.73],0.8701001296580819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISM2,Isthmin-2,1536,59,1.44 [1.05-1.98],0.0243916971519699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IST1,IST1 homolog,1510,57,0.93 [0.71-1.20],0.5603062303684119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA11,Integrin alpha-11,1749,72,0.90 [0.49-1.65],0.7359529136377745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA2,Integrin alpha-2,1502,60,0.88 [0.44-1.76],0.7120268334614839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA5,Integrin alpha-5,1756,72,2.41 [1.24-4.66],0.0093535206986964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA6,Integrin alpha-6,1749,72,0.73 [0.48-1.11],0.1452419954507716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAL,Integrin alpha-L,1481,58,0.84 [0.48-1.45],0.5234250144242222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAM,Integrin alpha-M,1756,72,1.87 [1.04-3.37],0.0375307181711069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAV,Integrin alpha-V,1767,73,0.71 [0.23-2.23],0.5591129447927106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAX,Integrin alpha-X,1504,59,1.00 [0.61-1.65],0.9852758100937936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1,Integrin beta-1,1755,72,2.47 [1.01-6.05],0.0477101476347841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1BP1,Integrin beta-1-binding protein 1,1685,69,1.52 [0.88-2.63],0.1286270054158906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1BP2,Integrin beta-1-binding protein 2,1715,70,0.93 [0.77-1.12],0.4318890032176937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB2,Integrin beta-2,1745,71,2.08 [1.08-4.00],0.0285188247555232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB5,Integrin beta-5,1749,73,1.19 [0.74-1.92],0.4613713232373813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB6,Integrin beta-6,1710,70,2.43 [1.20-4.89],0.0131461993341626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB7,Integrin beta-7,1767,73,1.27 [0.85-1.92],0.2462030920309573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGBL1,Integrin beta-like protein 1,1536,59,1.71 [1.17-2.49],0.0057750285207421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,1541,59,0.88 [0.25-3.16],0.8460873494379805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,1760,72,2.69 [1.58-4.59],0.0002820855983862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,1541,59,1.53 [0.61-3.85],0.3661611333739331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,1526,59,1.08 [0.61-1.92],0.7837883728329138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITM2A,Integral membrane protein 2A,1749,72,1.05 [0.74-1.50],0.7873772555909403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPA,Inosine triphosphate pyrophosphatase,1485,57,0.77 [0.53-1.11],0.1624444917612418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",1483,60,1.28 [0.97-1.70],0.0818838691941598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",1478,58,1.01 [0.59-1.73],0.9734848872876553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",1687,70,0.59 [0.37-0.94],0.0257337636711635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IZUMO1,Izumo sperm-egg fusion protein 1,1473,59,1.09 [0.67-1.76],0.7316285478390845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM2,Junctional adhesion molecule B,1759,71,3.73 [2.04-6.81],1.832733530426969e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM3,Junctional adhesion molecule C,1502,60,1.38 [0.90-2.13],0.144032964631735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JCHAIN,Immunoglobulin J chain,1710,70,1.17 [0.83-1.65],0.3578323999090166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,1473,59,0.83 [0.53-1.33],0.4448011938065398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JPT2,Jupiter microtubule associated homolog 2,1522,57,0.90 [0.68-1.20],0.477355874399669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JUN,Transcription factor AP-1,1710,70,1.33 [0.97-1.81],0.0726453152069138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,1737,71,1.65 [1.03-2.66],0.037151778245872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZN,Kazrin,1522,57,0.88 [0.70-1.11],0.2746629952603065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,1478,58,0.80 [0.47-1.36],0.4056226311156898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,1489,57,0.98 [0.67-1.42],0.90573728444294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNIP4,Kv channel-interacting protein 4,1687,70,0.95 [0.62-1.44],0.7947434470094872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCTD5,BTB/POZ domain-containing protein KCTD5,1496,57,1.09 [0.71-1.69],0.6941241282887728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KDM3A,Lysine-specific demethylase 3A,1481,58,0.97 [0.73-1.30],0.8494916728693567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KDR,Vascular endothelial growth factor receptor 2,1749,73,1.96 [0.86-4.42],0.1074794907284255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KEL,Kell blood group glycoprotein,1687,70,0.88 [0.49-1.56],0.6526659413892736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KHDC3L,KH domain-containing protein 3,1473,59,1.15 [0.84-1.57],0.3827724350194862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KHK,Ketohexokinase,1483,60,0.94 [0.66-1.35],0.7392950270663288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA0319,Dyslexia-associated protein KIAA0319,1517,58,1.21 [0.59-2.46],0.6007338113903173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA1549,UPF0606 protein KIAA1549,1504,59,1.20 [0.83-1.72],0.3381460831409604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA1549L,UPF0606 protein KIAA1549L,1504,59,0.90 [0.37-2.20],0.819513972343083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA2013,Uncharacterized protein KIAA2013,1526,59,0.62 [0.33-1.17],0.1418939242198338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF1C,Kinesin-like protein KIF1C,1485,57,1.34 [0.65-2.77],0.4289627774512848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF20B,Kinesin-like protein KIF20B,1478,58,1.12 [0.84-1.49],0.4502494978291494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF22,Kinesin-like protein KIF22,1485,57,0.74 [0.60-0.91],0.0036710634311943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIFBP,KIF-binding protein,1737,71,1.03 [0.80-1.32],0.812512587395851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,1526,59,1.25 [0.96-1.62],0.094579747868168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,1685,69,1.20 [0.93-1.54],0.1681973098590152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,1522,57,0.92 [0.79-1.07],0.3011747261498019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,1685,69,0.86 [0.72-1.03],0.1032182992939336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,1473,59,0.71 [0.46-1.10],0.1204764773212961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIRREL1,Kin of IRRE-like protein 1,1478,58,0.90 [0.52-1.55],0.6972957031602511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIRREL2,Kin of IRRE-like protein 2,1687,70,0.64 [0.38-1.09],0.0991690868853996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIT,Mast/stem cell growth factor receptor Kit,1760,72,0.87 [0.44-1.74],0.701613786614636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KITLG,Kit ligand,1750,72,1.36 [0.82-2.24],0.2358804886976523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLB,Beta-klotho,1687,70,1.26 [0.95-1.67],0.1040657540534332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLF4,Krueppel-like factor 4,1478,58,1.28 [0.76-2.15],0.3579643802108455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLHL41,Kelch-like protein 41,1532,59,0.84 [0.49-1.45],0.5357978580871025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK1,Kallikrein-1,1734,73,1.02 [0.87-1.20],0.7628346495105678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK10,Kallikrein-10,1744,73,1.71 [1.08-2.69],0.0215196458110392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK11,Kallikrein-11,1729,72,3.38 [2.34-4.88],9.006976653536927e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK12,Kallikrein-12,1685,69,0.94 [0.81-1.10],0.4595665515485564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK13,Kallikrein-13,1692,69,0.91 [0.59-1.39],0.6551505972856967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK14,Kallikrein-14,1767,73,1.17 [0.76-1.79],0.4812207593667563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK15,Kallikrein-15,1524,59,0.89 [0.55-1.46],0.648782787864633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK3,Prostate-specific antigen,1536,59,0.95 [0.73-1.24],0.7220347233268074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK4,Kallikrein-4,1767,73,1.86 [1.46-2.37],5.593184329388733e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK6,Kallikrein-6,1747,73,1.57 [0.84-2.93],0.1535077398523041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK7,Kallikrein-7,1463,57,0.55 [0.28-1.08],0.0846893876647427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK8,Kallikrein-8,1681,72,1.98 [1.19-3.32],0.0089226760385577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLKB1,Plasma kallikrein,1505,58,2.87 [1.05-7.79],0.0389949339729998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,1775,73,3.21 [1.96-5.26],3.4298138868520405e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,1478,58,0.81 [0.49-1.36],0.4271721872941731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRD1,Natural killer cells antigen CD94,1775,73,1.58 [1.03-2.41],0.0349236999534122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,1481,58,1.48 [0.97-2.26],0.0719940500595098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRK1,NKG2-D type II integral membrane protein,1517,58,1.88 [1.09-3.23],0.0225225873766181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT14,"Keratin, type I cytoskeletal 14",1634,66,1.39 [0.71-2.71],0.3336289937347612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT17,"Keratin, type I cytoskeletal 17",1485,57,1.32 [0.76-2.29],0.3273272090728507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT18,"Keratin, type I cytoskeletal 18",1737,71,1.18 [0.98-1.41],0.0798101099798901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT19,"Keratin, type I cytoskeletal 19",1745,72,2.04 [1.60-2.59],6.4532428919080515e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT5,"Keratin, type II cytoskeletal 5",1687,70,1.02 [0.70-1.49],0.9198968377401816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT6C,"Keratin, type II cytoskeletal 6C",1485,57,0.91 [0.46-1.78],0.7773898638239964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT8,"Keratin, type II cytoskeletal 8",1478,58,1.08 [0.91-1.28],0.3813086414617433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,1749,72,1.06 [0.75-1.50],0.7228641156066693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYNU,Kynureninase,1775,73,0.83 [0.57-1.21],0.3303954723190362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,L1CAM,Neural cell adhesion molecule L1,1749,73,2.00 [1.03-3.88],0.0412506603643954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,1532,60,0.89 [0.68-1.18],0.432805335065392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LACRT,Extracellular glycoprotein lacritin,1519,59,0.98 [0.51-1.90],0.9534905862490476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LACTB2,Endoribonuclease LACTB2,1750,72,0.94 [0.69-1.29],0.713053413631275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAG3,Lymphocyte activation gene 3 protein,1737,71,1.79 [1.25-2.55],0.0014441601907622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,1745,71,2.42 [1.75-3.35],1.0586989237380607e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,1731,71,1.16 [0.93-1.45],0.1939234074629421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMA1,Laminin subunit alpha-1,1485,57,0.68 [0.36-1.29],0.2354304762469228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMA4,Laminin subunit alpha-4,1752,71,2.60 [1.48-4.55],0.000874985236214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMB1,Laminin subunit beta-1,1483,60,1.72 [0.80-3.71],0.1676391175520256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP1,Lysosome-associated membrane glycoprotein 1,1501,59,3.27 [1.56-6.87],0.0017363680620817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP2,Lysosome-associated membrane glycoprotein 2,1690,69,2.12 [0.75-5.95],0.1560046876752504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP3,Lysosome-associated membrane glycoprotein 3,1772,73,1.39 [0.94-2.04],0.0951296952608779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMTOR5,Ragulator complex protein LAMTOR5,1526,59,0.93 [0.50-1.72],0.8079165557908429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAP3,Cytosol aminopeptidase,1710,70,0.89 [0.56-1.41],0.627933455767439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LARP1,La-related protein 1,1526,59,0.97 [0.65-1.44],0.8628500768453878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAT,Linker for activation of T-cells family member 1,1775,73,1.09 [0.83-1.44],0.5430344933441871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAT2,Linker for activation of T-cells family member 2,1737,71,1.01 [0.86-1.18],0.9328742819783142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LATS1,Serine/threonine-protein kinase LATS1,1481,58,0.86 [0.65-1.15],0.3075839430396002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAYN,Layilin,1725,71,3.68 [2.42-5.59],9.697144615000575e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LBP,Lipopolysaccharide-binding protein,1760,72,1.09 [0.76-1.54],0.6486938200935863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LBR,Delta(14)-sterol reductase LBR,1759,71,1.08 [0.83-1.41],0.5592931894639965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCAT,Phosphatidylcholine-sterol acyltransferase,1537,60,0.77 [0.27-2.26],0.6392260315636372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN15,Lipocalin-15,1532,59,1.39 [1.09-1.77],0.0080686101744512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN2,Neutrophil gelatinase-associated lipocalin,1709,71,1.78 [1.15-2.76],0.0097423725082028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCP1,Plastin-2,1536,59,1.17 [0.71-1.94],0.5375169592338909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LDLR,Low-density lipoprotein receptor,1753,72,1.02 [0.71-1.48],0.8968763646403418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,1532,59,0.88 [0.70-1.13],0.3180953225841688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LECT2,Leukocyte cell-derived chemotaxin-2,1532,60,1.57 [1.10-2.24],0.013035118954378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEFTY2,Left-right determination factor 2,1764,73,1.42 [0.97-2.07],0.0700708615027574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEG1,Protein LEG1 homolog,1438,56,1.35 [0.95-1.92],0.0924471198743785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LELP1,Late cornified envelope-like proline-rich protein 1,1478,58,0.93 [0.64-1.34],0.7017284153926486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEO1,RNA polymerase-associated protein LEO1,1532,59,1.44 [0.70-2.96],0.3152999070008116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEP,Leptin,1750,72,0.88 [0.66-1.18],0.3938314516871709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEPR,Leptin receptor,1750,72,2.12 [1.25-3.60],0.0052140777719555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LETM1,Mitochondrial proton/calcium exchanger protein,1532,59,0.95 [0.61-1.48],0.8242637329176181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS1,Galectin-1,1750,72,1.27 [0.73-2.22],0.3905087667209707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3,Galectin-3,1754,71,2.67 [1.41-5.05],0.0024597752250256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3BP,Galectin-3-binding protein,1541,59,1.83 [0.95-3.56],0.0726578502510475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS4,Galectin-4,1745,71,2.22 [1.69-2.91],1.0401811773746054e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS7_LGALS7B,Galectin-7,1753,71,1.34 [0.85-2.10],0.2042045590663227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS8,Galectin-8,1759,71,0.90 [0.64-1.27],0.5461257063721696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS9,Galectin-9,1748,71,2.78 [1.55-5.01],0.0006447362988274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGMN,Legumain,1752,71,1.67 [0.97-2.89],0.0643963446413646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LHB,Lutropin subunit beta,1685,69,1.16 [0.95-1.43],0.1478196671786022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,1742,70,0.79 [0.55-1.14],0.2051139965560429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIF,Leukemia inhibitory factor,1687,70,1.05 [0.74-1.49],0.7808794455564402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIFR,Leukemia inhibitory factor receptor,1749,72,9.31 [4.89-17.72],1.0753047908062151e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,1756,72,1.09 [0.61-1.93],0.7761500679604812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,1536,59,1.00 [0.84-1.20],0.9865961513906942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,1485,57,0.88 [0.50-1.57],0.677022587422472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,1750,72,2.11 [1.09-4.10],0.0270033260556655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,1532,60,0.75 [0.55-1.04],0.0837989003069102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,1773,72,1.22 [0.58-2.58],0.5983360014195228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,1769,72,1.02 [0.56-1.87],0.9368428988324646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,1710,70,2.29 [1.47-3.57],0.0002622846721952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,1773,72,1.14 [0.84-1.56],0.4094386578343322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIPF,Gastric triacylglycerol lipase,1483,60,1.01 [0.70-1.45],0.96310768718246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB1,Lamin-B1,1517,57,1.10 [0.78-1.56],0.5947628769350559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB2,Lamin-B2,1517,58,1.45 [0.67-3.12],0.342582761129064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,1532,59,2.00 [1.36-2.94],0.0004202934939856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD2,Leiomodin-2,1478,58,0.90 [0.59-1.36],0.616990794265353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LONP1,"Lon protease homolog, mitochondrial",1483,60,0.89 [0.68-1.17],0.4177434935005395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPA,Apolipoprotein(a),1498,57,0.93 [0.81-1.07],0.3239067757025027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,1737,71,1.22 [0.90-1.66],0.2019343901641532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPL,Lipoprotein lipase,1750,72,0.92 [0.61-1.40],0.6976184271450857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPO,Lactoperoxidase,1694,71,1.70 [1.27-2.29],0.000434952149827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPP,Lipoma-preferred partner,1485,57,0.81 [0.55-1.19],0.2736930893565639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,1485,57,0.98 [0.67-1.43],0.9269850361835352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,1489,57,1.18 [0.71-1.94],0.521680050973567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRG1,Leucine-rich alpha-2-glycoprotein,1541,59,3.43 [1.55-7.59],0.0023347633899994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,1761,73,2.17 [1.22-3.85],0.0083420836533365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,1475,58,0.95 [0.38-2.39],0.9088857913006236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,1737,71,1.84 [0.88-3.84],0.1055582353920424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP11,Low-density lipoprotein receptor-related protein 11,1750,72,2.16 [1.31-3.57],0.0025817441480928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP2,Low-density lipoprotein receptor-related protein 2,1489,57,1.11 [0.56-2.20],0.763620843912697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP2BP,LRP2-binding protein,1489,57,0.85 [0.59-1.23],0.3874517690547403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,1759,71,1.35 [1.01-1.82],0.0432290225295387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC25,Leucine-rich repeat-containing protein 25,1737,71,1.24 [0.74-2.07],0.4105928961344806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,1522,57,1.03 [0.58-1.84],0.914508786216012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC38,Leucine-rich repeat-containing protein 38,1489,57,1.36 [0.84-2.22],0.2122036714064065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC59,Leucine-rich repeat-containing protein 59,1532,60,0.75 [0.44-1.26],0.2770935250390134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,1526,59,0.86 [0.52-1.41],0.5426141204060617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRN1,Leucine-rich repeat neuronal protein 1,1710,70,0.60 [0.35-1.03],0.0623068626318643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,1489,57,0.71 [0.34-1.48],0.3631168910378042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,1532,59,0.53 [0.20-1.39],0.196511154743754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,1685,69,1.20 [0.82-1.74],0.3432415308014865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,1504,59,0.83 [0.58-1.19],0.3067343840001666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSP1,Lymphocyte-specific protein 1,1749,72,1.44 [0.87-2.37],0.1579067568605844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTA,Lymphotoxin-alpha,1749,72,0.92 [0.54-1.56],0.762995671062153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTA4H,Leukotriene A-4 hydrolase,1767,73,0.71 [0.49-1.02],0.0662670173102189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTB,Lymphotoxin-beta,1526,59,0.76 [0.34-1.70],0.5061119679500861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,1773,72,3.51 [2.30-5.37],6.873732301355921e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,1685,69,1.39 [1.06-1.83],0.0193007635256435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBR,Tumor necrosis factor receptor superfamily member 3,1740,71,3.27 [2.05-5.20],5.972113824934751e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTO1,Protein LTO1 homolog,1710,70,0.82 [0.46-1.46],0.4959198369983878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LUZP2,Leucine zipper protein 2,1526,59,1.23 [0.79-1.90],0.3553409770662764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LXN,Latexin,1721,71,0.91 [0.65-1.26],0.567188659973806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY6D,Lymphocyte antigen 6D,1730,70,1.57 [1.01-2.45],0.0472698880281566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY75,Lymphocyte antigen 75,1749,72,1.19 [0.70-2.02],0.5226244527972683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY9,T-lymphocyte surface antigen Ly-9,1728,71,2.77 [1.49-5.15],0.0013053932176087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY96,Lymphocyte antigen 96,1731,71,2.21 [1.44-3.38],0.0002814287164381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYAR,Cell growth-regulating nucleolar protein,1685,69,1.02 [0.68-1.53],0.9328411701493788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYN,Tyrosine-protein kinase Lyn,1737,71,1.02 [0.80-1.31],0.8815484223862593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD1,Ly6/PLAUR domain-containing protein 1,1687,70,0.85 [0.58-1.25],0.4112647829623194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD3,Ly6/PLAUR domain-containing protein 3,1730,71,2.52 [1.46-4.38],0.0009766153189218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD8,Ly6/PLAUR domain-containing protein 8,1685,69,1.42 [0.94-2.15],0.0958806428600206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPLA2,Acyl-protein thioesterase 2,1478,58,0.78 [0.57-1.07],0.1236118226107818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,1489,57,0.86 [0.64-1.14],0.2866766052381208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,1541,59,2.55 [0.79-8.25],0.1171866288197239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYZL2,Lysozyme-like protein 2,1473,59,0.94 [0.47-1.89],0.8568524219663856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LZTFL1,Leucine zipper transcription factor-like protein 1,1502,60,0.82 [0.58-1.16],0.2681407518606032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,M6PR,Cation-dependent mannose-6-phosphate receptor,1483,60,0.79 [0.39-1.60],0.5192733287953797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,1723,71,1.31 [0.99-1.72],0.0548188929958066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAEA,E3 ubiquitin-protein transferase MAEA,1685,69,1.11 [0.66-1.88],0.6946059237287627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAG,Myelin-associated glycoprotein,1489,57,0.58 [0.35-0.97],0.0367010835455514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAGEA3,Melanoma-associated antigen 3,1504,59,1.06 [0.78-1.45],0.7058556882325288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAGED1,Melanoma-associated antigen D1,1685,69,1.14 [0.73-1.77],0.5763747273649367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC2,MAM domain-containing protein 2,1532,60,2.55 [1.47-4.39],0.00079896859807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC4,Apical endosomal glycoprotein,1526,59,1.79 [1.23-2.61],0.0024179358626687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",1483,60,2.86 [1.09-7.50],0.032991014919656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAN2B2,Epididymis-specific alpha-mannosidase,1532,60,0.94 [0.62-1.42],0.7641166169044563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",1473,59,1.30 [0.83-2.04],0.2433103149571043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,1752,71,1.03 [0.87-1.22],0.7191682621552535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC1,MANSC domain-containing protein 1,1749,73,2.79 [1.47-5.32],0.0017778291291448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC4,MANSC domain-containing protein 4,1485,57,0.59 [0.38-0.91],0.0171142753329433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,1478,58,0.63 [0.27-1.42],0.2636139074212779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,1485,57,0.86 [0.54-1.37],0.5309208017867976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2,Microtubule-associated protein 2,1517,58,1.55 [1.01-2.39],0.0461126701073455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,1522,57,1.01 [0.68-1.51],0.9515574986364952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,1749,72,0.93 [0.76-1.14],0.5040349442199326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,1685,69,1.03 [0.82-1.28],0.8191271950471508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,1725,71,0.97 [0.81-1.16],0.7390653807876407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPK13,Mitogen-activated protein kinase 13,1473,59,0.92 [0.51-1.64],0.774478509608461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPK9,Mitogen-activated protein kinase 9,1749,72,1.61 [1.03-2.50],0.0350630935536247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPKAPK2,MAP kinase-activated protein kinase 2,1504,59,0.88 [0.63-1.23],0.4555592358157163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,1473,59,1.01 [0.86-1.19],0.874230498140498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPT,Microtubule-associated protein tau,1687,70,0.86 [0.58-1.27],0.4401166037908586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MARCO,Macrophage receptor MARCO,1750,72,0.86 [0.40-1.84],0.7019771765117925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",1498,59,0.89 [0.67-1.18],0.4240285431251249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MASP1,Mannan-binding lectin serine protease 1,1725,71,1.99 [0.83-4.76],0.1236255988390179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN2,Matrilin-2,1747,71,1.53 [0.82-2.87],0.1828278227847219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN3,Matrilin-3,1725,71,0.83 [0.45-1.55],0.5646280026452632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAVS,Mitochondrial antiviral-signaling protein,1685,69,1.03 [0.82-1.30],0.7770665572420126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAX,Protein max,1687,70,1.03 [0.85-1.26],0.7484372080615425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MB,Myoglobin,1773,72,1.32 [0.94-1.85],0.1117928777602948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MBL2,Mannose-binding protein C,1519,58,0.93 [0.74-1.16],0.5115536514524208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCAM,Cell surface glycoprotein MUC18,1760,72,2.60 [1.49-4.56],0.0008151941810758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",1532,59,0.76 [0.38-1.49],0.4187865579347505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCEMP1,Mast cell-expressed membrane protein 1,1481,58,0.86 [0.64-1.16],0.3164363547970799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCFD2,Multiple coagulation factor deficiency protein 2,1737,72,1.13 [0.73-1.75],0.5813045025425854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCTS1,Malignant T-cell-amplified sequence 1,1522,57,1.36 [0.59-3.11],0.4735656570069249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,1731,71,1.90 [1.41-2.55],2.3749566109129832e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDH1,"Malate dehydrogenase, cytoplasmic",1527,59,0.68 [0.36-1.29],0.2380393454314461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDK,Midkine,1744,73,2.18 [1.55-3.07],8.366968277855466e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDM1,Nuclear protein MDM1,1489,57,0.65 [0.29-1.45],0.2900973806282554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",1483,60,0.84 [0.64-1.09],0.1919715595265828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MED18,Mediator of RNA polymerase II transcription subunit 18,1685,69,1.00 [0.75-1.32],0.9778360908767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MED21,Mediator of RNA polymerase II transcription subunit 21,1485,57,0.88 [0.50-1.57],0.6761108588795849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,1745,71,1.16 [0.69-1.93],0.5804591147105898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,1485,57,1.22 [0.51-2.94],0.6535284594311042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,1771,72,1.88 [0.74-4.76],0.1856241128352901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MELTF,Melanotransferrin,1532,60,2.37 [1.11-5.08],0.0261242335746646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MENT,Protein MENT,1502,60,0.37 [0.14-1.00],0.0501463842447523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEP1A,Meprin A subunit alpha,1522,57,0.94 [0.68-1.29],0.6964375767494735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEP1B,Meprin A subunit beta,1750,72,0.85 [0.72-1.01],0.0593929906325722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEPE,Matrix extracellular phosphoglycoprotein,1745,71,0.50 [0.25-1.01],0.052531414137914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MERTK,Tyrosine-protein kinase Mer,1775,73,3.64 [1.89-7.01],0.0001135393683132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MESD,LRP chaperone MESD,1756,72,0.99 [0.84-1.17],0.9068436460126376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MET,Hepatocyte growth factor receptor,1753,70,1.36 [0.48-3.83],0.5586196176201057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP1,Methionine aminopeptidase 1,1687,70,0.64 [0.30-1.37],0.2528259145956694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",1749,72,0.96 [0.75-1.23],0.7382971139129773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP2,Methionine aminopeptidase 2,1764,73,0.99 [0.68-1.44],0.9569046798754858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP3,Microfibril-associated glycoprotein 3,1715,70,1.03 [0.68-1.57],0.8870332183130114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP3L,Microfibrillar-associated protein 3-like,1489,57,0.99 [0.67-1.45],0.9562408514307422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP4,Microfibril-associated glycoprotein 4,1502,60,3.46 [1.81-6.59],0.0001685774535833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP5,Microfibrillar-associated protein 5,1773,72,1.39 [0.86-2.24],0.174293336817553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFGE8,Lactadherin,1756,72,1.73 [1.24-2.41],0.0012904213596089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MGLL,Monoglyceride lipase,1750,71,0.95 [0.76-1.20],0.6897603715854486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,1749,72,0.96 [0.81-1.14],0.6461958885884027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MIA,Melanoma-derived growth regulatory protein,1749,73,0.92 [0.55-1.52],0.7371934174121495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MICALL2,MICAL-like protein 2,1489,57,1.00 [0.70-1.43],0.9812079794671568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,1749,72,1.00 [0.87-1.15],0.9971420540561308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MIF,Macrophage migration inhibitory factor,1753,72,1.03 [0.76-1.40],0.8640408766655131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MILR1,Allergin-1,1710,70,1.56 [1.06-2.29],0.0233714001088625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,1526,59,0.87 [0.70-1.09],0.216148665759825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MINK1,Misshapen-like kinase 1,1517,58,0.89 [0.68-1.17],0.4141616519880483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MITD1,MIT domain-containing protein 1,1731,71,0.95 [0.77-1.18],0.650023872530105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MKI67,Proliferation marker protein Ki-67,1481,58,0.56 [0.24-1.32],0.1868621936013667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLLT1,Protein ENL,1473,59,0.93 [0.63-1.37],0.7108286752491177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLN,Promotilin,1749,72,1.14 [0.91-1.44],0.2606606449185726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MME,Neprilysin,1737,71,1.39 [1.10-1.76],0.0055679067543469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP1,Interstitial collagenase,1708,69,1.48 [1.16-1.90],0.0017944191656456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP10,Stromelysin-2,1742,71,1.68 [1.22-2.32],0.0015795016881073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP12,Macrophage metalloelastase,1752,73,1.70 [1.26-2.30],0.0005589115025103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP13,Collagenase 3,1687,70,1.38 [0.71-2.66],0.3370593864897497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP15,Matrix metalloproteinase-15,1532,60,1.14 [0.72-1.82],0.5701323312021576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP3,Stromelysin-1,1756,72,1.19 [0.81-1.75],0.367875667059834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP7,Matrilysin,1714,70,2.70 [1.76-4.13],5.08239785407746e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP8,Neutrophil collagenase,1756,71,0.93 [0.70-1.24],0.6136604647897868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP9,Matrix metalloproteinase-9,1754,72,0.94 [0.67-1.32],0.714281243974519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",1485,57,0.91 [0.54-1.53],0.7105526961091165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MN1,Transcriptional activator MN1,1489,57,0.78 [0.46-1.33],0.3590440077157074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MNAT1,CDK-activating kinase assembly factor MAT1,1504,59,0.85 [0.47-1.55],0.6017458803900491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MNDA,Myeloid cell nuclear differentiation antigen,1746,72,0.98 [0.81-1.20],0.8649847767946771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOCS2,Molybdopterin synthase catalytic subunit,1502,60,0.94 [0.65-1.37],0.7547701410478627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOG,Myelin-oligodendrocyte glycoprotein,1767,73,1.65 [0.99-2.75],0.0551748060075939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORC3,MORC family CW-type zinc finger protein 3,1517,58,0.58 [0.21-1.59],0.2881479963305645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORF4L1,Mortality factor 4-like protein 1,1504,59,1.25 [0.75-2.08],0.3876685016151113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORF4L2,Mortality factor 4-like protein 2,1473,59,1.10 [0.61-1.99],0.7587691392112118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORN4,MORN repeat-containing protein 4,1473,59,0.84 [0.59-1.21],0.3523867340903077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPHOSPH8,M-phase phosphoprotein 8,1715,70,0.98 [0.74-1.30],0.9028085580008208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPI,Mannose-6-phosphate isomerase,1737,71,1.07 [0.84-1.36],0.5820261618655345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,1750,71,1.14 [0.85-1.52],0.3860232738785393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPO,Myeloperoxidase,1756,72,1.25 [0.83-1.87],0.2791244663139687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPRIP,Myosin phosphatase Rho-interacting protein,1522,59,1.15 [0.72-1.86],0.5587523323442622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRC1,Macrophage mannose receptor 1,1537,60,2.60 [1.17-5.77],0.0192260487571376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRI1,Methylthioribose-1-phosphate isomerase,1489,57,0.93 [0.64-1.36],0.7202041351719366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL24,"39S ribosomal protein L24, mitochondrial",1485,57,0.99 [0.50-1.96],0.967084387799382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL28,"39S ribosomal protein L28, mitochondrial",1532,59,0.62 [0.25-1.50],0.2879244505620105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL46,"39S ribosomal protein L46, mitochondrial",1687,70,0.68 [0.30-1.57],0.3663482862645317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL52,"39S ribosomal protein L52, mitochondrial",1472,59,1.27 [0.47-3.47],0.6388129338106677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",1532,59,1.00 [0.73-1.37],0.9948611209190852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPS16,"28S ribosomal protein S16, mitochondrial",1481,58,0.42 [0.13-1.35],0.1470267194384332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLN,Mesothelin,1734,71,1.18 [0.84-1.66],0.3268629573193023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLNL,Mesothelin-like protein,1489,57,0.81 [0.37-1.81],0.6145373727564627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSMB,Beta-microseminoprotein,1754,72,1.55 [1.17-2.05],0.0022483317521038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSR1,Macrophage scavenger receptor types I and II,1759,71,1.76 [1.17-2.65],0.0062181270948942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,1749,73,0.98 [0.74-1.29],0.880287114428466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MST1,Hepatocyte growth factor-like protein,1510,58,1.03 [0.64-1.68],0.8896491434202832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSTN,Growth/differentiation factor 8,1715,70,0.67 [0.45-0.98],0.0367124834922494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTDH,Protein LYRIC,1481,58,0.87 [0.68-1.13],0.3093921068576457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",1517,58,0.57 [0.18-1.78],0.3328904085117776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,1504,59,0.96 [0.77-1.19],0.6850298056164115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",1522,57,0.84 [0.63-1.12],0.2315036902572896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTPN,Myotrophin,1715,70,0.56 [0.26-1.23],0.146534352888943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTR,Methionine synthase,1485,57,0.96 [0.64-1.46],0.8658692067513971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTSS1,Protein MTSS 1,1522,57,1.02 [0.82-1.27],0.8699698454925642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTSS2,Protein MTSS 2,1526,59,0.91 [0.71-1.15],0.4290410097041996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTUS1,Microtubule-associated tumor suppressor 1,1504,59,0.94 [0.62-1.43],0.7826851844211837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC13,Mucin-13,1687,70,1.79 [1.34-2.39],8.000361787963885e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC16,Mucin-16,1737,71,1.07 [0.95-1.21],0.2580071070471187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC2,Mucin-2,1536,59,1.01 [0.77-1.31],0.9503834403062787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUCL3,Mucin-like protein 3,1473,59,1.19 [0.71-1.99],0.514961638086765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MVK,Mevalonate kinase,1710,70,1.14 [0.91-1.42],0.2486059883799018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MXRA8,Matrix remodeling-associated protein 8,1502,60,0.85 [0.40-1.84],0.6818069565531444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC1,"Myosin-binding protein C, slow-type",1532,60,1.28 [0.96-1.72],0.0950273558211621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC2,"Myosin-binding protein C, fast-type",1483,60,0.93 [0.70-1.26],0.6524944920058596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,1532,59,0.87 [0.58-1.31],0.5060030791364716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYDGF,Myeloid-derived growth factor,1532,60,0.99 [0.78-1.27],0.9602372408864952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH4,Myosin-4,1485,57,1.03 [0.59-1.81],0.9075756533849922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH7B,Myosin-7B,1473,59,1.04 [0.59-1.83],0.8948554348465548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH9,Myosin-9,1536,59,1.03 [0.83-1.28],0.794493772788095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",1485,57,0.63 [0.31-1.28],0.2031168946336449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL3,Myosin light chain 3,1483,60,1.04 [0.76-1.42],0.8224801345672828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL4,Myosin light chain 4,1483,60,1.05 [0.67-1.63],0.8451656388561202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL6B,Myosin light chain 6B,1489,57,1.00 [0.76-1.32],0.9880330964921163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",1489,57,1.10 [0.68-1.77],0.7024751621959056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYO6,Unconventional myosin-VI,1532,59,0.72 [0.33-1.57],0.4095473901083011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYO9B,Unconventional myosin-IXb,1710,70,1.01 [0.75-1.37],0.9381936776636356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOC,Myocilin,1756,72,0.91 [0.59-1.40],0.6541761947314187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM1,Myomesin-1,1478,58,0.88 [0.48-1.61],0.6789869545723155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM2,Myomesin-2,1485,57,0.91 [0.57-1.43],0.6747165806359925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM3,Myomesin-3,1502,60,1.08 [0.84-1.39],0.5341850142832125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MZB1,Marginal zone B- and B1-cell-specific protein,1749,71,1.15 [0.78-1.69],0.4732827213487197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MZT1,Mitotic-spindle organizing protein 1,1685,69,1.11 [0.73-1.67],0.6279691982757372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAA10,N-alpha-acetyltransferase 10,1485,57,0.50 [0.31-0.80],0.0038281631620871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAA80,N-alpha-acetyltransferase 80,1489,57,0.93 [0.76-1.13],0.4487133082228319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,1726,71,0.84 [0.58-1.22],0.3730392320466305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NACC1,Nucleus accumbens-associated protein 1,1526,59,0.77 [0.49-1.23],0.2753060033712673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NADK,NAD kinase,1750,72,0.98 [0.68-1.39],0.8896772518679603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGA,Alpha-N-acetylgalactosaminidase,1476,58,0.75 [0.43-1.30],0.3051197137794349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGK,N-acetyl-D-glucosamine kinase,1482,60,0.70 [0.46-1.05],0.0822008181952688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,1502,60,4.88 [1.70-14.05],0.0032695801639489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAMPT,Nicotinamide phosphoribosyltransferase,1685,69,1.13 [0.82-1.56],0.466761634336007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAP1L4,Nucleosome assembly protein 1-like 4,1521,57,0.66 [0.35-1.24],0.1929013427448411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAPRT,Nicotinate phosphoribosyltransferase,1517,58,0.38 [0.16-0.94],0.035284083689415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",1532,59,0.79 [0.47-1.31],0.3629891096299539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,1749,73,4.70 [2.56-8.64],6.239609115437859e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBN,Nibrin,1710,70,1.17 [0.85-1.60],0.3303513460242394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAM1,Neural cell adhesion molecule 1,1760,72,0.88 [0.47-1.66],0.6942161192302252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAM2,Neural cell adhesion molecule 2,1756,72,1.17 [0.54-2.54],0.6881727547345553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAN,Neurocan core protein,1759,71,0.49 [0.30-0.79],0.0033059076845248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCF2,Neutrophil cytosol factor 2,1746,72,1.07 [0.85-1.33],0.5824907306415155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCK2,Cytoplasmic protein NCK2,1752,71,0.98 [0.81-1.18],0.844168587137968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCLN,Nicalin,1710,70,0.98 [0.65-1.47],0.9292225747202658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR1,Natural cytotoxicity triggering receptor 1,1749,72,3.45 [2.09-5.69],1.1631836451689352e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,1522,57,3.20 [1.77-5.78],0.0001182790292956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,1767,73,2.80 [1.47-5.34],0.0016970513681489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDRG1,Protein NDRG1,1687,70,0.97 [0.69-1.38],0.8786999815781089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,1526,59,1.37 [1.04-1.80],0.0269488310461108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,1479,58,0.81 [0.40-1.63],0.5538177749338715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,1522,57,0.84 [0.63-1.10],0.2056918756949471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",1685,69,1.13 [0.86-1.49],0.3770455307824357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEB,Nebulin,1485,57,1.04 [0.50-2.18],0.915817388510246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECAP2,Adaptin ear-binding coat-associated protein 2,1485,57,0.76 [0.49-1.17],0.2165401401674209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN1,Nectin-1,1481,58,1.89 [1.02-3.52],0.0434598000128537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN2,Nectin-2,1750,72,4.09 [2.43-6.88],1.1054735615729736e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN4,Nectin-4,1749,73,2.29 [1.55-3.40],3.6303943282861456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,1481,58,0.59 [0.35-0.97],0.0368745865185763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEDD9,Enhancer of filamentation 1,1481,58,1.14 [0.57-2.28],0.7176222221241659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEFL,Neurofilament light polypeptide,1680,69,2.64 [2.03-3.45],6.479592473278377e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEK7,Serine/threonine-protein kinase Nek7,1504,59,0.67 [0.44-1.03],0.0681246584064478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL1,Protein kinase C-binding protein NELL1,1749,73,0.44 [0.31-0.60],6.21251407848115e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL2,Protein kinase C-binding protein NELL2,1752,71,1.55 [0.80-3.00],0.1930528894534534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NENF,Neudesin,1526,59,1.10 [0.92-1.33],0.2971621087984215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEO1,Neogenin,1532,59,1.89 [0.87-4.11],0.1090698833480254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEXN,Nexilin,1537,60,0.74 [0.52-1.05],0.0919214081850171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFASC,Neurofascin,1775,73,4.69 [2.72-8.06],2.385746596359756e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFAT5,Nuclear factor of activated T-cells 5,1481,58,0.92 [0.68-1.25],0.5851442151011252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",1749,72,0.99 [0.81-1.22],0.9282992352255864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",1710,70,1.16 [0.85-1.60],0.3541588464970604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFE2,Transcription factor NF-E2 45 kDa subunit,1483,60,0.89 [0.64-1.23],0.4789088301598251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFIC,Nuclear factor 1 C-type,1532,59,0.95 [0.48-1.90],0.8868495455061052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,1485,57,0.93 [0.66-1.31],0.6895622385634663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,1504,59,0.82 [0.47-1.43],0.480121073411517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKBIE,NF-kappa-B inhibitor epsilon,1685,69,1.31 [0.88-1.97],0.185529728590971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",1522,57,0.87 [0.68-1.10],0.2371549379873286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFX1,Transcriptional repressor NF-X1,1485,57,0.90 [0.62-1.30],0.5618663846544045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFYA,Nuclear transcription factor Y subunit alpha,1485,57,1.12 [0.68-1.84],0.6647899990448483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGF,Beta-nerve growth factor,1731,71,10.92 [1.78-66.92],0.0097390778315438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGFR,Tumor necrosis factor receptor superfamily member 16,1532,60,2.82 [1.67-4.77],0.0001073166463001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGRN,Neugrin,1517,58,0.97 [0.31-3.04],0.9567146515050274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NHLRC3,NHL repeat-containing protein 3,1465,57,3.55 [1.63-7.74],0.0014387368267929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NID1,Nidogen-1,1756,71,1.89 [1.13-3.18],0.0161426449288291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NID2,Nidogen-2,1756,72,1.23 [0.94-1.61],0.1389791501739765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NINJ1,Ninjurin-1,1685,69,1.28 [0.92-1.78],0.1370792138143375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NIT1,Deaminated glutathione amidase,1483,60,0.76 [0.44-1.34],0.348847345173896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NIT2,Omega-amidase NIT2,1527,60,0.94 [0.66-1.33],0.7339410303764923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NLGN1,Neuroligin-1,1489,57,1.08 [0.79-1.50],0.6210113401732082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NLGN2,Neuroligin-2,1478,58,0.55 [0.26-1.16],0.1165782717150937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NME1,Nucleoside diphosphate kinase A,1481,58,0.47 [0.14-1.65],0.2410435075353894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NME3,Nucleoside diphosphate kinase 3,1747,71,1.57 [0.70-3.55],0.2729530312703483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMI,N-myc-interactor,1517,59,0.82 [0.58-1.16],0.2640459970686634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,1731,71,1.16 [0.93-1.44],0.1802627582654356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMRK2,Nicotinamide riboside kinase 2,1473,59,1.28 [0.73-2.25],0.396130599380313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,1532,59,0.65 [0.41-1.03],0.067558449013239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOMO1,Nodal modulator 1,1756,72,2.33 [1.23-4.40],0.0092723253562509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOP56,Nucleolar protein 56,1485,57,1.00 [0.80-1.24],0.9763484922206668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS1,"Nitric oxide synthase, brain",1687,70,1.51 [1.08-2.11],0.0164095591178089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS2,"Nitric oxide synthase, inducible",1485,57,0.92 [0.47-1.81],0.8068287894114256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS3,"Nitric oxide synthase, endothelial",1687,70,1.29 [0.86-1.94],0.2243525419612971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH1,Neurogenic locus notch homolog protein 1,1773,72,7.59 [2.11-27.28],0.0019011136228129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH2,Neurogenic locus notch homolog protein 2,1536,59,3.57 [1.47-8.65],0.0048940513399261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH3,Neurogenic locus notch homolog protein 3,1773,72,1.47 [0.86-2.50],0.1566331862707433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPC2,NPC intracellular cholesterol transporter 2,1520,58,2.65 [1.37-5.13],0.0038632589087083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPDC1,Neural proliferation differentiation and control protein 1,1750,72,2.47 [1.63-3.74],1.936580451865772e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPHS1,Nephrin,1481,58,0.77 [0.36-1.61],0.481471984187084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPHS2,Podocin,1481,58,0.81 [0.60-1.09],0.1590047542395076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPL,N-acetylneuraminate lyase,1532,60,1.17 [0.73-1.87],0.5210697278289269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPB,Natriuretic peptides B,1715,70,1.35 [1.17-1.57],5.891091558882677e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPC,C-type natriuretic peptide,1749,72,1.15 [0.83-1.59],0.3993800199748649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPR1,Atrial natriuretic peptide receptor 1,1485,57,0.56 [0.24-1.29],0.1742593092490895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTN,Neuroplastin,1685,69,1.13 [0.89-1.44],0.3101405719484718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTX1,Neuronal pentraxin-1,1756,72,1.13 [0.72-1.78],0.5954289156265458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTX2,Neuronal pentraxin-2,1536,59,1.28 [0.64-2.55],0.4885790299609273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTXR,Neuronal pentraxin receptor,1750,72,0.99 [0.56-1.72],0.9598081995408831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPY,Pro-neuropeptide Y,1767,73,2.16 [1.53-3.05],1.3108467927097268e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRCAM,Neuronal cell adhesion molecule,1750,72,1.87 [0.98-3.56],0.0558739927819194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRGN,Neurogranin,1537,60,0.85 [0.66-1.10],0.2139480903798872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRN1,Neuritin,1532,59,0.58 [0.23-1.47],0.2532241399064358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP1,Neuropilin-1,1763,72,2.26 [1.10-4.63],0.0262779780033352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP2,Neuropilin-2,1756,72,1.86 [0.92-3.75],0.0851679389244839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRTN,Neurturin,1710,70,0.75 [0.48-1.18],0.2208872464785072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRXN3,Neurexin-3,1489,57,0.73 [0.33-1.62],0.441392592159862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NSFL1C,NSFL1 cofactor p47,1759,71,0.87 [0.63-1.20],0.3981200379304602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",1532,60,0.90 [0.65-1.25],0.5180436943796932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,1517,58,1.57 [0.91-2.73],0.1072861092155924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,1747,72,0.89 [0.70-1.12],0.312837078484285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5E,5'-nucleotidase,1749,73,1.23 [0.87-1.72],0.2381936490827477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTF3,Neurotrophin-3,1749,72,2.33 [1.32-4.09],0.0033399726333779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTF4,Neurotrophin-4,1685,69,0.98 [0.52-1.83],0.9467437005656988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTRK2,BDNF/NT-3 growth factors receptor,1750,72,1.29 [0.58-2.83],0.5316358272230783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTRK3,NT-3 growth factor receptor,1759,71,1.71 [0.69-4.26],0.2507692578271019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,1750,72,1.32 [1.14-1.53],0.0002473414879895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUB1,NEDD8 ultimate buster 1,1749,72,1.00 [0.79-1.27],0.9959356217657028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,1526,59,1.02 [0.81-1.29],0.8500637461655822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUCB2,Nucleobindin-2,1764,73,1.92 [1.15-3.20],0.0120468954161831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDC,Nuclear migration protein nudC,1775,73,0.98 [0.71-1.36],0.9159021958853634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,1483,60,1.05 [0.39-2.88],0.9180945207845136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,1485,57,0.60 [0.30-1.18],0.1373712488809306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT16,U8 snoRNA-decapping enzyme,1519,57,0.92 [0.69-1.24],0.5831673417483911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],1737,71,0.95 [0.66-1.37],0.7828385461046679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT5,ADP-sugar pyrophosphatase,1756,72,1.16 [0.78-1.73],0.460530071458572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUMB,Protein numb homolog,1481,58,0.86 [0.64-1.14],0.2936641495506754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUP50,Nuclear pore complex protein Nup50,1485,57,1.08 [0.55-2.14],0.8230247480576663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPE4,NXPE family member 4,1485,57,1.28 [0.67-2.45],0.4595564639771116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH1,Neurexophilin-1,1687,70,0.89 [0.50-1.58],0.68745975286302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH3,Neurexophilin-3,1481,58,0.93 [0.41-2.13],0.8718595118232804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OBP2B,Odorant-binding protein 2b,1724,71,1.28 [0.89-1.83],0.1838058675328551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OCLN,Occludin,1532,59,1.48 [0.93-2.35],0.1007003576166126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ODAM,Odontogenic ameloblast-associated protein,1685,70,1.08 [0.76-1.51],0.6760024558757567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OFD1,Oral-facial-digital syndrome 1 protein,1504,59,1.32 [1.00-1.75],0.0531921782316687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGA,Protein O-GlcNAcase,1522,57,0.90 [0.63-1.28],0.5647458279558075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGFR,Opioid growth factor receptor,1737,71,1.58 [0.84-2.97],0.1552625323499901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGN,Mimecan,1756,72,2.13 [1.39-3.28],0.0005349451209079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,1504,59,0.83 [0.53-1.31],0.4309301907218176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OLFM4,Olfactomedin-4,1440,56,0.98 [0.80-1.20],0.8554778344387707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OLR1,Oxidized low-density lipoprotein receptor 1,1740,71,1.02 [0.72-1.44],0.9061161832578132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMD,Osteomodulin,1752,71,0.77 [0.51-1.16],0.2134834981027596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMG,Oligodendrocyte-myelin glycoprotein,1737,71,0.86 [0.63-1.16],0.3123515013173276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMP,Olfactory marker protein,1478,58,0.79 [0.44-1.45],0.4517418855469521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPHN1,Oligophrenin-1,1517,58,0.89 [0.71-1.11],0.3094326340186902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPLAH,5-oxoprolinase,1483,60,0.97 [0.68-1.36],0.8410242308803437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPTC,Opticin,1737,71,1.12 [0.70-1.80],0.6348670757785124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ORM1,Alpha-1-acid glycoprotein 1,1536,58,3.09 [1.11-8.60],0.0306666497284137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSBPL2,Oxysterol-binding protein-related protein 2,1517,58,1.32 [0.72-2.44],0.3685089558278068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,1747,71,2.85 [1.58-5.15],0.0005279004787512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSM,Oncostatin-M,1743,72,0.92 [0.69-1.23],0.5877835308842859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSMR,Oncostatin-M-specific receptor subunit beta,1763,72,2.00 [0.71-5.61],0.1870362699506596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSTN,Osteocrin,1489,57,0.78 [0.35-1.73],0.5475229929615252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTOA,Otoancorin,1478,58,1.19 [0.78-1.81],0.4293946733874523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTUD6B,Deubiquitinase OTUD6B,1522,57,0.79 [0.51-1.22],0.2856384185398666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTUD7B,OTU domain-containing protein 7B,1532,59,0.84 [0.57-1.24],0.3851400288199645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",1483,60,0.72 [0.51-1.02],0.0649726360163179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OXT,Oxytocin-neurophysin 1,1759,71,1.09 [0.94-1.27],0.2548093433284866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,P4HB,Protein disulfide-isomerase,1736,73,1.45 [0.86-2.46],0.1620652984444112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PACS2,Phosphofurin acidic cluster sorting protein 2,1485,57,0.73 [0.47-1.12],0.1524147077723477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PADI2,Protein-arginine deiminase type-2,1710,70,1.33 [0.99-1.77],0.0541387357591008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PADI4,Protein-arginine deiminase type-4,1685,70,1.05 [0.83-1.33],0.6688358532743706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAEP,Glycodelin,1731,71,1.02 [0.85-1.22],0.8285602066714388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,1532,59,1.06 [0.88-1.28],0.5340339746822114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",1504,59,0.71 [0.41-1.24],0.2313947820980529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,1715,70,1.24 [0.86-1.78],0.2564841833001673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,1483,60,1.09 [0.65-1.83],0.746836966266838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,1469,59,1.04 [0.67-1.61],0.8704245936048544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAK4,Serine/threonine-protein kinase PAK 4,1687,70,0.86 [0.61-1.21],0.3796746338280757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALLD,Palladin,1481,58,1.22 [0.63-2.35],0.5535162937819611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM,Paralemmin-1,1514,57,1.91 [0.99-3.71],0.0549825906475344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM2,Paralemmin-2,1517,58,2.14 [1.38-3.32],0.0006417096172695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM3,Paralemmin-3,1485,57,1.06 [0.79-1.43],0.6853301065787603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,1765,72,0.74 [0.39-1.40],0.3493374342982458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAMR1,Inactive serine protease PAMR1,1756,72,1.15 [0.54-2.44],0.7117092242737533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAPPA,Pappalysin-1,1710,70,0.99 [0.62-1.58],0.969921770411134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARD3,Partitioning defective 3 homolog,1504,59,0.97 [0.70-1.33],0.8361937226346643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARK7,Parkinson disease protein 7,1756,72,0.91 [0.61-1.36],0.638905892287776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARP1,Poly [ADP-ribose] polymerase 1,1749,72,1.18 [0.89-1.58],0.2443769555683358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAXX,Protein PAXX,1502,60,0.93 [0.56-1.56],0.7883702809448274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,1473,59,0.42 [0.19-0.93],0.033442352744608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBLD,Phenazine biosynthesis-like domain-containing protein,1687,70,0.89 [0.62-1.28],0.529640094110367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,1522,57,0.81 [0.33-2.02],0.655781580445576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCARE,Photoreceptor cilium actin regulator,1478,58,0.93 [0.69-1.24],0.602946504609297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,1498,59,1.04 [0.70-1.54],0.8556945010567931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCBP2,Poly(rC)-binding protein 2,1532,59,0.92 [0.66-1.28],0.6165890528807532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH1,Protocadherin-1,1767,73,3.14 [1.45-6.79],0.0036845038662138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH12,Protocadherin-12,1532,59,1.58 [0.69-3.61],0.2795209371951395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH17,Protocadherin-17,1750,72,1.58 [0.98-2.55],0.0594082505748476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH7,Protocadherin-7,1522,57,1.13 [0.56-2.27],0.734168754382893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH9,Protocadherin-9,1522,57,1.49 [0.75-2.96],0.2555759163072755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDHB15,Protocadherin beta-15,1526,59,1.76 [1.07-2.91],0.02675035203022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCNA,Proliferating cell nuclear antigen,1473,59,1.12 [0.84-1.50],0.4440382388814365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,1526,59,1.12 [0.71-1.75],0.627731857865315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,1773,72,1.59 [0.95-2.64],0.0751068945015342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,1522,57,0.83 [0.60-1.16],0.28315042508298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,1532,60,0.95 [0.74-1.21],0.6791339519817434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1,Programmed cell death protein 1,1765,73,1.66 [1.09-2.55],0.0187616631107765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1LG2,Programmed cell death 1 ligand 2,1737,71,3.71 [2.01-6.83],2.619035864197801e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD5,Programmed cell death protein 5,1759,71,1.22 [0.86-1.74],0.2690390571277554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD6,Programmed cell death protein 6,1750,72,0.97 [0.73-1.30],0.8552600045289608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCL2,Phosducin-like protein 2,1473,59,0.59 [0.31-1.10],0.0976942906003952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",1473,59,1.10 [0.78-1.56],0.584398536914511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1485,57,1.14 [0.76-1.71],0.5271284201433104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",1502,60,0.91 [0.73-1.13],0.3864347150078937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFA,Platelet-derived growth factor subunit A,1773,72,1.35 [1.02-1.79],0.0384287066324866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFB,Platelet-derived growth factor subunit B,1752,71,1.23 [0.97-1.57],0.0935045194174391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFC,Platelet-derived growth factor C,1685,69,1.18 [0.60-2.32],0.6382443103276975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRA,Platelet-derived growth factor receptor alpha,1750,72,2.42 [1.28-4.57],0.0066229412871012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRB,Platelet-derived growth factor receptor beta,1773,72,1.38 [0.76-2.53],0.2931487416511575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA2,Protein disulfide-isomerase A2,1473,59,0.90 [0.47-1.73],0.7506424837661352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA3,Protein disulfide-isomerase A3,1502,60,1.34 [0.53-3.37],0.5311716242539427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA4,Protein disulfide-isomerase A4,1536,59,0.88 [0.59-1.31],0.522754758110969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA5,Protein disulfide-isomerase A5,1473,59,0.67 [0.42-1.06],0.08403319593341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDLIM5,PDZ and LIM domain protein 5,1532,59,0.85 [0.70-1.03],0.0979706026693965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDLIM7,PDZ and LIM domain protein 7,1752,71,1.02 [0.87-1.20],0.8069352659351301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",1685,69,1.06 [0.70-1.60],0.7971457156782822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDRG1,p53 and DNA damage-regulated protein 1,1489,57,0.82 [0.48-1.42],0.486821198056096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,1473,59,0.47 [0.20-1.07],0.0709053074469844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDZD2,PDZ domain-containing protein 2,1485,57,0.75 [0.47-1.20],0.2342755846226143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,1481,58,1.39 [0.92-2.08],0.1141295404425198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEAR1,Platelet endothelial aggregation receptor 1,1773,72,1.71 [0.67-4.36],0.2576067138038834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEBP1,Phosphatidylethanolamine-binding protein 1,1756,72,1.04 [0.73-1.49],0.8394287045566349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PECAM1,Platelet endothelial cell adhesion molecule,1756,72,1.34 [0.70-2.56],0.3847721573523602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,1483,60,0.57 [0.21-1.54],0.2674789650166392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PENK,Proenkephalin-A,1502,60,1.83 [1.01-3.31],0.0471361561359949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEPD,Xaa-Pro dipeptidase,1537,60,0.48 [0.20-1.15],0.1019352770810439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PER3,Period circadian protein homolog 3,1481,58,0.86 [0.69-1.07],0.1744027795113905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PF4,Platelet factor 4,1533,59,1.29 [1.00-1.66],0.0479871649415398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN2,Prefoldin subunit 2,1687,70,1.07 [0.73-1.57],0.7195456082176893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN4,Prefoldin subunit 4,1473,59,1.10 [0.70-1.72],0.6778806922285239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN6,Prefoldin subunit 6,1489,57,1.45 [1.12-1.86],0.004272139563831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",1734,71,1.01 [0.78-1.33],0.914624561019482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGA4,Pepsin A-4,1537,60,1.44 [1.07-1.94],0.0168109921902825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",1532,60,1.11 [0.70-1.74],0.6621533114421325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGF,Placenta growth factor,1775,73,3.58 [2.04-6.27],8.451175465876588e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP1,Peptidoglycan recognition protein 1,1769,72,1.25 [0.80-1.93],0.3226635150400406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,1522,57,1.79 [0.73-4.40],0.2029586677294346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP4,Peptidoglycan recognition protein 4,1485,57,1.19 [0.78-1.81],0.4284111219072496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGM2,Phosphoglucomutase-2,1489,57,0.86 [0.54-1.38],0.5412461571885536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGR,Progesterone receptor,1481,58,0.79 [0.56-1.12],0.1878229030203123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHACTR2,Phosphatase and actin regulator 2,1532,59,0.88 [0.71-1.08],0.2255483232503532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB1,Pleckstrin homology-like domain family B member 1,1522,57,1.55 [1.00-2.38],0.0478143198763824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB2,Pleckstrin homology-like domain family B member 2,1473,59,0.80 [0.58-1.10],0.1660984919612197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,1731,71,2.83 [1.37-5.86],0.004975948270619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,1502,60,0.99 [0.59-1.66],0.97679689218541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI16,Peptidase inhibitor 16,1537,60,1.41 [0.53-3.74],0.48755051802333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI3,Elafin,1732,71,1.37 [1.00-1.88],0.0493475262221477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",1532,59,0.78 [0.57-1.08],0.1291957628976954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIGR,Polymeric immunoglobulin receptor,1732,71,2.13 [1.43-3.18],0.0002119620403462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,1749,72,1.00 [0.72-1.39],0.9928796312570326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,1756,72,4.27 [2.60-7.01],9.336385052307504e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,1481,58,0.87 [0.55-1.39],0.5687451425265657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,1756,72,3.08 [1.92-4.96],3.250103599072904e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,1750,72,2.25 [1.51-3.37],7.371417627413699e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,1502,60,1.27 [0.87-1.84],0.216654798377567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PITHD1,PITH domain-containing protein 1,1469,59,1.11 [0.86-1.43],0.4296308675688737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD1,Polycystin-1,1532,60,5.79 [2.57-13.06],2.34002959816538e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD2,Polycystin-2,1485,57,1.03 [0.68-1.56],0.8955946697154147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKLR,Pyruvate kinase PKLR,1747,71,0.86 [0.63-1.18],0.3468615854043644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKN3,Serine/threonine-protein kinase N3,1504,59,1.06 [0.76-1.47],0.73949385259625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G10,Group 10 secretory phospholipase A2,1731,71,1.27 [0.89-1.81],0.187036207992702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G15,Phospholipase A2 group XV,1749,73,2.00 [0.99-4.05],0.0540032811467688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G1B,Phospholipase A2,1769,72,0.89 [0.58-1.37],0.5907241427211067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G2A,"Phospholipase A2, membrane associated",1746,70,1.02 [0.71-1.46],0.908438469913314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G4A,Cytosolic phospholipase A2,1752,71,0.97 [0.77-1.21],0.7678050446789024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G7,Platelet-activating factor acetylhydrolase,1756,72,0.61 [0.36-1.05],0.0735930329594004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAT,Tissue-type plasminogen activator,1771,72,1.00 [0.69-1.44],0.9831816099810374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAU,Urokinase-type plasminogen activator,1756,72,1.06 [0.54-2.07],0.8738259408935396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAUR,Urokinase plasminogen activator surface receptor,1739,71,4.12 [2.31-7.38],1.7666602933440496e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLB1,"Phospholipase B1, membrane-associated",1517,58,0.54 [0.35-0.82],0.0040724454773525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",1481,58,0.92 [0.50-1.70],0.7922992780399936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",1517,58,0.86 [0.67-1.09],0.2089653507642605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,1517,58,0.89 [0.63-1.25],0.5018979419508119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLG,Plasminogen,1507,57,4.43 [1.91-10.24],0.0005095279392025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLIN1,Perilipin-1,1687,70,1.35 [0.80-2.28],0.266782213718264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLIN3,Perilipin-3,1750,72,1.06 [0.67-1.69],0.8031387679433186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLPBP,Pyridoxal phosphate homeostasis protein,1750,72,0.92 [0.68-1.24],0.565854642948755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLSCR3,Phospholipid scramblase 3,1515,58,1.21 [0.78-1.89],0.3897616800174638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLTP,Phospholipid transfer protein,1765,72,0.75 [0.45-1.25],0.2756960276633988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXDC1,Plexin domain-containing protein 1,1685,69,1.33 [0.68-2.60],0.3987363594762793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXDC2,Plexin domain-containing protein 2,1517,58,1.40 [0.62-3.18],0.4237097518138314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNA4,Plexin-A4,1749,72,1.03 [0.79-1.33],0.8405514681255721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB2,Plexin-B2,1766,71,8.71 [4.69-16.15],6.649250351771778e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB3,Plexin-B3,1746,72,1.01 [0.66-1.55],0.9558111163534592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,1746,72,1.03 [0.92-1.15],0.6181162190496929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMCH,Pro-MCH,1485,57,1.33 [1.05-1.68],0.0190419834789106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMM2,Phosphomannomutase 2,1485,57,0.85 [0.55-1.31],0.4541663031968994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMS1,PMS1 protein homolog 1,1489,57,0.97 [0.60-1.58],0.9143783707646748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMVK,Phosphomevalonate kinase,1685,70,0.95 [0.79-1.14],0.5621531498694994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIP,Pancreatic triacylglycerol lipase,1537,60,0.98 [0.69-1.39],0.9075303492822108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,1517,58,1.05 [0.79-1.39],0.747997903776801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIPRP2,Pancreatic lipase-related protein 2,1745,71,1.05 [0.97-1.13],0.249043326111658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNMA1,Paraneoplastic antigen Ma1,1483,60,0.76 [0.49-1.17],0.2107417058633746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNMA2,Paraneoplastic antigen Ma2,1478,58,0.95 [0.52-1.73],0.8608172003362666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",1710,70,0.91 [0.74-1.13],0.4001350399674783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL,Podocalyxin,1737,71,1.05 [0.28-4.02],0.9400092529287012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL2,Podocalyxin-like protein 2,1749,73,2.60 [1.42-4.75],0.0019127120101808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POF1B,Protein POF1B,1481,58,1.79 [1.25-2.56],0.0013375256237243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,1481,58,0.80 [0.33-1.98],0.637347646123458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",1737,71,1.51 [1.01-2.25],0.0433355216095366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POMC,Pro-opiomelanocortin,1483,60,1.00 [0.72-1.40],0.9801664066918718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON1,Serum paraoxonase/arylesterase 1,1537,60,0.69 [0.32-1.53],0.3638178224465945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON2,Serum paraoxonase/arylesterase 2,1715,70,0.91 [0.52-1.60],0.7464022877321888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON3,Serum paraoxonase/lactonase 3,1752,71,0.53 [0.29-0.96],0.0351299662989049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POSTN,Periostin,1536,59,1.35 [0.70-2.59],0.3717780500576241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPBP,Platelet basic protein,1528,58,1.39 [1.03-1.87],0.0324513163053623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,1759,71,0.82 [0.52-1.28],0.3813245351049313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,1757,72,1.04 [0.84-1.28],0.7441789150738831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,1504,59,0.84 [0.52-1.35],0.4697169372552398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",1536,59,0.89 [0.60-1.34],0.5879397838166457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPL,Periplakin,1481,58,0.98 [0.47-2.06],0.9649256615534284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1A,Protein phosphatase 1A,1685,69,0.77 [0.37-1.62],0.4925264292624479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1B,Protein phosphatase 1B,1481,58,0.67 [0.38-1.20],0.1789511390953818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1F,Protein phosphatase 1F,1532,60,0.77 [0.49-1.22],0.2635549192820329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPME1,Protein phosphatase methylesterase 1,1737,71,0.93 [0.66-1.33],0.7049152117578724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,1526,59,0.76 [0.56-1.03],0.0798793690981781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,1749,73,0.96 [0.78-1.18],0.6915769077120237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,1504,59,0.80 [0.54-1.20],0.283544282399874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,1532,59,0.93 [0.68-1.27],0.6428835319075593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,1532,59,1.86 [1.14-3.04],0.0135045097173548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R2,Protein phosphatase inhibitor 2,1750,72,0.97 [0.75-1.25],0.8106515609865133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R9B,Neurabin-2,1775,73,1.02 [0.82-1.25],0.8861866126662141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,1522,57,0.91 [0.74-1.11],0.3507076885782337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP3R1,Calcineurin subunit B type 1,1731,71,1.34 [0.84-2.14],0.2260621604911265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPT1,Palmitoyl-protein thioesterase 1,1489,57,0.95 [0.67-1.36],0.7780756233592248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPY,Pancreatic prohormone,1742,72,1.17 [0.96-1.41],0.1191190805478927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PQBP1,Polyglutamine-binding protein 1,1685,69,1.10 [0.79-1.53],0.5610064913353303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAME,Melanoma antigen preferentially expressed in tumors,1473,59,0.48 [0.17-1.40],0.1811793826724317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAP1,Proline-rich acidic protein 1,1536,59,3.46 [1.70-7.04],0.0005955250281813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRC1,Protein regulator of cytokinesis 1,1526,59,0.74 [0.36-1.50],0.4042188508619994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRCP,Lysosomal Pro-X carboxypeptidase,1763,72,2.29 [1.34-3.91],0.002308405963621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX1,Peroxiredoxin-1,1693,71,0.95 [0.75-1.20],0.6741073814901188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX2,Peroxiredoxin-2,1510,59,0.75 [0.50-1.13],0.1680832131992866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",1710,70,1.04 [0.78-1.38],0.7982686543868438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX5,"Peroxiredoxin-5, mitochondrial",1775,73,0.91 [0.67-1.22],0.5214790477785567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX6,Peroxiredoxin-6,1767,73,0.99 [0.71-1.38],0.9488277398396328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PREB,Prolactin regulatory element-binding protein,1710,70,2.45 [1.30-4.62],0.0055998457053235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRELP,Prolargin,1745,71,4.82 [1.86-12.50],0.0012302548838664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG2,Bone marrow proteoglycan,1536,59,1.69 [1.08-2.64],0.0221618921989201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG3,Proteoglycan 3,1536,59,1.30 [0.81-2.09],0.2845820345768272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,1710,70,1.17 [0.82-1.68],0.3840858273376633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,1489,57,0.92 [0.41-2.06],0.8333874559133998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,1750,72,0.95 [0.75-1.22],0.712515725991279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,1515,58,0.94 [0.68-1.31],0.7234625816739174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKCQ,Protein kinase C theta type,1710,70,1.13 [0.71-1.80],0.6100937202077122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKD2,Serine/threonine-protein kinase D2,1485,57,1.21 [0.74-1.96],0.4468100828465733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKG1,cGMP-dependent protein kinase 1,1502,60,0.83 [0.69-1.00],0.0469534683716595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,1685,69,1.21 [0.90-1.64],0.1993979415943646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRL,Prolactin,1759,71,1.15 [0.90-1.47],0.2599512478136514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRND,Prion-like protein doppel,1517,58,1.03 [0.66-1.60],0.9088378329303056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROC,Vitamin K-dependent protein C,1760,72,1.22 [0.55-2.73],0.6217330147666993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROCR,Endothelial protein C receptor,1485,57,0.92 [0.39-2.14],0.8399050976381048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROK1,Prokineticin-1,1749,72,0.91 [0.63-1.31],0.6163376099520095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROS1,Vitamin K-dependent protein S,1541,59,1.42 [0.54-3.72],0.4765265232742369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRR4,Proline-rich protein 4,1494,60,1.19 [0.86-1.65],0.3003933735367218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRR5,Proline-rich protein 5,1481,58,0.72 [0.39-1.34],0.3006476571010843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRRT3,Proline-rich transmembrane protein 3,1483,60,1.54 [0.92-2.56],0.1006557679579657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS2,Trypsin-2,1760,72,1.32 [0.98-1.79],0.0669751497632531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS22,Brain-specific serine protease 4,1481,58,1.41 [0.68-2.89],0.3529203600280607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS27,Serine protease 27,1748,72,2.38 [1.45-3.91],0.0006222995809793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS53,Serine protease 53,1517,58,0.75 [0.40-1.40],0.3697768834950585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS8,Prostasin,1738,70,3.36 [2.24-5.04],4.918937401736388e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,1687,70,0.91 [0.76-1.09],0.3241874919768381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTG,Protogenin,1767,73,2.80 [1.29-6.05],0.0089661715193099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTN3,Myeloblastin,1713,71,1.13 [0.77-1.68],0.5324223255766872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRUNE2,Protein prune homolog 2,1504,59,0.91 [0.38-2.20],0.8359641960206726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAP,Prosaposin,1530,59,3.11 [1.34-7.20],0.0080293171873801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAPL1,Proactivator polypeptide-like 1,1522,57,0.98 [0.60-1.58],0.9184605959063796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSCA,Prostate stem cell antigen,1522,57,0.99 [0.89-1.09],0.7641445942240089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,1731,71,1.48 [1.20-1.82],0.0002354009501783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSIP1,PC4 and SFRS1-interacting protein,1749,72,0.92 [0.66-1.26],0.595095833529531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMA1,Proteasome subunit alpha type-1,1685,69,1.61 [1.10-2.37],0.0147626772972506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMC3,26S proteasome regulatory subunit 6A,1473,59,1.07 [0.47-2.43],0.8784964241159755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,1532,59,0.84 [0.50-1.42],0.5212852616362069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,1489,57,1.21 [0.79-1.87],0.380778665965928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,1737,71,0.82 [0.56-1.21],0.3202925460916928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSME1,Proteasome activator complex subunit 1,1730,71,1.00 [0.56-1.76],0.9871523345930452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSME2,Proteasome activator complex subunit 2,1719,69,1.03 [0.57-1.87],0.9098086812959872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMG3,Proteasome assembly chaperone 3,1749,72,0.81 [0.53-1.24],0.336615525897975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMG4,Proteasome assembly chaperone 4,1481,58,0.91 [0.58-1.40],0.6556690506416472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSPN,Persephin,1749,72,1.15 [0.93-1.41],0.1965520609198773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSRC1,Proline/serine-rich coiled-coil protein 1,1685,69,1.25 [0.90-1.73],0.1929213007211881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,1463,57,0.88 [0.71-1.10],0.2634261472290978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",1687,70,0.86 [0.42-1.76],0.6890172691823044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGDS,Prostaglandin-H2 D-isomerase,1746,71,2.46 [1.56-3.87],0.0001053662883057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGES2,Prostaglandin E synthase 2,1472,58,0.79 [0.50-1.25],0.3088471548939957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGR1,Prostaglandin reductase 1,1532,60,1.03 [0.79-1.34],0.8385144345147852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH,Parathyroid hormone,1489,57,1.06 [0.80-1.40],0.6817350700478908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,1749,72,1.22 [0.80-1.85],0.3493147412255156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTK7,Inactive tyrosine-protein kinase 7,1687,70,2.24 [1.29-3.90],0.0042350548329497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTN,Pleiotrophin,1715,70,1.13 [0.74-1.72],0.5621812948135223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,1481,58,1.39 [0.87-2.20],0.1662433460046999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,1731,71,1.11 [0.86-1.43],0.434505291421109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,1750,71,0.98 [0.78-1.23],0.8379196629358516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,1479,58,1.50 [0.95-2.35],0.0792472780506494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,1532,60,2.01 [0.92-4.41],0.0816405592911745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,1536,59,4.38 [1.63-11.82],0.0034954203944276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,1773,72,1.75 [0.88-3.46],0.1111538423679184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,1522,57,1.57 [1.06-2.30],0.0229064723677541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,1522,57,0.92 [0.31-2.73],0.8829474587637263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,1744,71,1.51 [0.66-3.47],0.329437310237242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,1723,71,2.00 [1.28-3.11],0.0022130027442996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,1517,58,1.17 [0.65-2.13],0.6014317200398902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,1773,72,1.06 [0.47-2.39],0.8901367347306761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,1532,60,1.11 [0.51-2.41],0.7840940604126114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,1502,60,0.74 [0.49-1.12],0.1503976186090189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,1683,69,1.14 [0.87-1.49],0.3500365561709445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTTG1,Securin,1504,59,0.97 [0.54-1.75],0.9203780432135116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTX3,Pentraxin-related protein PTX3,1749,72,1.70 [1.05-2.76],0.0303886368569548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVALB,Parvalbumin alpha,1759,73,1.01 [0.85-1.21],0.906960995208434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVR,Poliovirus receptor,1759,71,2.06 [1.38-3.08],0.0004250054259677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXDNL,Peroxidasin-like protein,1526,59,1.27 [0.96-1.68],0.0945306328450274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXN,Paxillin,1687,70,1.34 [0.94-1.91],0.1014037476425035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYDC1,Pyrin domain-containing protein 1,1483,60,1.05 [0.58-1.90],0.8827371943851116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYY,Peptide YY,1485,57,1.33 [1.06-1.67],0.0127119158434453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PZP,Pregnancy zone protein,1541,59,0.92 [0.54-1.55],0.7458573406069284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QDPR,Dihydropteridine reductase,1743,72,0.82 [0.50-1.33],0.4252599284398481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QPCT,Glutaminyl-peptide cyclotransferase,1758,72,3.01 [1.39-6.52],0.0053088452750457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QSOX1,Sulfhydryl oxidase 1,1503,55,1.69 [1.12-2.56],0.0124404987278412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB10,Ras-related protein Rab-10,1532,60,0.76 [0.48-1.21],0.2454539498256887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB11FIP3,Rab11 family-interacting protein 3,1532,60,0.94 [0.75-1.16],0.5606945919812947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB27B,Ras-related protein Rab-27B,1532,60,0.91 [0.68-1.22],0.5386836042296195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB2B,Ras-related protein Rab-2B,1526,59,0.67 [0.44-1.01],0.0534304783164451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB33A,Ras-related protein Rab-33A,1485,57,0.72 [0.49-1.06],0.0938456218491353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB37,Ras-related protein Rab-37,1710,70,0.97 [0.74-1.28],0.8271385138142695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB39B,Ras-related protein Rab-39B,1485,57,1.14 [0.89-1.46],0.307953503255957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,1478,58,1.03 [0.65-1.62],0.9046307435370856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB44,Ras-related protein Rab-44,1526,59,1.05 [0.67-1.66],0.8210686742319908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6A,Ras-related protein Rab-6A,1749,72,0.46 [0.30-0.70],0.0003601083757231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6B,Ras-related protein Rab-6B,1687,70,1.19 [0.78-1.83],0.4164690406686298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABEP1,Rab GTPase-binding effector protein 1,1502,60,0.86 [0.63-1.19],0.3714590636807818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABEPK,Rab9 effector protein with kelch motifs,1685,69,1.09 [0.75-1.58],0.6409194874721904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABGAP1L,Rab GTPase-activating protein 1-like,1710,70,0.83 [0.58-1.19],0.3144793758369434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAC3,Ras-related C3 botulinum toxin substrate 3,1489,57,1.21 [0.85-1.72],0.2816480913213447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAD23B,UV excision repair protein RAD23 homolog B,1685,69,1.12 [0.75-1.68],0.5771710139570451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAD51,DNA repair protein RAD51 homolog 1,1504,59,0.86 [0.49-1.51],0.6013947916633946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RALB,Ras-related protein Ral-B,1481,58,0.51 [0.21-1.24],0.1381167031191569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RALY,RNA-binding protein Raly,1526,59,1.15 [0.73-1.80],0.5425021096261313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANBP1,Ran-specific GTPase-activating protein,1483,60,0.80 [0.49-1.30],0.3741329890274079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANBP2,E3 SUMO-protein ligase RanBP2,1478,58,0.90 [0.41-1.98],0.7913715210081668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANGAP1,Ran GTPase-activating protein 1,1685,69,1.03 [0.66-1.62],0.8873746103232644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAP1A,Ras-related protein Rap-1A,1481,58,0.87 [0.59-1.29],0.4996183393888305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,1504,59,0.82 [0.51-1.32],0.4239418770590529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES1,Retinoic acid receptor responder protein 1,1685,69,1.49 [0.96-2.31],0.0781149272940718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES2,Retinoic acid receptor responder protein 2,1763,72,1.81 [1.29-2.54],0.000587528915475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASA1,Ras GTPase-activating protein 1,1687,70,1.56 [0.88-2.79],0.1304190544039176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,1473,59,0.77 [0.41-1.45],0.416780729634724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASSF2,Ras association domain-containing protein 2,1685,69,1.32 [1.04-1.67],0.021167135104567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBFOX3,RNA binding protein fox-1 homolog 3,1532,59,2.88 [1.75-4.74],3.125913913137644e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBKS,Ribokinase,1700,70,0.78 [0.53-1.14],0.204177778308561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM17,Splicing factor 45,1532,59,0.86 [0.61-1.20],0.3778913855118306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM19,Probable RNA-binding protein 19,1485,57,1.13 [0.67-1.91],0.6405138962147854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM25,RNA-binding protein 25,1473,59,0.77 [0.44-1.36],0.3673256614957941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP1,Retinol-binding protein 1,1489,57,1.10 [0.82-1.48],0.5385104860004069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP2,Retinol-binding protein 2,1737,71,1.49 [1.17-1.91],0.0014571325819503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP5,Retinol-binding protein 5,1737,71,1.30 [0.97-1.73],0.0746092753344274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP7,Retinoid-binding protein 7,1522,57,1.48 [1.08-2.03],0.013766330415123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBPMS,RNA-binding protein with multiple splicing,1481,58,0.87 [0.56-1.35],0.5286160219572589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBPMS2,RNA-binding protein with multiple splicing 2,1483,60,0.95 [0.75-1.20],0.6392217247815567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RCC1,Regulator of chromosome condensation,1526,59,1.25 [0.83-1.89],0.2776714131378641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RCOR1,REST corepressor 1,1715,70,1.29 [0.91-1.83],0.1500545536622078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,1483,60,2.10 [0.69-6.34],0.1889164259447994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REEP4,Receptor expression-enhancing protein 4,1532,59,0.95 [0.66-1.39],0.8049349585958783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1A,Lithostathine-1-alpha,1747,71,2.38 [1.78-3.19],6.270830423788564e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1B,Lithostathine-1-beta,1773,72,1.80 [1.35-2.40],5.8688543514006965e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3A,Regenerating islet-derived protein 3-alpha,1773,72,1.79 [1.35-2.38],4.60280558446611e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3G,Regenerating islet-derived protein 3-gamma,1526,59,0.82 [0.43-1.56],0.5433254989275118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG4,Regenerating islet-derived protein 4,1747,71,2.62 [1.88-3.66],1.3969357157739098e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELB,Transcription factor RelB,1481,58,1.21 [0.74-1.97],0.4478382008605404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELT,Tumor necrosis factor receptor superfamily member 19L,1756,72,2.53 [1.38-4.66],0.0027998906765535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REN,Renin,1750,72,1.59 [1.32-1.92],1.2908308185782052e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REPS1,RalBP1-associated Eps domain-containing protein 1,1481,58,0.75 [0.36-1.56],0.4467302882806632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REST,RE1-silencing transcription factor,1473,59,0.80 [0.38-1.67],0.5468312527371083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,1737,71,1.40 [0.83-2.36],0.2138906713024418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RETN,Resistin,1752,72,1.48 [0.96-2.28],0.0781647452274668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REXO2,"Oligoribonuclease, mitochondrial",1485,57,0.90 [0.47-1.72],0.7482322885408698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RFC4,Replication factor C subunit 4,1526,59,0.97 [0.33-2.83],0.9598585408907732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGCC,Regulator of cell cycle RGCC,1532,59,0.79 [0.58-1.07],0.128612170739518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,1504,59,0.75 [0.45-1.25],0.2692511955440236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMA,Repulsive guidance molecule A,1759,71,1.07 [0.56-2.04],0.8358127523670837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMB,RGM domain family member B,1759,71,1.67 [0.81-3.43],0.1610456293182701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGS10,Regulator of G-protein signaling 10,1532,59,0.78 [0.51-1.18],0.2435425049957256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGS8,Regulator of G-protein signaling 8,1710,70,1.27 [0.98-1.65],0.0662111080440293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RHOC,Rho-related GTP-binding protein RhoC,1721,70,1.00 [0.84-1.19],0.974679108829259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RICTOR,Rapamycin-insensitive companion of mTOR,1481,58,0.58 [0.27-1.25],0.1672438713633382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,1502,60,1.43 [1.00-2.05],0.0473534361377697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RILP,Rab-interacting lysosomal protein,1761,73,0.78 [0.56-1.08],0.1366334942345688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RILPL2,RILP-like protein 2,1532,60,0.92 [0.73-1.18],0.5238806019363642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,1485,57,1.28 [0.95-1.73],0.1066556670946777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RLN1,Prorelaxin H1,1532,59,0.98 [0.60-1.60],0.9250309182560644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RLN2,Prorelaxin H2,1500,60,0.93 [0.66-1.30],0.6650537768164315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE1,Ribonuclease pancreatic,1537,60,3.52 [1.85-6.71],0.000127625942866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE10,Inactive ribonuclease-like protein 10,1483,60,1.90 [1.37-2.63],0.0001090738032191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE3,Eosinophil cationic protein,1744,72,0.98 [0.82-1.17],0.8074035490172642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE4,Ribonuclease 4,1481,57,3.35 [1.42-7.87],0.0056130418290511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE6,Ribonuclease K6,1520,58,1.67 [0.99-2.80],0.0534904693425644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASEH2A,Ribonuclease H2 subunit A,1532,59,0.72 [0.40-1.28],0.2651256237730761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASET2,Ribonuclease T2,1767,72,4.35 [2.31-8.20],5.439854975140844e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF149,E3 ubiquitin-protein ligase RNF149,1483,60,3.24 [1.81-5.77],7.079165334425253e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF168,E3 ubiquitin-protein ligase RNF168,1481,58,0.58 [0.27-1.25],0.1642389191746774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF31,E3 ubiquitin-protein ligase RNF31,1481,58,0.43 [0.17-1.05],0.0650305123769163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF4,E3 ubiquitin-protein ligase RNF4,1504,59,0.53 [0.31-0.90],0.0177625891851059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF41,E3 ubiquitin-protein ligase NRDP1,1685,69,1.05 [0.77-1.44],0.7654551027543786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF43,E3 ubiquitin-protein ligase RNF43,1504,59,1.21 [0.82-1.78],0.3276273275821103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF5,E3 ubiquitin-protein ligase RNF5,1483,60,0.73 [0.52-1.01],0.0547012006104656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO1,Roundabout homolog 1,1747,71,1.74 [0.89-3.43],0.1078829736433881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO2,Roundabout homolog 2,1759,71,0.66 [0.27-1.63],0.3694585140895648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO4,Roundabout homolog 4,1483,60,1.58 [0.40-6.27],0.5187634424444799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,1750,72,1.50 [0.83-2.68],0.1763792815154696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RP2,Protein XRP2,1737,71,1.28 [0.84-1.93],0.2494539906957471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPA2,Replication protein A 32 kDa subunit,1481,58,0.69 [0.29-1.65],0.4067129997258066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPE,Ribulose-phosphate 3-epimerase,1504,59,0.93 [0.67-1.31],0.6827445400518244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,1489,57,0.68 [0.33-1.39],0.2888378742099209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPL14,60S ribosomal protein L14,1483,60,0.89 [0.46-1.71],0.7167400359354442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPS10,40S ribosomal protein S10,1485,57,1.18 [0.68-2.06],0.5582913872764828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRAS,Ras-related protein R-Ras,1489,57,0.95 [0.79-1.15],0.5839356895969718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,1685,69,1.10 [0.74-1.64],0.6511585391941167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,1685,69,1.03 [0.75-1.41],0.8750983600988551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRP15,RRP15-like protein,1478,58,1.02 [0.75-1.38],0.9190150921798408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO1,R-spondin-1,1731,71,2.53 [1.39-4.61],0.002483334384457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO3,R-spondin-3,1767,73,1.91 [1.01-3.62],0.0475929946780223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTBDN,Retbindin,1737,71,1.35 [0.78-2.36],0.2863006859008135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTKN2,Rhotekin-2,1485,57,1.38 [0.91-2.07],0.1255725289816842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",1532,59,0.82 [0.63-1.07],0.1393325995125377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4R,Reticulon-4 receptor,1767,73,3.15 [1.84-5.41],3.063437202879175e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RUVBL1,RuvB-like 1,1685,69,1.21 [1.00-1.46],0.0526382017853274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RWDD1,RWD domain-containing protein 1,1759,71,0.96 [0.69-1.34],0.8274524101247693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RYR1,Ryanodine receptor 1,1485,57,0.75 [0.34-1.67],0.4813668998288953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A11,Protein S100-A11,1732,71,1.09 [0.75-1.60],0.6428330594003147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A12,Protein S100-A12,1719,70,1.18 [0.89-1.56],0.247006250392637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A13,Protein S100-A13,1481,58,1.09 [0.54-2.18],0.8096325070238037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A14,Protein S100-A14,1532,59,0.50 [0.28-0.89],0.0195230178634489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A16,Protein S100-A16,1685,70,0.91 [0.64-1.29],0.5960595446821534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A3,Protein S100-A3,1526,59,1.16 [0.73-1.84],0.5286527304668327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A4,Protein S100-A4,1749,73,0.87 [0.62-1.22],0.4109142503123285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100G,Protein S100-G,1532,59,0.74 [0.42-1.28],0.2787365782955968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100P,Protein S100-P,1715,70,1.56 [1.20-2.03],0.0009263380930879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAA4,Serum amyloid A-4 protein,1541,59,0.55 [0.15-2.03],0.3720477164080257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAFB2,Scaffold attachment factor B2,1532,59,0.92 [0.36-2.35],0.8601911556514419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAG,S-arrestin,1478,58,1.18 [0.68-2.02],0.5573557580797182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,1749,72,1.08 [0.82-1.43],0.5685301095108672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAP18,Histone deacetylase complex subunit SAP18,1504,59,1.05 [0.77-1.44],0.741917884041962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SARG,Specifically androgen-regulated gene protein,1529,60,1.00 [0.81-1.25],0.9686635959250078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,1485,57,1.09 [0.59-2.03],0.7852285841911761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAT1,Diamine acetyltransferase 1,1485,57,0.88 [0.49-1.59],0.668431973845952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAT2,Thialysine N-epsilon-acetyltransferase,1504,59,1.14 [0.86-1.52],0.3482082316492401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SATB1,DNA-binding protein SATB1,1532,59,1.05 [0.44-2.50],0.9194156412494598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SBSN,Suprabasin,1535,59,0.71 [0.36-1.41],0.3318827280303468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCAMP3,Secretory carrier-associated membrane protein 3,1737,71,1.03 [0.80-1.32],0.8306106795379729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARA5,Scavenger receptor class A member 5,1759,71,2.99 [1.62-5.54],0.0004902847668279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB1,Scavenger receptor class B member 1,1687,70,1.28 [0.94-1.73],0.1160684616133272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB2,Lysosome membrane protein 2,1698,71,3.33 [2.20-5.05],1.3206610134633712e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF1,Scavenger receptor class F member 1,1773,72,1.43 [0.91-2.26],0.1233977009966976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF2,Scavenger receptor class F member 2,1759,71,4.27 [2.43-7.52],4.595640575990883e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG2,Secretogranin-2,1758,73,3.95 [2.33-6.69],3.462147534326132e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG3,Secretogranin-3,1747,71,1.33 [0.74-2.39],0.3445329895650554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB1A1,Uteroglobin,1747,71,1.66 [1.13-2.43],0.0094049226500811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB2A2,Mammaglobin-A,1485,57,0.57 [0.20-1.61],0.2890528022318611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB3A1,Secretoglobin family 3A member 1,1502,60,1.42 [0.54-3.73],0.4737336991428635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB3A2,Secretoglobin family 3A member 2,1750,71,1.18 [0.93-1.48],0.1674707097694545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGN,Secretagogin,1710,70,2.48 [1.72-3.58],1.3456662817822356e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCIN,Adseverin,1478,58,0.82 [0.57-1.18],0.2780325762903051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCLY,Selenocysteine lyase,1761,73,1.07 [0.74-1.54],0.717621494289435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN2A,Sodium channel protein type 2 subunit alpha,1478,58,0.77 [0.42-1.39],0.3821604321324581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN2B,Sodium channel subunit beta-2,1489,57,1.39 [0.55-3.54],0.4883193051651084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN3A,Sodium channel protein type 3 subunit alpha,1489,57,0.53 [0.23-1.25],0.147036328663711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN3B,Sodium channel subunit beta-3,1478,58,0.94 [0.52-1.71],0.8465398211262273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN4B,Sodium channel subunit beta-4,1483,60,1.28 [0.79-2.07],0.3119766752800951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCP2,Non-specific lipid-transfer protein,1685,69,1.08 [0.81-1.45],0.600796311022939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,1481,60,0.78 [0.47-1.29],0.3332240317268589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRG1,Scrapie-responsive protein 1,1532,60,1.76 [0.84-3.70],0.1340465992504933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRIB,Protein scribble homolog,1483,60,0.93 [0.68-1.26],0.6374951841675595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRN1,Secernin-1,1749,72,1.07 [0.74-1.56],0.7085836498993776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCT,Secretin,1489,57,1.17 [0.69-2.01],0.5583412109900705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC1,Syndecan-1,1750,72,1.11 [0.71-1.74],0.6448985526107682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC4,Syndecan-4,1750,72,0.93 [0.62-1.40],0.7294355118140432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDCCAG8,Serologically defined colon cancer antigen 8,1526,59,0.92 [0.74-1.14],0.4449210385656165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDHB,Succinate dehydrogenase,1522,57,0.92 [0.63-1.36],0.685119674721363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDK2,Protein sidekick-2,1502,60,1.75 [0.98-3.14],0.0597330534633615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEC31A,Protein transport protein Sec31A,1483,60,0.85 [0.62-1.16],0.3067281660504706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEL1L,Protein sel-1 homolog 1,1483,60,1.52 [0.90-2.55],0.1144908692272541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELE,E-selectin,1773,72,1.47 [1.02-2.11],0.0405920054581696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELENOP,Selenoprotein P,1541,59,0.70 [0.24-2.09],0.528532019450888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELL,L-selectin,1541,59,0.99 [0.36-2.72],0.9843013954157518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELP,P-selectin,1760,72,1.24 [0.87-1.76],0.233910262060626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELPLG,P-selectin glycoprotein ligand 1,1749,72,0.94 [0.48-1.86],0.8575672854781857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3F,Semaphorin-3F,1750,72,1.73 [0.85-3.51],0.1272505656979651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3G,Semaphorin-3G,1502,60,1.10 [0.66-1.85],0.7130045517097223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA4C,Semaphorin-4C,1737,71,1.33 [0.89-1.97],0.1615055014808921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA4D,Semaphorin-4D,1759,71,0.92 [0.45-1.87],0.8100820939657635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA6C,Semaphorin-6C,1481,58,0.42 [0.13-1.34],0.143529486942859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA7A,Semaphorin-7A,1771,72,2.54 [1.38-4.66],0.0026429013526713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN3,Neuronal-specific septin-3,1532,59,1.01 [0.74-1.38],0.95371470861769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN7,Septin-7,1504,59,1.06 [0.66-1.68],0.8170428443868627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN8,Septin-8,1511,57,1.93 [1.19-3.15],0.0080345604634825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN9,Septin-9,1737,71,1.36 [0.69-2.69],0.37875020161867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA1,Alpha-1-antitrypsin,1509,58,24.86 [1.43-432.11],0.0274162314349679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA11,Serpin A11,1773,72,1.25 [0.77-2.03],0.3715972007772838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA12,Serpin A12,1714,71,0.96 [0.81-1.15],0.6761338540872042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA3,Alpha-1-antichymotrypsin,1534,59,4.97 [1.17-21.15],0.0301465491762279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA4,Kallistatin,1505,57,3.32 [1.18-9.34],0.022909613235911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA5,Plasma serine protease inhibitor,1512,57,1.72 [0.82-3.60],0.1537788517764846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA6,Corticosteroid-binding globulin,1541,59,10.97 [2.87-41.89],0.0004566542154433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA7,Thyroxine-binding globulin,1541,59,1.84 [0.51-6.63],0.3536504530127344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA9,Serpin A9,1725,70,1.07 [0.80-1.43],0.662407033295054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB1,Leukocyte elastase inhibitor,1751,72,0.99 [0.79-1.23],0.9122917899177494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB5,Serpin B5,1715,70,0.78 [0.55-1.10],0.1579827627834824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB6,Serpin B6,1753,71,1.01 [0.71-1.42],0.970991053016982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB8,Serpin B8,1775,73,1.17 [0.89-1.54],0.2738261165918907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB9,Serpin B9,1731,71,1.20 [0.62-2.30],0.5946465643911688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINC1,Antithrombin-III,1535,58,14.20 [2.89-69.75],0.0010830271180121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPIND1,Heparin cofactor 2,1535,58,1.67 [0.73-3.84],0.2257764464545112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINE1,Plasminogen activator inhibitor 1,1773,72,1.39 [1.01-1.91],0.0453888435594581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINE2,Glia-derived nexin,1532,60,1.16 [0.82-1.64],0.3923135968090444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF1,Pigment epithelium-derived factor,1511,57,4.50 [1.79-11.33],0.0014227499198874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF2,Alpha-2-antiplasmin,1500,57,4.15 [0.70-24.48],0.1160942355091206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPING1,Plasma protease C1 inhibitor,1535,58,10.14 [2.89-35.65],0.0003026457626639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINH1,Serpin H1,1504,59,1.04 [0.86-1.25],0.7013416779976072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINI1,Neuroserpin,1498,59,0.74 [0.33-1.67],0.4712949552684633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINI2,Serpin I2,1522,57,1.03 [0.67-1.58],0.8986865610540521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,1687,70,1.05 [0.76-1.44],0.7693467327610148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,1724,71,0.65 [0.32-1.31],0.2289686206668437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6,Seizure protein 6 homolog,1489,57,0.98 [0.43-2.23],0.966217739616315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L,Seizure 6-like protein,1749,73,2.91 [1.58-5.35],0.0006077836889364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L2,Seizure 6-like protein 2,1737,71,1.90 [0.95-3.77],0.0677704616500637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SF3B4,Splicing factor 3B subunit 4,1737,71,1.06 [0.80-1.41],0.6628934504734929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP1,Secreted frizzled-related protein 1,1723,71,2.13 [1.33-3.42],0.0017393424898855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP4,Secreted frizzled-related protein 4,1502,60,0.93 [0.52-1.65],0.797521801480416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPA1,Pulmonary surfactant-associated protein A1,1685,69,1.37 [1.04-1.81],0.0244972241653519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPA2,Pulmonary surfactant-associated protein A2,1685,69,0.98 [0.65-1.47],0.9046737272222122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPD,Pulmonary surfactant-associated protein D,1750,72,1.10 [0.80-1.50],0.5585295687915462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SGSH,N-sulphoglucosamine sulphohydrolase,1511,60,1.35 [0.92-1.96],0.1228090324823325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH2B3,SH2B adapter protein 3,1685,69,0.95 [0.77-1.17],0.6237827279318844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH2D1A,SH2 domain-containing protein 1A,1749,72,1.06 [0.73-1.53],0.77077611403883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,1478,58,0.69 [0.40-1.19],0.1770672986939022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3BP1,SH3 domain-binding protein 1,1522,57,0.76 [0.44-1.33],0.3402309727714968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3GL3,Endophilin-A3,1492,59,1.17 [0.89-1.55],0.2672990327334252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3GLB2,Endophilin-B2,1517,58,0.94 [0.65-1.36],0.7442811569049306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHBG,Sex hormone-binding globulin,1537,60,0.98 [0.64-1.49],0.921011141606802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHC1,SHC-transforming protein 1,1473,59,0.93 [0.72-1.18],0.5391127196085893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHD,SH2 domain-containing adapter protein D,1480,57,1.08 [0.84-1.38],0.5465226324383623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHH,Sonic hedgehog protein,1481,58,0.92 [0.52-1.62],0.7725527474230729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHISA5,Protein shisa-5,1536,59,2.23 [1.25-3.98],0.0068782828925617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",1750,71,0.94 [0.74-1.18],0.5767600624925293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHPK,Sedoheptulokinase,1504,59,1.15 [0.69-1.94],0.5860546595089866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIAE,Sialate O-acetylesterase,1746,73,1.39 [0.91-2.15],0.1314718550836453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC1,Sialoadhesin,1752,71,2.23 [1.44-3.44],0.0003185285805707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,1749,72,3.39 [1.98-5.82],9.39812498017448e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,1687,70,0.99 [0.74-1.32],0.9391518713694206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,1756,72,1.28 [1.03-1.60],0.0293197462013929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,1767,73,6.18 [3.54-10.80],1.5328613509908496e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,1750,72,2.35 [1.15-4.80],0.0184905331673771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,1483,60,1.58 [0.99-2.50],0.053613673457842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,1764,73,1.50 [0.77-2.92],0.2333599921275004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIL1,Nucleotide exchange factor SIL1,1483,60,1.94 [1.11-3.37],0.0196176127274888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,1754,71,1.40 [0.93-2.11],0.1067516570423892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPB1,Signal-regulatory protein beta-1,1742,71,2.51 [1.66-3.79],1.249572070846024e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,1481,58,0.96 [0.70-1.32],0.808968805705152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,1737,71,1.02 [0.80-1.29],0.8957205059896275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",1687,70,1.12 [0.78-1.60],0.5468334601836817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,1710,70,1.35 [0.92-1.96],0.1228068028852191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKAP1,Src kinase-associated phosphoprotein 1,1725,71,1.12 [0.83-1.51],0.4458819435559253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKAP2,Src kinase-associated phosphoprotein 2,1752,71,1.01 [0.82-1.23],0.94589044284349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKIV2L,Helicase SKI2W,1485,57,0.96 [0.51-1.80],0.9003324730315926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLA2,Src-like-adapter 2,1532,59,0.96 [0.76-1.20],0.7056289527774009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF1,Signaling lymphocytic activation molecule,1710,70,1.42 [1.02-1.97],0.037861823835792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF6,SLAM family member 6,1685,69,1.95 [1.40-2.72],7.329555393714734e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF7,SLAM family member 7,1749,72,1.78 [1.29-2.47],0.0005366877454654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF8,SLAM family member 8,1685,69,1.44 [0.98-2.12],0.0653604131715447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC12A2,Solute carrier family 12 member 2,1485,57,0.93 [0.35-2.46],0.8890627708016886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC13A1,Solute carrier family 13 member 1,1526,59,1.04 [0.67-1.61],0.8651396487937473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC16A1,Monocarboxylate transporter 1,1687,70,0.98 [0.66-1.47],0.9368376117062994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC1A4,Neutral amino acid transporter A,1489,57,0.96 [0.54-1.70],0.8876530697378874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC27A4,Long-chain fatty acid transport protein 4,1687,70,1.01 [0.75-1.36],0.9615179376640636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC28A1,Sodium/nucleoside cotransporter 1,1473,59,1.12 [0.74-1.70],0.5824120000082451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,1473,59,1.28 [0.75-2.20],0.3634611525280332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A14,Zinc transporter ZIP14,1687,70,2.16 [1.34-3.47],0.0014516629332821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A5,Zinc transporter ZIP5,1749,72,1.44 [1.11-1.85],0.0054986374617041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC44A4,Choline transporter-like protein 4,1489,57,1.11 [0.77-1.62],0.5660667554732284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC4A1,Band 3 anion transport protein,1536,59,0.84 [0.49-1.45],0.5410316233424939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC51B,Organic solute transporter subunit beta,1485,57,1.00 [0.68-1.48],0.98062215149475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,1502,60,0.86 [0.64-1.14],0.2847225478939313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,1522,57,0.95 [0.57-1.58],0.8409888129943992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",1473,59,0.94 [0.62-1.44],0.7876394999261496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLIT2,Slit homolog 2 protein,1687,70,1.21 [0.84-1.73],0.3085488072691832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK1,SLIT and NTRK-like protein 1,1481,58,0.70 [0.33-1.48],0.346336510933775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK2,SLIT and NTRK-like protein 2,1767,73,1.90 [1.15-3.15],0.0125887051838328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK6,SLIT and NTRK-like protein 6,1715,70,2.29 [1.34-3.91],0.0025215576867905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLK,STE20-like serine/threonine-protein kinase,1504,59,1.03 [0.75-1.43],0.8356924798133755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLMAP,Sarcolemmal membrane-associated protein,1522,57,0.88 [0.66-1.18],0.39127779094096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,1523,59,1.00 [0.50-2.00],0.9964223220678694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD1,Mothers against decapentaplegic homolog 1,1685,69,1.06 [0.83-1.35],0.6260334038480564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD2,Mothers against decapentaplegic homolog 2,1526,59,0.82 [0.58-1.16],0.2680146858187958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD3,Mothers against decapentaplegic homolog 3,1526,59,0.93 [0.58-1.47],0.7441990603991823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD5,Mothers against decapentaplegic homolog 5,1737,71,0.71 [0.26-1.94],0.5080232058459139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMARCA2,Probable global transcription activator SNF2L2,1687,70,0.94 [0.69-1.27],0.6694815669264769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMC3,Structural maintenance of chromosomes protein 3,1473,59,1.07 [0.67-1.73],0.7693936192999111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,1522,57,1.15 [0.83-1.61],0.4016535054277861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC1,SPARC-related modular calcium-binding protein 1,1767,73,3.25 [1.85-5.71],3.985314260837631e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC2,SPARC-related modular calcium-binding protein 2,1752,71,1.71 [1.04-2.81],0.0329493640682746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPD1,Sphingomyelin phosphodiesterase,1744,71,1.33 [0.89-1.99],0.1649493909284728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPD3,Sphingomyelin phosphodiesterase 3,1481,58,0.70 [0.39-1.26],0.2334604544950689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,1749,71,0.93 [0.68-1.28],0.6489826894363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,1526,59,0.78 [0.53-1.17],0.2312598812525083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMS,Spermine synthase,1478,58,0.72 [0.46-1.14],0.1631859778020236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMTN,Smoothelin,1514,58,1.04 [0.81-1.33],0.7818728392152898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP23,Synaptosomal-associated protein 23,1750,72,0.93 [0.74-1.17],0.5349018213963166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP25,Synaptosomal-associated protein 25,1478,58,0.67 [0.40-1.11],0.1197310210860657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP29,Synaptosomal-associated protein 29,1749,73,1.04 [0.84-1.30],0.6987232523744852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAPIN,SNARE-associated protein Snapin,1532,59,0.90 [0.60-1.35],0.6087642559292389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCA,Alpha-synuclein,1502,60,0.90 [0.74-1.10],0.3174286291630586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCG,Gamma-synuclein,1731,71,1.67 [1.23-2.28],0.0011742608803538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",1483,60,1.37 [0.70-2.66],0.3578400399534825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',1517,58,1.18 [0.79-1.78],0.417638033436853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNU13,NHP2-like protein 1,1485,57,1.05 [0.73-1.53],0.7847071365316363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX15,Sorting nexin-15,1502,60,0.89 [0.57-1.38],0.5911000315438182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX18,Sorting nexin-18,1522,57,1.34 [0.79-2.26],0.2761930363833776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX2,Sorting nexin-2,1526,59,1.05 [0.80-1.39],0.7205367814997345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX5,Sorting nexin-5,1483,60,0.70 [0.31-1.57],0.383596616300502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX9,Sorting nexin-9,1750,72,0.97 [0.72-1.31],0.85544734097344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD1,Superoxide dismutase [Cu-Zn],1721,71,0.93 [0.60-1.44],0.7427897055195047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",1756,72,0.86 [0.55-1.35],0.5192771624102279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD3,Extracellular superoxide dismutase,1537,60,0.93 [0.60-1.45],0.7502394100318222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORBS1,Sorbin and SH3 domain-containing protein 1,1532,59,0.97 [0.52-1.80],0.9234727182549894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORCS2,VPS10 domain-containing receptor SorCS2,1685,69,2.57 [1.59-4.17],0.000125355956607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORD,Sorbitol dehydrogenase,1756,72,0.85 [0.65-1.11],0.2393499165962216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORT1,Sortilin,1750,72,1.81 [1.10-3.00],0.0202115703549678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOST,Sclerostin,1750,72,1.15 [0.68-1.93],0.6103509486649297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,1489,57,0.71 [0.35-1.41],0.3264829972609371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOX2,Transcription factor SOX-2,1531,59,0.53 [0.17-1.61],0.260743259215096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOX9,Transcription factor SOX-9,1489,57,1.74 [0.67-4.52],0.2546274170724352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,1532,59,1.02 [0.43-2.45],0.962842767707584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPAG1,Sperm-associated antigen 1,1532,59,0.63 [0.38-1.05],0.0787707336394392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPARC,SPARC,1749,73,1.35 [0.99-1.83],0.0565356045424508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPARCL1,SPARC-like protein 1,1747,71,1.69 [0.78-3.67],0.18479974019112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPART,Spartin,1502,60,0.90 [0.66-1.23],0.5000129156498793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPESP1,Sperm equatorial segment protein 1,1532,60,1.32 [0.62-2.80],0.4710183392479511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK1,Serine protease inhibitor Kazal-type 1,1756,72,2.05 [1.49-2.82],1.173429739895374e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK2,Serine protease inhibitor Kazal-type 2,1502,60,1.52 [0.85-2.69],0.1556653966487753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK4,Serine protease inhibitor Kazal-type 4,1749,72,2.34 [1.82-3.00],3.2274375702892216e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK5,Serine protease inhibitor Kazal-type 5,1756,72,1.21 [0.67-2.21],0.5266319620552693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK6,Serine protease inhibitor Kazal-type 6,1767,73,1.19 [0.81-1.75],0.3701348706802529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK8,Serine protease inhibitor Kazal-type 8,1485,57,0.71 [0.32-1.57],0.3975160201601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT1,Kunitz-type protease inhibitor 1,1751,72,2.44 [1.38-4.30],0.0021047985536001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT2,Kunitz-type protease inhibitor 2,1752,71,2.86 [1.77-4.62],1.898262024325276e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT3,Kunitz-type protease inhibitor 3,1522,57,0.96 [0.82-1.13],0.6503037152478925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPOCK1,Testican-1,1731,71,0.53 [0.25-1.14],0.1046566318460958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON1,Spondin-1,1747,71,3.41 [2.07-5.60],1.347039803521559e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON2,Spondin-2,1743,72,2.17 [1.28-3.68],0.0039572089015431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPP1,Osteopontin,1771,72,1.39 [0.94-2.05],0.1010511110896009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",1481,58,0.64 [0.34-1.22],0.1730128804164835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRING1,SREBP regulating gene protein,1473,59,1.18 [0.86-1.63],0.3092341650870108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR1B,Cornifin-B,1504,59,1.00 [0.75-1.34],0.9839942414820771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR3,Small proline-rich protein 3,1517,58,1.19 [0.83-1.70],0.3365994497379256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRY2,Protein sprouty homolog 2,1710,70,0.86 [0.69-1.08],0.2005392309461409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",1478,58,1.16 [0.57-2.38],0.675972117679337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPTLC1,Serine palmitoyltransferase 1,1517,58,0.35 [0.14-0.86],0.0217081706052084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRC,Proto-oncogene tyrosine-protein kinase Src,1744,72,0.99 [0.84-1.18],0.9399681726733776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRP14,Signal recognition particle 14 kDa protein,1737,71,1.21 [0.87-1.67],0.2518759974277633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPK2,SRSF protein kinase 2,1749,72,1.01 [0.80-1.28],0.906378444031112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPX,Sushi repeat-containing protein SRPX,1532,60,1.65 [0.89-3.08],0.1133316795126076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSB,Lupus La protein,1687,70,1.35 [0.98-1.85],0.0638194585200095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",1481,58,0.84 [0.40-1.75],0.6418303218064584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,1750,72,0.96 [0.82-1.12],0.5780281376314447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,1760,72,1.06 [0.66-1.71],0.8099599619673814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSH3,Protein phosphatase Slingshot homolog 3,1473,59,0.47 [0.18-1.27],0.1369306158347915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,1522,57,0.84 [0.52-1.37],0.4908679889179623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST13,Hsc70-interacting protein,1502,60,0.70 [0.45-1.10],0.1189613019470294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",1737,71,1.81 [1.25-2.61],0.0015064977171403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",1773,72,2.86 [1.51-5.43],0.001250763517832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",1481,58,0.68 [0.34-1.39],0.2924405852080114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAB2,Stabilin-2,1536,59,1.95 [0.80-4.74],0.1426115358794296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAM,Signal transducing adapter molecule 1,1526,59,1.09 [0.58-2.05],0.7915475045102532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAMBP,STAM-binding protein,1725,71,1.01 [0.72-1.40],0.970054144434136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAT2,Signal transducer and activator of transcription 2,1481,58,0.87 [0.64-1.19],0.3794106581891432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAT5B,Signal transducer and activator of transcription 5B,1737,71,0.96 [0.83-1.12],0.6303313031020218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,1473,59,1.36 [1.03-1.79],0.0305281152586162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC1,Stanniocalcin-1,1759,71,2.23 [1.49-3.34],9.743016857304788e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC2,Stanniocalcin-2,1753,71,2.86 [1.24-6.58],0.0134577337411874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STEAP4,Metalloreductase STEAP4,1478,58,0.88 [0.59-1.30],0.5217343126331374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STIP1,Stress-induced-phosphoprotein 1,1753,72,0.93 [0.68-1.28],0.6650088300394639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK11,Serine/threonine-protein kinase STK11,1715,70,0.91 [0.68-1.22],0.5419362623034241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK24,Serine/threonine-protein kinase 24,1687,70,0.91 [0.65-1.29],0.6073719917733009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK4,Serine/threonine-protein kinase 4,1750,72,0.87 [0.69-1.11],0.2651668758127803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STOML2,"Stomatin-like protein 2, mitochondrial",1473,59,0.92 [0.71-1.19],0.5218021662308601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX16,Syntaxin-16,1685,69,1.00 [0.69-1.45],0.9995263902062298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX1B,Syntaxin-1B,1489,57,1.23 [0.70-2.16],0.4645191579706622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX3,Syntaxin-3,1517,58,0.40 [0.15-1.04],0.0599562596002364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX4,Syntaxin-4,1737,71,1.03 [0.74-1.42],0.8753838934979609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX5,Syntaxin-5,1481,58,1.21 [0.84-1.73],0.3090682739987475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX6,Syntaxin-6,1685,69,1.02 [0.73-1.43],0.910430074575739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX7,Syntaxin-7,1481,58,1.04 [0.61-1.77],0.8822878959076607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX8,Syntaxin-8,1749,72,1.06 [0.70-1.59],0.7922724617780112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STXBP1,Syntaxin-binding protein 1,1532,59,0.82 [0.60-1.11],0.1952284280460355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STXBP3,Syntaxin-binding protein 3,1685,69,0.89 [0.54-1.48],0.6658847324871763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUGP1,SURP and G-patch domain-containing protein 1,1522,57,0.80 [0.44-1.48],0.4813749372533122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUGT1,Protein SGT1 homolog,1685,69,0.96 [0.74-1.25],0.7541193818978034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SULT1A1,Sulfotransferase 1A1,1759,71,0.87 [0.75-1.02],0.0822839583128819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SULT2A1,Bile salt sulfotransferase,1749,72,1.20 [0.96-1.51],0.1155175281382732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUMF1,Formylglycine-generating enzyme,1481,58,0.85 [0.53-1.35],0.4930022590943856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,1759,71,1.36 [0.90-2.05],0.1442054637767779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUOX,"Sulfite oxidase, mitochondrial",1532,59,0.99 [0.71-1.38],0.9452434206708706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD1,Sushi domain-containing protein 1,1715,70,1.08 [0.70-1.69],0.7191499429995125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD2,Sushi domain-containing protein 2,1756,72,2.08 [1.10-3.91],0.0238721741245145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD4,Sushi domain-containing protein 4,1526,59,1.15 [0.67-1.99],0.6095681450750244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD5,Sushi domain-containing protein 5,1495,59,2.27 [1.19-4.32],0.0125031343050178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SV2A,Synaptic vesicle glycoprotein 2A,1489,57,0.99 [0.68-1.45],0.9727946346308238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SWAP70,Switch-associated protein 70,1522,57,1.15 [0.62-2.14],0.6509758709075202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYAP1,Synapse-associated protein 1,1502,60,0.82 [0.54-1.24],0.350470406935137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,1478,58,0.59 [0.33-1.06],0.0775175175403855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYT1,Synaptotagmin-1,1517,58,1.01 [0.48-2.09],0.9892137733911096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYTL4,Synaptotagmin-like protein 4,1532,60,0.84 [0.61-1.17],0.3139381396531405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,1504,59,0.87 [0.69-1.10],0.2387474425943927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACC3,Transforming acidic coiled-coil-containing protein 3,1737,71,0.99 [0.83-1.18],0.9033031148717656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACSTD2,Tumor-associated calcium signal transducer 2,1552,64,3.96 [2.33-6.74],3.728299879186914e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TADA3,Transcriptional adapter 3,1526,59,0.74 [0.39-1.39],0.3526346297184975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAFA5,Chemokine-like protein TAFA-5,1737,71,2.38 [1.59-3.56],2.7664549659141985e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAGLN3,Transgelin-3,1473,59,1.08 [0.74-1.59],0.6808698239328734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TALDO1,Transaldolase,1533,59,1.08 [0.63-1.85],0.7771631098812776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TANK,TRAF family member-associated NF-kappa-B activator,1710,70,1.16 [0.86-1.56],0.3277062671254634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAP1,Antigen peptide transporter 1,1504,59,0.93 [0.61-1.42],0.7318436183263142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARBP2,RISC-loading complex subunit TARBP2,1687,70,1.05 [0.80-1.36],0.7313521661368221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",1489,57,1.34 [1.07-1.68],0.0121170230221761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",1526,59,0.66 [0.33-1.35],0.2606030202887135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAX1BP1,Tax1-binding protein 1,1517,58,1.09 [0.75-1.59],0.6447139528078221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D17,TBC1 domain family member 17,1687,70,1.17 [0.73-1.89],0.508396000209062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D23,TBC1 domain family member 23,1737,71,1.01 [0.80-1.26],0.9571323266073124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D5,TBC1 domain family member 5,1749,72,1.03 [0.80-1.33],0.8226154008500699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCA,Tubulin-specific chaperone A,1502,60,0.87 [0.65-1.17],0.3567017800570132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCB,Tubulin-folding cofactor B,1731,71,0.95 [0.78-1.17],0.6263154868780826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCC,Tubulin-specific chaperone C,1731,71,1.02 [0.79-1.31],0.8942108222810562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,1685,69,1.03 [0.80-1.32],0.8150942060566584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBR1,T-box brain protein 1,1489,57,0.82 [0.47-1.45],0.4973378213325958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCL1A,T-cell leukemia/lymphoma protein 1A,1730,71,0.94 [0.76-1.15],0.5264716303028881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCL1B,T-cell leukemia/lymphoma protein 1B,1715,70,0.94 [0.70-1.25],0.6607666235748283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN1,Transcobalamin-1,1497,57,0.50 [0.23-1.08],0.0792348249276286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN2,Transcobalamin-2,1771,72,1.73 [1.03-2.93],0.040096418780926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCOF1,Treacle protein,1532,60,1.66 [0.93-2.95],0.0864632727479023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCP11,T-complex protein 11 homolog,1504,59,0.62 [0.32-1.19],0.1509020698666775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCTN3,Tectonic-3,1532,60,1.91 [0.87-4.21],0.1074162124996047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDGF1,Teratocarcinoma-derived growth factor 1,1687,70,1.05 [0.91-1.21],0.4743891442505954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDO2,"Tryptophan 2,3-dioxygenase",1489,57,1.05 [0.59-1.87],0.8682093237620923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,1526,59,1.04 [0.77-1.41],0.7850534540368989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDRKH,Tudor and KH domain-containing protein,1687,70,0.86 [0.67-1.12],0.2644810975423124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEF,Thyrotroph embryonic factor,1485,57,0.57 [0.29-1.14],0.1134470151026578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEK,Angiopoietin-1 receptor,1749,73,2.34 [1.02-5.37],0.0446676745810706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TERF1,Telomeric repeat-binding factor 1,1481,58,0.49 [0.19-1.25],0.1343314997979338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TET2,Methylcytosine dioxygenase TET2,1502,59,0.96 [0.73-1.26],0.7692436693399967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEX101,Testis-expressed protein 101,1489,57,1.12 [0.72-1.75],0.6131040671423674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEX33,Testis-expressed protein 33,1504,59,1.25 [0.67-2.35],0.4817808948581651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TF,Serotransferrin,1541,59,5.34 [1.77-16.11],0.002983279875116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFAP2A,Transcription factor AP-2-alpha,1478,58,0.74 [0.45-1.21],0.2321197036566278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF1,Trefoil factor 1,1747,72,1.60 [1.32-1.94],1.5111429480835576e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF2,Trefoil factor 2,1750,71,2.49 [1.91-3.23],1.206441213343847e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF3,Trefoil factor 3,1745,71,2.00 [1.49-2.67],3.0613027790011395e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI,Tissue factor pathway inhibitor,1754,71,1.47 [0.86-2.53],0.1597279361651923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI2,Tissue factor pathway inhibitor 2,1747,73,1.49 [1.14-1.96],0.0038476411624043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFRC,Transferrin receptor protein 1,1761,72,1.11 [0.65-1.90],0.710821195840269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TG,Thyroglobulin,1526,59,1.14 [0.92-1.41],0.2236354727148485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFA,Protransforming growth factor alpha,1749,72,1.50 [1.02-2.22],0.0408733501684937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB1,Transforming growth factor beta-1 proprotein,1772,73,1.97 [1.22-3.20],0.0058850483013557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB2,Transforming growth factor beta-2 proprotein,1526,59,1.19 [0.78-1.81],0.4234956122415894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,1748,71,1.16 [0.58-2.32],0.6709769925962543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR1,TGF-beta receptor type-1,1481,58,0.82 [0.23-2.94],0.7575775137449143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR2,TGF-beta receptor type-2,1749,73,2.74 [1.93-3.88],1.6558107354651133e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR3,Transforming growth factor beta receptor type 3,1773,72,2.02 [1.06-3.85],0.0332322882874774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,1746,72,0.85 [0.64-1.12],0.2523377178310085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGOLN2,Trans-Golgi network integral membrane protein 2,1537,60,2.83 [1.35-5.95],0.005977385249528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,1469,59,1.02 [0.77-1.34],0.907816328213468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBD,Thrombomodulin,1750,72,2.41 [1.34-4.35],0.0034230696017354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS2,Thrombospondin-2,1756,72,1.74 [1.28-2.37],0.0004042486291545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS4,Thrombospondin-4,1756,71,1.09 [0.72-1.66],0.685306181177653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THOP1,Thimet oligopeptidase,1743,72,0.60 [0.33-1.11],0.1036749447495774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THPO,Thrombopoietin,1715,70,1.32 [0.79-2.21],0.2882823187817219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THRAP3,Thyroid hormone receptor-associated protein 3,1485,57,1.08 [0.86-1.35],0.490979971117905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THSD1,Thrombospondin type-1 domain-containing protein 1,1473,58,0.79 [0.36-1.76],0.5719202936210304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THTPA,Thiamine-triphosphatase,1523,59,0.91 [0.69-1.22],0.546165332101961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THY1,Thy-1 membrane glycoprotein,1759,71,2.72 [1.48-5.01],0.0012836414803618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIA1,Nucleolysin TIA-1 isoform p40,1691,69,0.98 [0.83-1.16],0.8366661924393581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIE1,Tyrosine-protein kinase receptor Tie-1,1773,72,1.33 [0.78-2.25],0.2963477491698053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",1681,70,1.21 [0.78-1.86],0.3969623518920582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,1504,59,1.52 [0.93-2.47],0.096385487102741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,1760,72,0.97 [0.62-1.52],0.90184398416054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,1532,60,0.74 [0.39-1.40],0.3537893145596554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,1517,58,0.96 [0.72-1.28],0.7949605188196117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP1,Metalloproteinase inhibitor 1,1732,70,3.63 [2.18-6.05],7.274260462293078e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP2,Metalloproteinase inhibitor 2,1532,60,1.60 [0.78-3.28],0.2044396431195108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP3,Metalloproteinase inhibitor 3,1752,71,1.05 [0.91-1.22],0.4986575401997909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP4,Metalloproteinase inhibitor 4,1756,72,1.87 [1.19-2.94],0.0065086934497331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TINAGL1,Tubulointerstitial nephritis antigen-like,1747,72,3.02 [1.25-7.29],0.0136929058664592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TJAP1,Tight junction-associated protein 1,1749,73,1.01 [0.79-1.28],0.9470182225780958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TJP3,Tight junction protein ZO-3,1478,58,1.27 [0.77-2.08],0.3447781884897994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TK1,"Thymidine kinase, cytosolic",1504,59,1.11 [0.68-1.80],0.6739864251083507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR1,Toll-like receptor 1,1481,58,1.78 [0.77-4.10],0.1753138237465209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR2,Toll-like receptor 2,1504,59,1.64 [0.55-4.89],0.3741652444353871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR3,Toll-like receptor 3,1775,73,1.14 [0.83-1.57],0.4197939932858773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR4,Toll-like receptor 4,1481,58,1.23 [0.50-3.03],0.6531779872144529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,1489,57,0.85 [0.50-1.43],0.5331830194651961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED1,Transmembrane emp24 domain-containing protein 1,1504,59,1.03 [0.65-1.62],0.9028575442224016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED10,Transmembrane emp24 domain-containing protein 10,1485,57,0.67 [0.30-1.51],0.3340632519870408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED4,Transmembrane emp24 domain-containing protein 4,1485,57,0.69 [0.38-1.27],0.2388078392403292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED8,Protein TMED8,1522,57,0.88 [0.70-1.12],0.2967149027078837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM106A,Transmembrane protein 106A,1526,59,0.89 [0.62-1.27],0.5231507711372612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM132A,Transmembrane protein 132A,1483,60,0.77 [0.52-1.14],0.197313521041411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM25,Transmembrane protein 25,1532,59,1.15 [0.69-1.92],0.5795443807094453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMOD4,Tropomodulin-4,1473,59,0.88 [0.46-1.69],0.7084568638602653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11B,Transmembrane protease serine 11B,1478,58,1.40 [1.13-1.74],0.0025369029950866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11D,Transmembrane protease serine 11D,1511,57,1.62 [0.90-2.92],0.1056997117440029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS15,Enteropeptidase,1737,71,1.21 [0.96-1.52],0.1121494365307857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS5,Transmembrane protease serine 5,1720,71,2.31 [1.33-4.03],0.003039433183407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMSB10,Thymosin beta-10,1756,72,1.16 [0.88-1.52],0.2926615354892706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNC,Tenascin,1760,72,1.48 [0.99-2.22],0.055398123048398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNF,Tumor necrosis factor,1713,70,1.53 [1.09-2.16],0.0152221860245317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,1522,57,0.95 [0.59-1.53],0.8258967001084018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,1710,70,1.32 [0.74-2.37],0.3476844347365233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,1502,60,0.78 [0.53-1.15],0.2145818700257181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,1731,71,5.05 [3.17-8.06],9.671862456679438e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,1731,71,1.65 [1.34-2.04],3.033478825145118e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,1759,72,1.01 [0.66-1.55],0.9704812656735248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,1775,73,2.78 [1.95-3.97],1.7122117408241042e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,1745,71,2.64 [1.57-4.44],0.0002638149060847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,1749,73,3.50 [2.30-5.33],4.889400751976571e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,1747,71,2.24 [1.31-3.81],0.0030852673189751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,1710,70,1.09 [0.66-1.81],0.7233658133839915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,1747,71,3.93 [2.46-6.27],9.997002390044697e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,1502,60,2.30 [1.28-4.15],0.005452829755172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,1767,73,2.22 [1.51-3.27],4.575408609662371e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,1756,72,4.41 [2.69-7.23],4.235572998359274e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,1756,72,1.58 [1.24-2.03],0.0002691988390116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,1759,71,3.20 [1.71-6.00],0.00027775120036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,1772,73,2.75 [1.79-4.23],3.934064779246272e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,1731,71,1.71 [1.24-2.37],0.0012308312885916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,1759,71,1.51 [1.00-2.28],0.0520141277182942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,1731,71,2.41 [1.67-3.48],2.749586129279452e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,1775,73,0.70 [0.33-1.51],0.365243702033421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,1749,72,0.78 [0.55-1.10],0.1608262866991828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,1775,73,0.95 [0.49-1.86],0.8846224426676871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,1752,71,3.31 [1.70-6.41],0.0004039653775808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,1772,72,1.32 [0.67-2.60],0.4236682513441538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,1731,71,1.21 [0.84-1.73],0.3013262266940781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,1536,59,1.29 [0.68-2.44],0.4386318712052437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNIP1,TNFAIP3-interacting protein 1,1517,58,0.95 [0.72-1.26],0.7295654806000298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNN,Tenascin-N,1536,59,1.71 [0.98-2.98],0.0608679751144431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNNI3,"Troponin I, cardiac muscle",1715,70,1.03 [0.78-1.36],0.8174850972973262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNPO1,Transportin-1,1504,59,0.77 [0.37-1.57],0.4673172620030674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNR,Tenascin-R,1731,71,1.33 [0.82-2.16],0.2511587006563641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNXB,Tenascin-X,1756,72,0.61 [0.31-1.21],0.1600342721437621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,1532,60,0.85 [0.61-1.19],0.3517026440122794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP1,DNA topoisomerase 1,1522,57,1.00 [0.82-1.23],0.9833532896834932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP1MT,"DNA topoisomerase I, mitochondrial",1473,59,0.52 [0.26-1.04],0.0637720312604364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP2B,DNA topoisomerase 2-beta,1481,58,0.86 [0.63-1.17],0.3426977878299289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOR1AIP1,Torsin-1A-interacting protein 1,1483,60,1.06 [0.68-1.65],0.8059321538191867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53,Cellular tumor antigen p53,1685,69,1.01 [0.62-1.66],0.957355965425246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53BP1,TP53-binding protein 1,1481,58,0.93 [0.69-1.27],0.6632755230998713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53I3,Quinone oxidoreductase PIG3,1464,56,0.81 [0.51-1.30],0.3892018420129022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,1715,70,0.65 [0.26-1.61],0.3514559408537555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP73,Tumor protein p73,1489,57,0.77 [0.35-1.69],0.5219232510907292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPBGL,Trophoblast glycoprotein-like,1489,57,0.83 [0.41-1.67],0.6032314608542584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPD52L2,Tumor protein D54,1502,60,0.89 [0.71-1.11],0.293219464620488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPK1,Thiamin pyrophosphokinase 1,1532,60,0.33 [0.14-0.76],0.0089315807485369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPM3,Tropomyosin alpha-3 chain,1485,57,1.45 [0.88-2.41],0.1482867359939583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPMT,Thiopurine S-methyltransferase,1685,69,0.83 [0.60-1.15],0.2626242806205289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPP1,Tripeptidyl-peptidase 1,1732,71,1.62 [1.07-2.43],0.0212477990543722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPPP2,Tubulin polymerization-promoting protein family member 2,1504,59,1.02 [0.73-1.43],0.9244524688175352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPPP3,Tubulin polymerization-promoting protein family member 3,1687,70,1.15 [0.67-1.96],0.6148860319406445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPR,Nucleoprotein TPR,1485,57,1.00 [0.62-1.60],0.9923225224036312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPRKB,EKC/KEOPS complex subunit TPRKB,1473,59,1.11 [0.78-1.56],0.5658898792209881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSAB1,Tryptase alpha/beta-1,1769,73,1.18 [0.77-1.80],0.4509086152859178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSD1,Tryptase delta,1532,59,1.32 [0.65-2.69],0.4383995257805094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSG1,Tryptase gamma,1481,58,0.82 [0.30-2.22],0.690200916130089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPT1,Translationally-controlled tumor protein,1710,70,1.01 [0.74-1.39],0.938250625552028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF2,TNF receptor-associated factor 2,1749,72,1.26 [0.94-1.69],0.1170756321284258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",1481,58,1.50 [0.91-2.48],0.1129137923193712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,1485,57,0.96 [0.53-1.74],0.8860436364787718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,1504,59,0.94 [0.70-1.27],0.7082381378885941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREH,Trehalase,1536,59,1.35 [0.96-1.91],0.0830501014467478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREM2,Triggering receptor expressed on myeloid cells 2,1745,71,1.45 [1.05-2.01],0.0250453210564683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREML1,Trem-like transcript 1 protein,1537,60,1.00 [0.64-1.56],0.995037485398037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREML2,Trem-like transcript 2 protein,1756,72,1.58 [0.87-2.84],0.1303086750852458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,1767,73,1.14 [0.83-1.58],0.4099822803121155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,1749,72,1.01 [0.77-1.32],0.9622813739204844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM24,Transcription intermediary factor 1-alpha,1498,59,0.83 [0.55-1.23],0.3421751508553504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,1522,57,0.92 [0.72-1.17],0.4866721261467366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM26,Tripartite motif-containing protein 26,1473,59,0.78 [0.48-1.29],0.3361711128648274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM40,E3 ubiquitin ligase TRIM40,1489,57,0.67 [0.47-0.95],0.0258811712833596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM5,Tripartite motif-containing protein 5,1749,72,0.91 [0.72-1.15],0.4188837503056495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,1526,59,0.85 [0.64-1.11],0.2289970909792505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,1485,57,0.56 [0.30-1.06],0.0731394935079854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSC1,Hamartin,1481,58,0.77 [0.50-1.18],0.233537233861201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSC22D1,TSC22 domain family protein 1,1532,59,0.92 [0.64-1.33],0.6754507564125513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSHB,Thyrotropin subunit beta,1750,72,0.88 [0.67-1.15],0.3527055308138681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSLP,Thymic stromal lymphopoietin,1715,70,1.11 [0.80-1.54],0.5468263154540776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSNAX,Translin-associated protein X,1485,57,0.58 [0.29-1.13],0.1071065536878015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN1,Tetraspanin-1,1715,70,0.87 [0.57-1.33],0.513067457867513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN15,Tetraspanin-15,1485,57,0.89 [0.53-1.51],0.6760069237287307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN7,Tetraspanin-7,1478,58,0.78 [0.54-1.12],0.1767283285174736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN8,Tetraspanin-8,1522,57,1.13 [0.89-1.44],0.323501913997482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPYL1,Testis-specific Y-encoded-like protein 1,1481,58,0.89 [0.48-1.66],0.7259756372227426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TST,Thiosulfate sulfurtransferase,1686,70,0.88 [0.66-1.17],0.3877768590756197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTF2,Transcription termination factor 2,1489,57,0.83 [0.50-1.37],0.4568741390911192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTN,Titin,1485,57,0.99 [0.69-1.42],0.956726770133501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTR,Transthyretin,1525,58,1.55 [0.63-3.80],0.3371513867172454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TUBB3,Tubulin beta-3 chain,1478,58,0.61 [0.24-1.58],0.3108580166902675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TWF2,Twinfilin-2,1536,59,0.86 [0.65-1.15],0.3125853396778495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXK,Tyrosine-protein kinase TXK,1504,59,1.02 [0.74-1.39],0.913308370237914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXLNA,Alpha-taxilin,1731,71,1.05 [0.83-1.33],0.6673041103145425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXN,Thioredoxin,1505,56,0.76 [0.41-1.41],0.3815890759219008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC15,Thioredoxin domain-containing protein 15,1749,73,2.52 [1.30-4.87],0.0059877732273805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC5,Thioredoxin domain-containing protein 5,1759,71,1.14 [0.85-1.52],0.3903324705919297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC9,Thioredoxin domain-containing protein 9,1517,58,0.79 [0.50-1.27],0.3335963827375029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNL1,Thioredoxin-like protein 1,1477,58,0.93 [0.71-1.22],0.5840725665018485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",1756,72,0.97 [0.64-1.47],0.8987488300701383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYMP,Thymidine phosphorylase,1737,71,0.97 [0.72-1.32],0.8608351431337774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,1750,72,0.89 [0.43-1.86],0.7662330025704525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",1481,58,1.82 [1.19-2.79],0.0053857209992496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBAC1,Ubiquitin-associated domain-containing protein 1,1737,71,1.20 [0.65-2.22],0.558211420450916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,1526,59,0.51 [0.20-1.31],0.1604271259316035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,1532,60,0.97 [0.65-1.44],0.8792046520017105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,1481,58,0.57 [0.33-0.97],0.0390139859062669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBQLN3,Ubiquilin-3,1485,57,1.27 [0.92-1.77],0.1457001172100036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBXN1,UBX domain-containing protein 1,1502,60,0.95 [0.68-1.34],0.7731751632357954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,1522,57,0.95 [0.79-1.13],0.526753578821929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UGDH,UDP-glucose 6-dehydrogenase,1485,57,1.00 [0.79-1.26],0.9755769720159292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,1485,57,0.50 [0.19-1.35],0.1726096580818104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ULBP2,UL16-binding protein 2,1731,71,3.88 [2.48-6.07],3.1391261476385827e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UMOD,Uromodulin,1771,72,0.51 [0.38-0.69],1.3554145527924153e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNC5D,Netrin receptor UNC5D,1481,58,0.77 [0.28-2.10],0.6060540233982921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNC79,Protein unc-79 homolog,1473,59,1.01 [0.66-1.55],0.9633218593684842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNG,Uracil-DNA glycosylase,1526,59,0.69 [0.33-1.46],0.3313538499779903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPB1,Beta-ureidopropionase,1532,60,1.12 [0.90-1.40],0.321172727030253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPK3A,Uroplakin-3a,1478,58,0.79 [0.56-1.11],0.1811651877154984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPK3BL1,Uroplakin-3b-like protein 1,1503,59,1.02 [0.67-1.55],0.9122757293440432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UROD,Uroporphyrinogen decarboxylase,1502,60,0.85 [0.58-1.22],0.3709053756506921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UROS,Uroporphyrinogen-III synthase,1489,57,1.07 [0.73-1.56],0.7432635084034264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USO1,General vesicular transport factor p115,1737,71,0.98 [0.77-1.24],0.8519928901681304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,1526,59,0.95 [0.68-1.34],0.7835760202503775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,1517,58,1.57 [0.95-2.59],0.0767927178612973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,1485,57,0.80 [0.56-1.13],0.2053648113893045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,1715,70,1.03 [0.82-1.28],0.810076535775981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UXS1,UDP-glucuronic acid decarboxylase 1,1685,69,1.43 [0.96-2.14],0.0764269022067728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAMP5,Vesicle-associated membrane protein 5,1715,70,1.10 [0.78-1.54],0.5810759997347759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAMP8,Vesicle-associated membrane protein 8,1481,58,0.87 [0.66-1.15],0.3338927329148238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,1749,72,1.01 [0.79-1.29],0.9484638988298004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASN,Vasorin,1729,71,2.25 [1.09-4.64],0.0275839432955015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASP,Vasodilator-stimulated phosphoprotein,1537,60,0.72 [0.52-1.01],0.0554201778469986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,1737,71,0.56 [0.19-1.67],0.2988585422234677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAV3,Guanine nucleotide exchange factor VAV3,1478,58,0.91 [0.71-1.16],0.433077684850941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAM1,Vascular cell adhesion protein 1,1760,72,3.51 [1.90-6.48],5.9535146703081695e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAN,Versican core protein,1759,71,1.60 [0.81-3.18],0.1780416222846463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCPKMT,Protein-lysine methyltransferase METTL21D,1473,59,1.00 [0.74-1.36],0.9909766936097876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFA,Vascular endothelial growth factor A,1769,72,1.50 [1.08-2.10],0.0161388395916879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFB,Vascular endothelial growth factor B,1481,58,2.28 [1.05-4.96],0.0370739071588472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFC,Vascular endothelial growth factor C,1749,73,1.48 [1.04-2.11],0.0298671338483655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFD,Vascular endothelial growth factor D,1770,72,2.51 [1.53-4.12],0.000253158499255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VGF,Neurosecretory protein VGF,1532,59,1.77 [0.88-3.53],0.1077308373661506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIM,Vimentin,1715,70,0.88 [0.75-1.04],0.1256599962355641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,1483,60,0.48 [0.15-1.51],0.2066039906712866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIT,Vitrin,1532,60,1.09 [0.58-2.05],0.7974548101696807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VMO1,Vitelline membrane outer layer protein 1 homolog,1737,71,1.74 [1.24-2.44],0.0014573149669915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VNN1,Pantetheinase,1537,60,1.36 [0.97-1.93],0.0765976868853215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VNN2,Vascular non-inflammatory molecule 2,1737,71,1.14 [0.72-1.80],0.5779517604569173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,1504,59,1.03 [0.71-1.48],0.8947105513330222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS37A,Vacuolar protein sorting-associated protein 37A,1737,71,1.06 [0.82-1.38],0.6362927270601556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS4B,Vacuolar protein sorting-associated protein 4B,1526,59,0.88 [0.67-1.14],0.3281155471106037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,1737,71,0.97 [0.75-1.26],0.8423372236814592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,1526,59,1.15 [0.71-1.86],0.5683319189147205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,1485,57,1.47 [0.83-2.60],0.1873164713247224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,1526,59,2.07 [1.54-2.78],1.35400238346999e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,1753,71,3.40 [2.30-5.01],7.105476292288825e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,1746,72,1.05 [0.76-1.44],0.775878879305567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSNL1,Visinin-like protein 1,1517,58,0.55 [0.29-1.05],0.0684962197249136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM1,V-set and transmembrane domain-containing protein 1,1687,70,1.30 [0.86-1.96],0.2174985713503666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,1504,59,0.72 [0.37-1.39],0.3257969528087009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,1715,70,1.13 [0.79-1.63],0.5102156572471006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,1759,71,0.78 [0.57-1.05],0.1022600933068458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,1685,69,2.01 [1.07-3.76],0.0289631192073106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,1502,60,0.87 [0.57-1.34],0.5393620871899227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWA1,von Willebrand factor A domain-containing protein 1,1764,73,1.62 [1.02-2.56],0.039094912376507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWA5A,von Willebrand factor A domain-containing protein 5A,1473,59,0.94 [0.68-1.31],0.7239649548148388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2,Brorin,1719,71,2.62 [1.64-4.19],5.646969479270575e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,1532,59,1.39 [1.01-1.92],0.0452459006512126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWF,von Willebrand factor,1773,72,1.22 [0.91-1.62],0.1794574211409342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",1756,72,0.88 [0.51-1.50],0.6369652291934438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WAS,Wiskott-Aldrich syndrome protein,1710,70,0.90 [0.64-1.27],0.5394929720176797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,1715,70,0.96 [0.77-1.19],0.7046590170465883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,1687,70,0.87 [0.70-1.09],0.2311186912503137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASHC3,WASH complex subunit 3,1517,58,0.95 [0.69-1.31],0.7549929509286446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASL,Neural Wiskott-Aldrich syndrome protein,1481,58,1.14 [0.81-1.61],0.4377583512802929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WDR46,WD repeat-containing protein 46,1526,59,1.24 [0.70-2.18],0.4604760627530383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC1,WAP four-disulfide core domain protein 1,1497,59,1.15 [0.81-1.62],0.4403082548901025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC12,WAP four-disulfide core domain protein 12,1763,72,1.19 [0.87-1.62],0.2770586637504762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC2,WAP four-disulfide core domain protein 2,1665,67,2.79 [2.04-3.82],1.1445017143877115e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",1724,71,0.89 [0.53-1.49],0.6565132140693097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",1747,71,2.33 [1.32-4.10],0.0033158918496735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WIF1,Wnt inhibitory factor 1,1767,73,0.92 [0.52-1.63],0.7748620917051061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WNT9A,Protein Wnt-9a,1710,70,3.08 [1.88-5.03],7.574008942763104e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,1731,71,0.94 [0.63-1.39],0.7405375853850281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XCL1,Lymphotactin,1767,73,1.32 [0.99-1.76],0.0562669374763121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XG,Glycoprotein Xg,1761,72,2.59 [1.63-4.11],5.415031274855979e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XIAP,E3 ubiquitin-protein ligase XIAP,1481,58,0.93 [0.61-1.41],0.7316592645163995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XPNPEP2,Xaa-Pro aminopeptidase 2,1749,73,0.94 [0.77-1.15],0.5599437139039188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XRCC4,DNA repair protein XRCC4,1687,70,0.97 [0.54-1.74],0.9154081570689628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YAP1,Transcriptional coactivator YAP1,1517,58,3.26 [1.75-6.10],0.00020647343382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",1522,57,0.91 [0.77-1.08],0.2648525564524295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YES1,Tyrosine-protein kinase Yes,1737,71,1.03 [0.86-1.23],0.7508763576220205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YJU2,Splicing factor YJU2,1526,59,0.69 [0.32-1.49],0.3390494372934045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YOD1,Ubiquitin thioesterase OTU1,1485,57,0.86 [0.57-1.30],0.4757986648188663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YTHDF3,YTH domain-containing family protein 3,1710,70,0.97 [0.76-1.23],0.7847374134364704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YWHAQ,14-3-3 protein theta,1502,60,0.83 [0.60-1.15],0.2628469791736113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YY1,Transcriptional repressor protein YY1,1481,58,1.08 [0.43-2.69],0.8681132408360939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBP1,Z-DNA-binding protein 1,1481,58,1.25 [0.72-2.16],0.4361018830076186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,1685,69,1.09 [0.83-1.44],0.5348471546546953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,1715,70,1.09 [0.69-1.73],0.7119303453023113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,1485,57,0.85 [0.54-1.34],0.4893459257880348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZFYVE19,Abscission/NoCut checkpoint regulator,1522,57,0.83 [0.63-1.10],0.1992981643384694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZHX2,Zinc fingers and homeoboxes protein 2,1517,58,1.38 [0.83-2.30],0.2194041465935848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF174,Zinc finger protein 174,1481,58,0.60 [0.23-1.53],0.2808772539681539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF75D,Zinc finger protein 75D,1504,59,1.10 [0.76-1.60],0.6190051275528863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF830,Zinc finger protein 830,1526,59,0.92 [0.65-1.31],0.6533636081956081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNRD2,Protein ZNRD2,1522,57,0.99 [0.70-1.38],0.9320602887508068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,1526,59,0.86 [0.52-1.43],0.5604460276611645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZP3,Zona pellucida sperm-binding protein 3,1483,60,0.98 [0.89-1.08],0.6959734653623662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZP4,Zona pellucida sperm-binding protein 4,1473,59,0.92 [0.39-2.18],0.8565738077520504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZPR1,Zinc finger protein ZPR1,1478,58,1.11 [0.88-1.39],0.386094448237143
